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Abstract 
Obesity is the single biggest risk factor for type 2 diabetes mellitus (T2DM). Weight 
gain chronically induces endoplasmic reticulum (ER) stress in adipocytes, which 
activates the unfolded protein response (UPR) and leads to inflammation and insulin 
resistance. Therefore, investigating ways to combat inflammation through ER stress 
may reduce obesity mediated T2DM. One candidate to improve metabolic health 
may be cruciferous vegetables, such as broccoli, known to reduce inflammation and 
the risk of various cancers. Mathematical modelling may be a useful tool in order to 
identify how time and other factors may impact the UPR, however little experimental 
time series data exist to support the parameterisation and validation process. The 
aim was therefore to determine whether perturbation of human adipocytes with 
tunicamycin and broccoli extract can lead to significant changes in the UPR over time, 
deriving a novel mathematical model to characterise the relevant components of the 
UPR. Chub-S7 pre-adipocyte cells were grown, differentiated and treated with 
broccoli extract, tunicamycin, or a combination of the two (17 time points over 72 
hours). Western blotting and qRT-PCR were used to assess ER stress markers, whilst 
the influence of broccoli on other cellular functions was analysed through 
appropriate assays. A qualitatively realistic mathematical model of part of the UPR 
was developed using nonlinear ordinary differential equations (ODEs), utilising 
experimental time series data for parameterisation and validation. The time series 
data identified novel expression profiles of proteins involved in the UPR, and 
highlighted that broccoli extract could significantly reduce the impact of tunicamycin 
on ER stress over time (p<0.05), as well as reactive oxygen species (ROS) (p<0.05) and 
mitochondrial dysfunction (p<0.05). These findings identify that broccoli extract 
appears to reduce the impact of tunicamycin on human adipocytes, and highlight the 
importance of modelling changes within the UPR to understand its response over 
time.  
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Thesis Outline 
This thesis explores the UPR through systems biology and laboratory techniques with 
an aim to develop a mathematical model of the process and to investigate factors 
that stimulate and protect against ER stress. This is important as the UPR is activated 
when cells are under stress, which occurs in many diseases and is one of the 
prominent links between obesity and T2DM. As such, developing a mathematical 
model of the UPR in order to better understand its pathway dynamics, as well as 
investigating dietary factors that may protect against its activation, may provide an 
insight as to how the risk of T2DM may be reduced in obese patients. Previous 
researchers have developed mathematical models of the UPR, however these often 
lacked biological experimental data in the parameterisation and validation process. 
Dietary factors such as broccoli have not been well studied in their potential role of 
preventing UPR activation, and this thesis therefore provides a novel insight into how 
a broccoli extract may impact on the link between obesity and T2DM.  
As such, the hypothesis and research aims for this thesis are as follows:  
Broccoli, in the form of freeze dried broccoli powder, protects adipocytes against ER 
stress induced by tunicamycin. Time series data from this research will aid in the 
construction of a mathematical model characterising the unfolded protein response. 
Research Aims: 
1. To create a mathematical model of a pathway in the unfolded protein 
response using experimental time series data. 
2. To study ER stress in more detail by analysing how the expression of key ER 
stress proteins varies over time following treatment with tunicamycin. 
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3. To investigate the potential protective effects of broccoli against ER stress in 
adipocytes. 
4. To examine the effects of broccoli on other mechanisms that also contribute 
to metabolic disease, such as ROS and mitochondrial dysfunction. 
A brief overview of how these aims can be met is described below: 
Chapter 2 summarises relevant background information on obesity, adipose tissue 
and related metabolic diseases, as well as mathematical modelling of the ER stress 
pathway to understand its dynamics. The first half of this chapter leads the reader 
from the consequences of obesity and type 2 diabetes mellitus to endoplasmic 
reticulum stress and other cellular mechanisms which may be altered by the addition 
of a broccoli extract. The focus on the second half of this chapter is primarily on the 
process of creating a mathematical model of a biological response, culminating in a 
review of previous models of the unfolded protein response.   
Chapter 3 highlights the importance of continuously considering complexity when 
developing a model of a biological pathway and outlines an initial model of the 
unfolded protein response. This chapter utilised standard laboratory techniques 
including cell culture and Western blotting to gather data that was used to 
parameterise the initial model. This provided important information as to which time 
points may be relevant to study in order to gain more information about the 
expression patterns of proteins involved in the unfolded protein response. 
Chapter 4 expands on the model developed in Chapter 3, extending the model to 
include further components of the unfolded protein response. Further to this, more 
biological insight was gained into the expression profiles of proteins involved in the 
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unfolded protein response through carrying out a comprehensive time series 
analysis, studying 17 time points with the Western blot technique. These data were 
also used to parameterise and validate the developed mathematical model.  
Chapter 5 investigates whether a freeze dried broccoli extract impacts the unfolded 
protein response that has been chemically induced in adipocytes. Studying time 
series data provided information on which specific components of the unfolded 
protein response may be most affected by the addition of a broccoli extract and how 
this may impact endoplasmic reticulum stress experienced by an adipocyte. 
The final results chapter, Chapter 6, studies how a broccoli extract may impact other 
cellular mechanisms related to ER stress that are also associated with the 
development of insulin resistance, such as mitochondrial dysfunction and reactive 
oxygen species. Further to this, transcriptomics analysis revealed a potential 
mechanism of action for the broccoli extract. 
Conclusions of this body of work, including limitations and future work, are discussed 
in Chapter 7 which provides a detailed overview of the work and how it may impact 
in the real world.  
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1.1 Obesity, Adipose Tissue and Metabolic Disease 
1.1.1 Adipose Tissue Heterogeneity 
Obesity is described by the World Health Organisation (WHO) as an abnormal or 
excessive fat accumulation that may impair health (World Health Organisation 2017). 
There are two broad categories that fat, or adipose tissue, in mammals can be divided 
into: brown adipose tissue (BAT) and white adipose tissue (WAT) (Figure 1.1.1.1). 
These two types of adipose tissue have different functions: BAT is specialised in the 
dissipation of energy through the production of heat, whilst WAT stores excess 
energy as triglycerides (Saely, Geiger et al. 2012). BAT plays an important role in body 
thermogenesis and is uniquely responsible for classical non-shivering thermogenesis, 
a form of heat production activated when an organism is in need of extra heat, e.g. 
postnatally, during entry into a febrile state, and during arousal from hibernation 
(Cannon and Nedergaard 2004). In response to certain conditions, such as chronic 
cold exposure and exercise, adipocyte ‘browning’ can occur in which brown-like 
adipocytes appear in white adipose depots. These cells are known as ‘beige’, or ‘brite’ 
adipocytes and their production is associated with increased energy expenditure, 
decreased body weight and increased insulin sensitivity (Wu, Boström et al. 2012, 
Kajimura, Spiegelman et al. 2015, Sidossis and Kajimura 2015). 
 There is a high proportion of metabolically active BAT in new-borns, however this 
proportion decreases with age and despite human adults having some metabolically 
active BAT, WAT comprises the vast majority of human adipose tissue. WAT 
expansion occurs during obesity, which is the main risk factor for several metabolic 
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disorders and will therefore be considered in more detail in this thesis. The 
distribution of BAT and WAT depots in humans is demonstrated in Figure 1.1.1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.1.1 Distribution of adipose tissue: Mammalian adipose tissue is distributed 
throughout the body in distinct depots. White adipose tissue depots store excess energy as 
triglycerides, while brown adipose tissue depots dissipate energy through the production of 
heat. Figure from (Pacheco, Garcia et al. 2018). 
 
Within the body there are distinct regional depots of WAT which differ in structural 
organisation, cellular size, and biological function, and it is the distribution of fat 
between these depots that can influence the risk of different metabolic disorders 
(Bjørndal, Burri et al. 2011). The two main WAT depots are subcutaneous adipose 
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tissue (SAT) and visceral adipose tissue (VAT). SAT, which makes up about 85% of all 
body fat, is found just beneath the skin and functions as both an energy reserve and 
padding for the body (Frayn and Karpe 2014). VAT is stored deeper within the 
abdominal cavity and surrounds a number of internal organs, including the liver, 
pancreas and intestines. The distribution of fat throughout the different depots 
seems to be more important than the total adipose tissue mass in contributing to the 
risk of developing obesity-associated diseases (Bjørndal, Burri et al. 2011). VAT 
accumulation has a much higher association with an adverse metabolic, dyslipidemic 
and atherogenic obesity phenotype, whilst SAT accumulation is more benign 
(Neeland, Ayers et al. 2013).  
This variation in contribution to obesity-associated diseases by fat depots outlines 
one of the limitations of the body mass index (BMI), the most commonly used 
measure for identifying obesity, which is calculated based on the weight and height 
of a subject. Although it is intended to estimate body fat percentage, it does not 
differentiate between muscle mass and fat mass, nor between SAT and VAT. BMI is 
calculated by dividing a subject’s weight (W, kg) by the square of their height (h, m2) 
using the following equation (Nuttall 2015): 
𝐵𝑀𝐼 =
𝑊
ℎ2
  (𝑘𝑔𝑚−2) 
This formula was developed nearly 200 years ago and despite its limitations is still 
widely used for the preliminary diagnosis of obesity due to its simplicity, safety and 
minimal cost (De Lorenzo, Soldati et al. 2016). There are six classifications defined by 
BMI value, which range from underweight (<18.5kg/m2) to class III obesity (≥ 
40.0kg/m2) (Table 1.1.1.2) (World Health Organisation 2017) . However, there is 
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much debate about where the limits to each classification should lie, and other 
measures such as waist circumference are often used to complement BMI estimates 
(World Health Organisation 2017). 
 
Table 1.1.1.2 BMI Classifications: Body mass index (BMI) measurements, calculated by 
dividing a subject’s weight by the square of their height, and their corresponding weight 
classification (World Health Organisation 2017).  
 
 
1.1.2 Risk Factors for Obesity 
There are many factors that can contribute to the risk of developing obesity, 
including calorie intake, physical exercise, medical conditions, prescription drugs, and 
socio-demographic factors (Rosiek, Maciejewska et al. 2015). One of the major risk 
factors for obesity is an unhealthy diet which is described by WHO not just as an 
individual problem, but as a societal problem (World Health Organisation 2017). 
Despite the advice of WHO to eat more fruit, vegetables, legumes, nuts and grains 
and to cut down on salt, sugar and fats, people often ignore this advice or follow diets 
that are not necessarily supported by scientific evidence. Although this has led to an 
increase in obesity in the general population, there are also socio-demographic 
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factors that affect the risk of developing obesity. For instance, women have a higher 
adiposity relative to men, yet men are more likely to develop metabolic disorders. 
This is attributed to men having more VAT distributed in their central region, leading 
to an ‘apple-shaped’ body which carries greater risk. Women, however, are 
characterised by less VAT and more SAT, especially in their lower body, creating a 
‘pear-shaped’ body (White and Tchoukalova 2014). This is true until the menopause 
where VAT increases from between 5-8% of the total body fat to 15-20% (Karvonen-
Gutierrez and Kim 2016). This varied fat distribution between genders explains the 
difference in the risk of developing obesity-related disorders between the two 
groups. The redistribution of adipose depots in postmenopausal women, resulting in 
increased VAT, has also been attributed to increased risk of obesity related diseases 
(Atapattu 2015). 
Ethnicity also contributes to the risk of obesity, with stark differences between ethnic 
groups observed from childhood (Falconer, Park et al. 2014). In the UK, Black African, 
Black Caribbean and South Asian children are more likely to be overweight or obese 
than White children (Zilanawala, Davis-Kean et al. 2015). Although socioeconomic, 
cultural and family routine factors, as well as maternal BMI, may contribute to this 
disparity, after adjustment for these factors Black Caribbean children were found to 
have a higher chance of developing obesity and Pakistani children were less likely to 
develop obesity in the UK, as demonstrated in Figure 1.1.2 (Zilanawala, Davis-Kean 
et al. 2015). The reasons behind these findings are unknown, however one possible 
explanation is altered WAT function in different ethnicities, which has been 
extensively documented (Araneta and Barrett-Connor 2005, Rahman, Temple et al. 
2009, Staiano, Broyles et al. 2013). 
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Figure 1.1.2 Contribution of Ethnicity to Risk of Obesity: Ethnicity can contribute to obesity 
risk. In the UK, Black Caribbean children were more likely to develop obesity than Caucasians, 
whilst Pakistani children were less likely to develop the condition (Zilanawala, Davis-Kean et 
al. 2015). Figure adapted from (My Healthy Waist 2018). 
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Black 
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1.1.3 Adipose Tissue Function 
Obese patients have increased amounts of adipose tissue, which, despite initially 
being thought of as metabolically inert, is now recognised as a highly active metabolic 
and endocrine organ that secretes a variety of adipokines to fulfil its function 
(Goossens 2008). In conditions of obesity, the adipose tissue is remodelled through 
changes to the number and/or size of adipocytes which creates a dysfunctional form 
of adipose tissue (Choe, Huh et al. 2016). This dysfunctional adipose tissue, which 
has larger adipocytes, has been shown to favour expressing pro-inflammatory factors 
compared to smaller, metabolically normal adipocytes (Skurk, Alberti-Huber et al. 
2007). This contributes to the chronic low grade inflammation that is present in 
obesity and is involved in the pathogenesis of many chronic diseases, including 
T2DM, for which obesity is the single biggest risk factor (Ye 2014, diabetes.co.uk 
2017). There are many factors that contribute to this chronic inflammation, with 
glucose, lipids and inflammatory insults, such as gut-derived factors, all exacerbating 
the problem (Collier, Dossett et al. 2008, van Diepen, Berbée et al. 2013, 
Schedlowski, Engler et al. 2014, Ye 2014). This can lead to insulin resistance, a state 
where cells become less sensitive to insulin, causing the body to increase its 
production. Over time, this can develop into T2DM due to the body’s inability to 
produce enough insulin to induce the required response from cells. 
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1.1.4 Diagnosis of Type 2 Diabetes Mellitus 
Diabetes mellitus is a condition defined by chronic hyperglycaemia (high circulating 
glucose levels) caused by insufficient insulin signalling. Diabetes mellitus can be 
separated into three main groups depending on the specific mechanism causing the 
disease: (i) type 1 diabetes mellitus, resulting from the inability of the pancreas to 
produce enough insulin; (ii) type 2 diabetes mellitus, whereby cells fail to respond 
sufficiently to insulin, often followed by a lack of insulin production; (iii) gestational 
diabetes mellitus, occurring when pregnant women develop high blood sugar levels. 
As of 2016, almost 3.6 million people in the UK have been diagnosed with diabetes, 
with a further 1 million people suspected to have undiagnosed T2DM (Diabetes UK 
2016). It is a major public health problem that has been described as a global 
epidemic, with the prevalence of T2DM expected to double within the next 20 years 
(Marín-Peñalver, Martín-Timón et al. 2016). 
In order to diagnose type 2 diabetes mellitus (T2DM), plasma glucose levels are 
measured to confirm chronic hyperglycaemia. Following WHO guidelines, patients 
are diagnosed as diabetic if their fasted plasma glucose levels are above 7.0 mmol/L 
(126 mg/dl) or if 2 hours post a 75g oral glucose tolerance test (OGTT) their plasma 
glucose is above 11.1 mmol/L (200 mg/dl) (World Health Organisation and 
International Diabetes Federation 2006). Normal blood glucose levels are defined as 
a fasting plasma glucose level of <6.1 mmol/L (<110 mg/dl) and a 2hr value of < 7.8 
mmol/L (<140 mg/dl) in the OGTT. Borderline T2DM (neither T2DM nor normal blood 
glucose levels) is defined as falling between the normal and diabetic values, and is 
also known as an impaired fasting glucose state (Seino, Nanjo et al. 2010) (Table 
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1.1.4). Haemoglobin A1c (HbA1c) levels are also used to diagnose and monitor diabetic 
status. HbA1c is produced in the blood in response to haemoglobin being exposed to 
plasma glucose, and it is seen as the gold standard for assessing glycaemic control in 
people who are already diagnosed. This is due to it reflecting the average plasma 
glucose level over the previous 2-3 months in a single measurement, as well as the 
fact that it can be performed at any time of day and does not require any special 
preparation such as fasting (World Health Organisation and International Diabetes 
Federation 2006).  HbA1c levels of 6.5% or over indicate diabetes, levels of 6.0% - 
6.4% suggest impaired glucose regulation, or prediabetes, whilst levels lower than 
6.0% are considered non-diabetic according to WHO guidelines (World Health 
Organisation 2011). 
 
 
Table 1.1.4 Plasma Glucose Levels and their Corresponding Diabetes Status: In order to 
diagnose Type 2 Diabetes Mellitus, plasma glucose levels are measured following fasting, as 
well as 2 hours post an oral glucose tolerance test. Patients are diagnosed using the glucose 
levels and diabetic categories above (World Health Organisation 2011).  
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1.1.5 Co-Morbidities of T2DM 
There are many comorbidities associated with T2DM. The biggest comorbidity of 
T2DM is obesity, which not only increases the risk of developing T2DM, but also 
increases the risk of cardiovascular comorbidities, limits patients’ ability to engage in 
physical activity and increases insulin resistance (American Association of Clinical 
Endocrinologists). T2DM is also linked to dyslipidaemia, whereby the body 
experiences decreased levels of high density lipoprotein (HDL) and increased levels 
of triglycerides, along with postprandial lipemia (a high concentration of emulsified 
fat in the blood) (Goldberg 2001).  This can lead to accelerated macrovascular disease 
in T2DM patients, and may ultimately lead to heart attack, stroke and other 
conditions involving the heart and circulation (Tseng, Tseng et al. 2012). These 
conditions can also be exacerbated by hypertension, of which at least 67% of T2DM 
sufferers have, or are being treated for (American Association of Clinical 
Endocrinologists). Other comorbidities of T2DM include retinopathy, chronic kidney 
disease, cardiovascular disease, and non-alcoholic fatty liver disease (American 
Association of Clinical Endocrinologists , Cusi 2016). It is largely due to these 
comorbidities that the cost of treating diabetes and its complications is so high, at 
nearly £14 billion per year, or 10-15% of the annual NHS budget (diabetes.co.uk 
2017). 
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1.1.6 Treatment of T2DM 
It is important to treat T2DM effectively, and subjects must avoid states of 
hyperglycaemia (high blood sugar levels) and hypoglycaemia (low blood sugar levels) 
in order to reduce pathophysiology and severe side effects of such states. Adequate 
control of blood sugar levels reduces the risk and severity of the associated 
comorbidities and can prevent the accumulation of ketones in the blood, which can 
induce diabetic coma if left untreated. There are several ways of controlling T2DM, 
ranging from diet to surgery. Lifestyle changes are recommended for all sufferers of 
T2DM, as losing weight can help to improve insulin sensitivity and make diabetes 
easier to manage (diabetes.co.uk 2017). Altering dietary intake and physical exercise 
are usually the first steps in the treatment of T2DM as they are the two main 
determinants of weight (Marín-Peñalver, Martín-Timón et al. 2016). The dietary 
aspects that are recommended not only contribute to the control of blood glucose 
levels, but can also contribute to improved blood pressure, lipid profile, sleep quality, 
depression and quality of life related to health (Marín-Peñalver, Martín-Timón et al. 
2016). It has been proposed that patients suffering from T2DM should have a 
reduced calorie intake of 500-1000kcal below their calorie needs in order to reduce 
weight and improve their insulin sensitivity (Gargallo Fernández Manuel, Breton 
Lesmes et al. 2012). It is important for T2DM patients to consider the source of their 
calorie intake as well as the calorie count itself. For instance, although it is the total 
amount of carbohydrate consumed that has the strongest influence on glycaemic 
response,  it is preferable that the intake of carbohydrates comes from vegetables, 
fruits, whole grains, legumes and dairy products as opposed to sources that contain 
added fats, sugars or sodium (Gray 2000 [Updated 2015]). It is also recommended 
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for people with diabetes to consume at least the amount of fibre and whole grains 
that is recommended for the general public. A high fibre diet promotes early satiety, 
may be less caloric, lower in fat and added sugars, and may therefore help to combat 
obesity and prevent the risk of heart disease and colon cancer (Gray 2000 [Updated 
2015]). 
As well as lifestyle changes, many pharmacological agents are available to aid the 
control of T2DM (Olokoba, Obateru et al. 2012). The most common drug that is 
prescribed is Metformin, which reduces hepatic glucose production and absorption 
of glucose from the gastrointestinal tract, as well as increasing insulin uptake in the 
periphery, thereby improving insulin sensitivity (Tran, Zielinski et al. 2015). 
Metformin’s high efficacy, low hypoglycaemia risk, and potential for weight loss 
make it a popular drug choice for both patients and doctors. Other drugs are available 
that treat T2DM in a variety of ways, including slowing carbohydrate digestion, 
assisting insulin in post-prandial glucose levels, and preventing the production of 
glucose in the liver (Tran, Zielinski et al. 2015). Although initially T2DM may be able 
to be treated with lifestyle choices and oral medication, T2DM gets progressively 
worse and thus insulin therapy is often introduced. Patients and physicians can be 
reluctant to start insulin due to the fact that it must be injected, it can induce 
hypoglycaemia if not correctly administered, and can induce weight gain (Swinnen, 
Hoekstra et al. 2009).  
A final method of inducing weight loss and improving T2DM is bariatric surgery. This 
can involve one of several procedures that either reduces the size of the stomach 
(gastric band or sleeve gastrectomy) or bypasses a large portion of the stomach 
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(gastric bypass). In a study by Schauer et al., a group of T2DM patients that 
underwent surgery had 22-24% weight reduction, compared to ~4% in those who 
underwent intensive medical therapy (Schauer, Bhatt et al. 2014). After a three year 
follow-up, the surgical group had significantly more rapid, larger and more sustained 
reductions in HbA1c values and fasting plasma glucose than the medical-therapy 
group (Schauer, Bhatt et al. 2014). Similar results were found in another study, albeit 
one with a small number of subjects: 50% of the 38 participants who underwent 
bariatric surgery sustained a T2DM remission at five years, compared with none of 
the 15 participants who underwent medical therapy (Mingrone, Panunzi et al. 2015). 
Whilst these results seem positive and show that bariatric surgery may represent a 
useful way to induce T2DM remission, further research is needed to determine the 
long term benefits of using bariatric surgery as treatment for T2DM. It is also 
important to balance the positive effects with an understanding of the cost, 
availability and risks of surgery, as well as the fact that diabetes remission is not 
guaranteed. 
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1.1.7 Mechanisms Contributing to Metabolic Diseases  
There are many mechanisms that can contribute to the risk of developing metabolic 
diseases such as T2DM. Oxidative stress has been implicated as a major contributory 
factor to the pathophysiology of a number of diseases and conditions including 
cancer, sepsis and metabolic diseases (Stepien, Heaton et al. 2017). It occurs when 
cells can no longer cope with the number of Reactive Oxygen Species (ROS) that are 
produced. Oxidation of molecules is essential for life, and during metabolism in 
eukaryotes, oxidation results in the formation of ROS. Cells naturally produce 
antioxidants to counterbalance this ROS production, and to protect the cell from ROS 
damage. However, if ROS production increases to a point where antioxidants can no 
longer protect against them, the highly reactive ROS molecules can cause damage 
and stress within the cell. This process can lead to the development of insulin 
resistance, dyslipidemia, β-cell dysfunction, impaired glucose tolerance and 
ultimately T2DM (Tangvarasittichai 2015). 
Mitochondrial dysfunction is another mechanism that can increase the risk of 
developing T2DM. It arises either from an inadequate number of mitochondria, an 
inability to provide necessary substrates to mitochondria, or a dysfunction in their 
electron transport and adenosine triphosphate (ATP)-synthesis machinery (Nicolson 
2014). In these situations, the oxidation of fuels used to create energy is reduced and, 
as such, lipid accumulation occurs which can contribute to the inhibition of insulin 
signalling. Additionally, decreases in substrate oxidation can lead to electron leakage 
through the electron transport chain (ETC) and the subsequent formation of 
superoxide, a form of ROS. This can lead to mitophagy (removal of damaged 
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mitochondria and prevention of cell death) or, under high stress levels, apoptosis 
(Montgomery and Turner 2015). Through these mechanisms, mitochondrial 
dysfunction can contribute to the development of metabolic diseases such as T2DM. 
Studies have indicated that adipose tissue hypoxia can also contribute to insulin 
resistance (Ye 2011) (Regazzetti, Peraldi et al. 2009). Hypoxia can occur in the adipose 
tissue of obese individuals as it expands. Despite the substantial increase in adipose 
tissue mass, the proportion of cardiac output and the extent of the blood flow to the 
tissue are not increased, resulting in adipocyte clusters that are distant from the 
vasculature (Trayhurn 2013). This can initiate the inflammatory process and can also 
contribute to insulin resistance in these cells. 
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1.1.8 Endoplasmic Reticulum Stress 
One cellular mechanism that forms a link between obesity and T2DM is endoplasmic 
reticulum stress. The endoplasmic reticulum (ER) is a dynamic organelle found within 
most eukaryotic cells, which has essential functions responsible for cellular 
homeostasis, development, and stress responsiveness. These functions include (i) 
synthesis, folding, modification, and transport of proteins; (ii) synthesis and 
distribution of phospholipids and steroids; (iii) storage of calcium ions within its 
lumen and their regulated release into the cytoplasm (Bravo, Parra et al. 2013). 
Perturbations affecting any of these processes can lead to ER stress, causing an 
aggregation of unfolded and misfolded proteins in the lumen of the ER. ER stress can 
be induced in a number of situations including nutrient and energy fluctuations, viral 
infections, hypoxia, the presence of toxins and increased demand on the synthetic 
machinery (Hotamisligil 2006). When the ER becomes stressed, it initiates a complex 
response system known as the unfolded protein response (UPR) in an attempt to 
restore the functional integrity of the organelle. 
The mammalian UPR consists of three main branches, each involving a different 
transmembrane protein that senses the stress: protein kinase RNA-like endoplasmic 
reticulum kinase (PERK), inositol-requiring enzyme-1 alpha (IRE1α), and activating 
transcription factor 6 (ATF6). In unstressed conditions, these three transmembrane 
proteins are bound by the chaperone binding immunoglobulin protein (BiP) via their 
luminal domain, rendering them inactive. Accumulation of unfolded and misfolded 
proteins in the ER results in the movement of BiP away from these transmembrane 
sensor proteins to assist with the folding of the aggregated proteins. Dissociation of 
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BiP leads to the dimerisation and trans-autophosphorylation of IRE1α and PERK, as 
well as the translocation of ATF6 to the Golgi apparatus. This activates the three 
proteins and initiates complex signalling cascades that are transduced to the 
cytoplasm via the cytoplasmic portion of each protein (Bravo, Parra et al. 2013, 
Dufey, Sepúlveda et al. 2014) (Figure 1.1.8.1).  
 
 
Figure 1.1.8.1 The Unfolded Protein Response: The unfolded protein response (UPR) is 
initiated by an accumulation of unfolded or misfolded proteins in the endoplasmic reticulum 
(ER). Under homeostatic conditions, the chaperone binding immunoglobulin protein (BiP) is 
bound to the transmembrane sensor proteins activating transcription factor 6 (ATF6), 
protein kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme-
1 alpha (IRE1α). Upon accumulation of unfolded proteins, BiP dissociates from the sensor 
proteins in order to assist with the folding of nascent proteins. This activates ATF6, PERK and 
IRE1, initiating three protein cascades that result in general translation attenuation and 
upregulation of specific proteins involved in protein folding and protein degradation in an 
attempt to reduce the ER workload. Figure from (Eizirik, Miani et al. 2013).  
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Under ER stress conditions, one of the three signalling cascades begins with the 
dimerisation of IRE1 and the subsequent phosphorylation of its alpha subunit, 
forming phospho-IRE1α (P-IRE1α). This activates the endoribonuclease activity of 
IRE1α which catalyses the splicing of a 26 base-pair intron from the ubiquitously 
expressed mRNA of unspliced X-box binding protein-1 (u-XBP1). This results in a 
frameshift and the subsequent translation of a 40kDa spliced isoform (sp-XBP1) 
rather than the 33kDa unspliced isoform (u-XBP1). The spliced, active isoform 
regulates genes involved in ER protein synthesis, folding, glycosylation, endoplasmic 
reticulum-associated protein degradation (ERAD), redox metabolism, autophagy, 
lipid biogenesis and vesicular trafficking (Bravo, Parra et al. 2013). The proteins that 
are then translated help to alleviate the stress experienced by the ER and return the 
cell to homeostasis (Figure 1.1.8.2).  
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Figure 1.1.8.2 IRE1 Arm of the Unfolded Protein Response: Under conditions of endoplasmic 
reticulum stress, binding immunoglobulin protein (BiP) dissociates from inositol-requiring 
enzyme 1 (IRE1), resulting in dimerisation and the phosphorylation of the alpha subunit of 
IRE1. This active, phosphorylated form of IRE1 splices the mRNA of unspliced X-box binding 
protein 1 (u-XBP1), producing spliced-XBP1 (sp-XBP1), with the resultant protein 
upregulating the translation of other proteins which assist in reducing the stress, such as 
endoplasmic reticulum oxidoreductin 1 (ERO1), BiP, and stress-associated endoplasmic 
reticulum protein 1 (SERP1). Figure adapted from (Andruska, Zheng et al. 2015). 
 
Dimerisation and phosphorylation of another of the transmembrane sensor proteins, 
PERK, activates its cytoplasmic kinase domain. This domain catalyses the 
phosphorylation of the alpha subunit of eukaryotic translation initiation factor-2 
(eIF2α), increasing the affinity of eIF2α for eIF2β. Under normal conditions, eIF2β 
u -
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provides the vital role of guanosine diphosphate (GDP)/guanosine triphosphate 
(GTP) exchange during cap-dependent protein translation. Phosphorylated eIF2α (P-
eIF2α) sequesters eIF2β, thereby inhibiting GDP/GTP exchange and thus cap-
dependent protein translation (Lewerenz and Maher 2009). Through this process, 
general protein translation is reduced, preventing more nascent proteins from 
entering the ER and contributing to the stress. Some mRNAs contain an upstream 
open reading frame (ORF) in their 5’-untranslated region which, under normal 
conditions, prevents translation; however, when eIF2α is phosphorylated, the ORF is 
bypassed and translation occurs (Barbosa, Peixeiro et al. 2013, Bravo, Parra et al. 
2013, Dufey, Sepúlveda et al. 2014). One such protein that is preferentially translated 
when eIF2α is phosphorylated is activating transcription factor 4 (ATF4), a 
transcription factor that upregulates a cluster of UPR target genes involved in amino 
acid metabolism, antioxidant response, folding, and the regulation of apoptosis 
(Dufey, Sepúlveda et al. 2014). Two genes upregulated by ATF4 are C/EBP 
homologous protein (CHOP), and growth arrest and DNA damage-inducible 34 
(GADD34). GADD34 contributes to a negative feedback loop that dephosphorylates 
P-eIF2α under prolonged ER stress, whilst CHOP regulates the transcription of 
proteins that trigger apoptosis. These proteins, which are only translated following 
sustained ER stress, represent a ‘switch’ in the aim of the UPR from returning the cell 
to homeostasis to promoting cell death in order to protect the organism (Dufey, 
Sepúlveda et al. 2014, Ariyasu, Yoshida et al. 2017) (Figure 1.1.8.3). 
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Figure 1.1.8.3 PERK Arm of the Unfolded Protein Response: Under conditions of 
endoplasmic reticulum stress, protein kinase RNA-like endoplasmic reticulum kinase (PERK) 
is activated, causing it to dimerise and autophosphorylate. Phospho-PERK then 
phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2α) which upregulates 
activating transcription factor 4 (ATF4). ATF4 in turn upregulates proteins such as C/EBP 
homologous protein (CHOP) and growth arrest and DNA damage-inducible 34 (GADD34) 
which, after prolonged ER stress, initiate apoptotic processes in order to protect the 
organism. Figure adapted from (Andruska, Zheng et al. 2015). 
 
 
ATF6 activation differs from that of IRE1α and PERK in that, under ER stress 
conditions, it is transported in vesicles to the Golgi apparatus where it is cleaved by 
proteases. The N-terminal fragment, p50ATF6, then translocates to the nucleus 
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where it promotes the transcription of chaperones such as BiP, transcription factors 
CHOP and XBP1, as well as other UPR genes (Bravo, Parra et al. 2013, Ariyasu, Yoshida 
et al. 2017) (Figure 1.1.8.4). 
 
Figure 1.1.8.4 ATF6 Arm of the Unfolded Protein Response: During endoplasmic reticulum 
stress, the alpha subunit of activating transcription factor 6 (p90-ATF6α) is translocated to 
the Golgi, where it is cleaved by proteases. The N-terminal fragment, p50-ATF6α, then enters 
the nucleus and upregulates chaperones and co-chaperones such as binding immunoglobulin 
protein (BiP) and protein kinase inhibitor p58 (p58IPK) in order to reduce the stress 
experienced by the ER. Figure adapted from (Andruska, Zheng et al. 2015). 
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1.1.9 Inflammation and Insulin Resistance 
There is a significant presence of ER stress in obese patients (Boden, Duan et al. 2008, 
Kawasaki, Asada et al. 2012), and whilst the definitive cause of this is unknown there 
are several possible ways in which ER stress could be caused by obesity. Firstly, it 
could be due to the increased demand for protein production required to process 
excess nutrients and support the expansion of adipose tissue. It is also possible that 
the nutrients themselves may serve as direct signals that induce ER stress, for 
example free fatty acid (FFA) levels are increased in the serum of obese patients and 
it has been shown that FFAs can lead to insulin resistance through the JNK (c-Jun N 
terminal kinase) pathway. It could be that ER stress is the means through which FFAs 
activate JNK (Kawasaki, Asada et al. 2012).  
Many of the mechanisms that contribute to insulin resistance and other metabolic 
disorders are associated with ER stress. For instance, the reduced vasculature that 
occurs in obese adipose tissue leads to hypoxia and glucose deprivation, which are 
both inducers of ER stress (Gregor and Hotamisligil 2007, Ye 2011, de la Cadena, 
Hernández-Fonseca et al. 2014). Furthermore, prolonged ER stress can generate 
oxidative stress and induce mitochondrial dysfunction via Ca2+ signalling. Similarly 
mitochondrial dysfunction can induce ER stress through disturbances in Ca2+ 
homeostasis (Park 2014).  
Once ER stress is induced, each arm of the UPR produces proteins that contribute 
either to homeostasis of the cell by reducing ER stress, or to apoptosis if ER stress 
cannot be relieved. However, during this process pro-inflammatory proteins are also 
upregulated. If activated acutely, ER stress and inflammation safeguard the cellular 
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viability and functions. When chronically induced however, they can contribute to 
many diseases including T2DM,  neurodegenerative diseases, atherosclerosis, 
arthritis, respiratory diseases, irritable bowel syndrome, cardiovascular diseases, and 
cancer (Chaudhari, Talwar et al. 2014). For example, the P-IRE1α arm of the UPR 
induces the activation of several inflammatory markers including NF-ĸB (nuclear 
factor kappa-light-chain-enhancer of activated B cells) and JNK (Urano, Wang et al. 
2000, Ozcan, Cao et al. 2004, Wang and Kaufman 2014, Cao, Luo et al. 2016). NF-ĸB 
is a master controller of inflammation which enters the nucleus and upregulates 
further inflammatory cytokines, whilst activated JNK triggers the inhibitory 
phosphorylation of serine residues on the insulin receptor substrate 1 (IRS-1) 
(Lawrence 2009, Cao, Luo et al. 2016). IRS-1 is essential in transmitting signals from 
insulin receptors to intracellular pathways that respond to the insulin signal. Tyrosine 
phosphorylation of IRS-1 by the insulin receptor is necessary in this process as it 
introduces multiple binding sites for proteins that transmit the signal further 
downstream. When JNK is activated by the P-IRE1α arm of the UPR, however, it leads 
to the inhibitory phosphorylation of a serine molecule on IRS-1 which prevents the 
necessary tyrosine phosphorylation and contributes to reduced insulin sensitivity 
(Aguirre, Uchida et al. 2000, Sun, Wang et al. 2015). This demonstrates one of the 
ways in which obesity can lead to T2DM, via ER stress. 
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1.1.10 ER Stress and its Impact on Oxidative Stress 
Prolonged activation of the ER stress pathway may generate oxidative stress 
alongside inflammation, causing a toxic accumulation of reactive oxygen species 
(ROS) within the cell. This is due to the increase in production of chaperones, which 
aid the folding of nascent proteins by forming disulphide bonds in the ER lumen. 
These chaperones use molecular oxygen as the final electron recipient in this process, 
generating reduced molecular oxygen that subsequently accumulates in the ER. 
Short term activation of the UPR buffers this effect through upregulation of Nrf2 
(nuclear factor erythroid 2-related 2) via the PERK pathway, which neutralises the 
toxic species (Gregor and Hotamisligil 2007). Prolonged activation, however leads to 
increased ROS levels that induce further inflammatory responses and ER stress 
(Ozgur, Turkan et al. 2014). 
The activities of resident ER folding enzymes are highly dependent on redox 
homeostasis, and as such the ER redox state must be carefully maintained to allow 
disulphide formation in nascent proteins whilst maintaining sufficient reducing 
power to break incorrectly formed disulphides (Wilkinson and Gilbert 2004). The 
redox state in the ER is therefore tightly controlled by several redox mechanisms, 
such as the glutathione disulphide/glutathione (GSSG/GSH) cycle, and protein 
disulphide isomerase (PDI) reactions (Chong, Shastri et al. 2017). Glutathione exists 
in two states – reduced (GSH), and oxidised (GSSG). While reduced, GSH is able to 
donate a reducing equivalent (H+ + e-) to other molecules, such as ROS, to neutralise 
them. During this process, glutathione becomes reactive itself and binds with 
another reactive glutathione molecule to form glutathione disulphide (GSSG). 
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Through this process, GSH helps to maintain the ER thiol redox environment 
(Chakravarthi, Jessop et al. 2006, Dixon, Heath et al. 2008).  
Protein disulphide isomerase (PDI) is one of the most abundant proteins in the ER. It 
is an essential folding catalyst and chaperone that assists in the critical role of native 
disulphide bond formation (oxidation), breakage (reduction) and rearrangement 
(isomerisation) in proteins (Wilkinson and Gilbert 2004, Winter, McCormack et al. 
2007). The oxidase activity of PDI allows it to form disulphide bonds in protein 
substrates. However, disulphide formation that occurs early during the folding of 
nascent proteins is often prone to error – either between the wrong cysteine groups, 
or between the right cysteine groups, but in an incorrect configuration due to an 
incorrect temporal order (Wilkinson and Gilbert 2004). This impedes further folding 
and can result in a misfolded or unfolded protein. In order to correct this, the 
incorrect disulphide bond must be broken and reformed in the correct manner. PDI 
is able to continually modify disulphide bonds as long as it is oxidised after each 
reaction. Oxidation of PDI involves endoplasmic reticulum oxireductin 1 (ERO1) and 
possibly glutathione, which mediate the removal of electrons from PDI (Chakravarthi, 
Jessop et al. 2006, Dandekar, Mendez et al. 2015).  
When increased levels of ROS occur, the careful balance of redox homeostasis in the 
ER can be disrupted. This prevents ER-resident proteins such as PDI and glutathione 
from functioning correctly, and thus the re-folding or degrading of unfolded and 
misfolded proteins is not carried out and ER stress can worsen (Ozgur, Turkan et al. 
2014).  
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1.1.11 ER Stress and its Impact on Mitochondrial Dysfunction 
An additional consequence of increased ROS levels produced during ER stress is the 
release of calcium ions from the ER, the main intracellular reservoir for calcium, 
which are then taken up by the mitochondria. Most eukaryotic cells rely on 
mitochondrial oxidative phosphorylation to supply the energy source ATP (adenosine 
triphosphate); however, mitochondria are also important in determining continued 
cell survival and cell death. The ER forms physical contacts with mitochondria known 
as mitochondria-associated membranes, or MAMs, which have been associated with 
the delicate balance between supporting the survival of the cell and initiating the cell 
death pathway. Crosstalk between the two organelles is important for the 
monitoring of calcium homeostasis, as well as regulating lipid metabolism, autophagy 
and mitophagy (Marchi, Patergnani et al. 2014, Rieusset 2018). During the early 
stages of ER stress, the number of mitochondria-ER interactions increases, facilitating 
improved calcium transfer from the ER to the mitochondria. This initial increase in 
calcium enhances mitochondrial bioenergetics and ATP production that safeguards 
cellular functions. However, the sudden influx of calcium into mitochondria following 
prolonged ER stress, along with ROS accumulation and ATP depletion, instead 
promotes mitochondrial collapse and triggers apoptotic cell death (Figure 1.1.11). 
This occurs through upregulation of pro-apoptotic proteins and opening of the 
mitochondrial permeability transition pore (MPTP), which depolarises the inner 
membrane leading to mitochondrial swelling, release of cytochrome c, cell damage 
and apoptosis (Sivitz and Yorek 2010, Malhotra and Kaufman 2011, Bravo, Gutierrez 
et al. 2012, Chaudhari, Talwar et al. 2014). This pathway demonstrates one of the 
ways in which chronic ER stress can lead to cell death. 
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Figure 1.1.11 Ca2+ signalling between Endoplasmic Reticula and Mitochondria: Ca2+ transfer 
between endoplasmic reticula (ER) and mitochondria is important to monitor calcium 
homeostasis, and to regulate lipid metabolism, autophagy and mitophagy. Initial Ca2+ 
transfer during early ER stress enhances mitochondrial bioenergetics and ATP production 
which safeguards cellular functions, whilst increased Ca2+ transfer during prolonged ER stress 
promotes apoptosis. Figure from (Filadi, Zampese et al. 2012). 
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1.1.12 Mitochondrial Dysfunction  
Dysfunctional mitochondria may have a direct link to insulin resistance and the 
development of T2DM (Lowell and Shulman 2005). Healthy mitochondrial function 
depends on the number of mitochondria within the cell, as well as their morphology 
and metabolism. For mitochondrial function to be efficient, mitochondria must 
constantly move throughout the cell and localise to intracellular sites where ATP 
production is most essential. As they move, mitochondria undergo highly co-
ordinated processes of fission, whereby the organelle divides into two or more 
separate structures, and fusion, where two separate organelles join together to form 
one (Figure 1.1.12) (Scott and Youle 2010). This continuous process both mixes the 
mitochondrial genome whilst distributing the mitochondria into an efficient network, 
and maintains an optimal number of healthy mitochondria. This important balance 
of fission and fusion relies on proteins such as mitofusin (MFN), involved in docking 
the mitochondria, and the presenillin-associated rhomboid-like (PARL) protein which 
maintains morphological integrity. There is evidence showing that MFN is reduced in 
obese humans and rodents (Bach, Pich et al. 2003), and that insulin resistance can 
arise when polymorphisms of PARL occur (Walder, Kerr-Bayles et al. 2005, Sivitz and 
Yorek 2010). 
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Figure 1.1.12 Mitochondrial Dynamics: Mitochondria undergo constant fission and fusion 
events within the cell. This allows mitochondrial DNA to mix, and an optimal number of 
healthy mitochondria to be maintained. Figure from (Seo, Joseph et al. 2010). 
 
Further to mitochondrial dynamics being involved in the development of insulin 
resistance, perturbed mitochondrial biogenesis can also contribute to the problem. 
A reduction in mitochondrial biogenesis can lead to a decrease in substrate oxidation 
for molecules such as fatty acids, which leads to an accumulation of lipids. Through 
this process, diacylglycerols (DAG) and ceramides (CER), metabolically active lipid 
mediators, accumulate and can inhibit insulin signalling. DAG activates protein kinase 
C which inhibits the insulin receptor (Li, Soos et al. 2004), whilst CER inhibits protein 
kinase B which is required for the insulin-induced translocation of glucose 
transporter 4 (GLUT4) to the plasma membrane (Summers, Garza et al. 1998, 
Montgomery and Turner 2015). Decreases in substrate oxidation also affect electron 
flow through the electron transport chain (ETC), which causes electron leakage and 
formation of ROS, independent from the ROS linked to ER stress discussed in section 
1.1.10. ROS can damage mitochondria and lead to mitophagy or apoptosis, 
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decreasing mitochondrial number and further reducing substrate oxidation, 
aggravating the existing lipid accumulation (Montgomery and Turner 2015). 
In terms of reduced mitochondrial function in white adipose tissue in obesity and 
T2DM, mitochondrial number and functions such as respiration and fatty acid 
oxidation are all decreased in the adipocytes of db/db mice, which are used as a 
model of obesity and diabetes due to their deficient leptin receptor activity (Choo, 
Kim et al. 2006). It is possible that mitochondrial dysfunction in adipose tissue may 
result in a lack of suppression of lipolysis. Increased levels of free fatty acids (FFA) 
that are formed through lipolysis have been shown to inhibit insulin-stimulated 
glucose uptake into muscle and liver (Boden 1999, Krebs and Roden 2005), and as 
such the FFA release due to mitochondrial dysfunction in adipocytes could contribute 
to the insulin resistance seen in T2DM. As well as this, it has been found that both 
genetic and diet-induced obesity result in decreased mitochondrial density and 
oxidative phosphorylation activity in adipose tissue (Richardson, Kashyap et al. 2005, 
Sparks, Xie et al. 2005). This could contribute to adipose tissue dysfunction and 
exacerbation of insulin resistance. 
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1.1.13 Factors that may Stimulate or Mitigate ER Stress 
As discussed, obesity is one condition that induces ER stress, which can then 
contribute to reduced insulin sensitivity. There are several perturbations associated 
with obesity that may initiate ER stress in adipose tissue, for instance; overnutrition, 
endotoxemia, hyperglycaemia, elevated circulating free fatty acids, and glucose 
deprivation (Pagliassotti, Moran et al. 2014). Overnutrition is one of the main factors 
contributing to obesity, and this places an increased demand on the endoplasmic 
reticulum as it must synthesise proteins to aid in the processing and storage of these 
nutrients. Some nutrients may also potentially act as ER-stress-inducing signals 
themselves (Gregor and Hotamisligil 2007). Lipopolysaccharide (LPS), also known in 
the literature as endotoxin, is a bacterial fragment that forms the outer membrane 
of gram-negative bacteria and is naturally found in the gut. It has been shown to 
increase the expression of ER stress markers in human primary adipocytes (Alhusaini, 
McGee et al. 2010). The same study also demonstrated that high glucose and 
saturated fatty acids both increase levels of ER stress markers. Similarly, Jiao et al. 
showed that ER stress was induced in 3T3-L1 mouse adipocytes following exposure 
to a mixture of free fatty acids (Jiao, Ma et al. 2011). The exact mechanisms for these 
inducers of ER stress are currently unknown, and more work is required to determine 
if these results represent in vivo situations. As discussed previously, due to the 
decreased vasculature of adipose tissue in obese patients, areas of such tissue can 
become hypoxic. This hypoxia can induce insulin resistance in these cells which thus 
leads to glucose deprivation. Additionally, N-linked glycosylation, an important 
process in the production and correct folding of some proteins, requires glucose for 
the process to be carried out. Glucose deprivation can therefore lead to ER stress, as 
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without correct N-linked glycosylation, misfolded and unfolded proteins will 
accumulate and trigger the UPR (Xu, Bailly-Maitre et al. 2005, Gregor and Hotamisligil 
2007). Tunicamycin, a chemical formed from a mixture of antibiotics, also blocks N-
linked glycosylation and is commonly used as an artificial inducer of ER stress in 
experiments. Other chemicals that are often used to artificially induce ER stress 
include thapsigargin, Brefedin A, dithiothreitol (DTT), and MG132, which all act in 
different ways to induce this stress (Oslowski and Urano 2011). 
Thapsigargin inhibits sarcoplasmic/endoplasmic reticulum Ca2+/ATPase (SERCA), and 
thus reduces the levels of calcium in the ER. This leads to many chaperones that are 
calcium-dependent, such as calnexin, losing their chaperone activity causing a build-
up of unfolded proteins. Brefeldin A prevents the transport of proteins from the ER 
to the Golgi apparatus, and induces the retrograde transport of proteins from the 
Golgi back to the ER, again leading to the accumulation of proteins in the ER. DTT is 
a strong reducing agent and prevents the formation of disulphide bonds. This induces 
ER stress very quickly; however, it also blocks disulphide-bond formation of nascent 
proteins in the cytosol and therefore is not only specific to inducing ER stress. MG132 
however, blocks the ERAD (ER-associated protein degradation) pathway and thus 
prevents the degradation of misfolded proteins, allowing them to build up in the ER 
lumen (Oslowski and Urano 2011). 
As well as these factors that stimulate ER stress, there are also factors that mitigate 
it. Unsurprisingly, weight loss in obese patients reduces ER stress. This is documented 
in several studies with patients who underwent bariatric surgery, in the adipose 
tissue of obese and lean individuals, and in the adipose tissue of people with a range 
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of BMIs (Boden, Duan et al. 2008, Sharma, Das et al. 2008, Gregor, Yang et al. 2009, 
Boden and Merali 2011). Antioxidants have also been found to prevent and reduce 
ER stress in liver cells (Malhotra, Miao et al. 2008), and to partially protect against ER 
stress in adipocytes (Kajimoto, Minami et al. 2014). Additionally, improving the lipid 
profile has been shown to protect against ER stress. Reports have shown that high 
density lipoprotein (HDL) inhibits the ER stress response induced by oxidised low 
density lipoprotein (ox-LDL) in human endothelial cells, macrophages, and more 
recently, 3T3-L1 adipocytes (Muller, Salvayre et al. 2011, Niculescu, Sanda et al. 2013, 
Song, Wu et al. 2016). There is also evidence that anti-inflammatory mediators, such 
as ethyl pyruvate and bullatine A, can protect against ER stress (Ren, Zhou et al. 2014, 
Wang, Liu et al. 2014). 
Whilst losing weight is most likely to reduce ER stress and the development of T2DM, 
many obese people struggle to achieve and maintain a healthy BMI. It may therefore 
be beneficial to investigate other ways of reducing ER stress and the risk of T2DM. 
This would allow such people to improve their metabolic health whilst they are trying 
to lose weight, and maintain this healthier status even if they do not achieve and 
maintain a healthy BMI. One possible way of doing this is to research those dietary 
factors that may prevent or reduce the intensity of ER stress, thus reducing the risk 
of obese individuals developing T2DM. 
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1.1.14 The Impact of Broccoli on Health 
Studies have shown that diets rich in cruciferous vegetables, such as broccoli, reduce 
the risk of myocardial infarction and cardiovascular related mortality, and reduce the 
incidence or progression of various cancers, including lung (Lam, Ruczinski et al. 
2010), bowel (Seow, Yuan et al. 2002), kidney (Hsu, Chow et al. 2007), and prostate 
(Kirsh, Peters et al. 2007, Bosetti, Filomeno et al. 2012) (Traka, Saha et al. 2013). 
Broccoli has naturally high levels of glucoraphanin which can lead to the upregulation 
of antioxidants once ingested, and it is this that has been attributed to these health 
benefits. There is now a ‘Super Broccoli’, known as Beneforté that has been 
specifically bred to contain 2-3 times more glucoraphanin than other broccoli 
varieties and is now available at 10 popular supermarkets in the UK (Quadram 
Institute Bioscience 2013). Cruciferous vegetables have also been shown to lower 
inflammation in vivo in both animal and human studies (Youn, Kim et al. 2010, Hwang 
and Lim 2014, Jiang, Wu et al. 2014), as well as improving the lipid profile of humans 
(Bahadoran, Mirmiran et al. 2012, Jeon, Kim et al. 2013, Armah, Derdemezis et al. 
2015). Broccoli therefore has many of the qualities described above that have been 
shown to reduce ER stress, and has also been shown to have health benefits 
demonstrated in numerous other diseases. Hence, it is possible that broccoli may 
protect against ER stress, and therefore reduce the risk of obese patients developing 
T2DM.  
Cruciferous vegetables are characterised by their high content of glucosinolates, 
which are converted to isothiocyanates by the enzyme myrosinase. Myrosinase is 
physically separated from the glucosinolates within the plant cells, but is released 
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when the cells are damaged, for instance by microbial attack, insect predation, and 
mechanical food processing such as chewing or food preparation (Herr and Büchler 
2010). The primary glucosinolate in broccoli is glucoraphanin, which upon interaction 
with myrosinase is converted to the isothiocyanate sulforaphane, which has a key 
role in the anti-carcinogenic effects of broccoli. There are several diverse 
mechanisms by which sulforaphane acts in an anti-carcinogenic manner, including 
eliminating ROS and enhancing antioxidative cellular activity, inducing cell cycle 
arrest and apoptosis in cancer cells, reducing inflammatory mediators, inhibiting 
angiogenesis-activating transcription factors, and eliminating tumorigenic pancreatic 
cancer stem cells (Juge, Mithen et al. 2007). The mechanisms by which sulforaphane 
acts depend upon the stage of carcinogenesis, and it is likely that multiple 
mechanisms interact to reduce carcinogenic risk by modulating cell growth and cell 
death signals to suppress cancer progression (Juge, Mithen et al. 2007, Clarke, 
Dashwood et al. 2008). The mechanism by which broccoli reduces inflammation has 
not been as thoroughly studied as its anti-cancer properties, however it is thought 
that the sulforaphane produced from broccoli inactivates NF-κB, a key modulator in 
inflammatory pathways, and can also inhibit the production of cytokines which are 
upregulated during inflammation (Mirmiran, Bahadoran et al. 2012).  
A study by Zhang et al. has also shown that sulforaphane can induce adipocyte 
browning, as well as promote glucose and lipid utilisation (Zhang, Chen et al. 2016). 
This is important, as adipocyte browning, the process of brown adipocytes appearing 
in WAT, has the potential to protect against diet-induced obesity (Cui and Chen 
2016). Additionally, this study reported that sulforaphane upregulated glucose 
uptake, lipolysis and fatty acid oxidation, while suppressing the synthesis of 
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triglycerides. These findings suggest that the browning of adipocytes, induced by 
sulforaphane, in turn promotes glucose and lipid utilisation in adipocytes and 
therefore has the potential to improve metabolic load on the body (Zhang, Chen et 
al. 2016). This research, along with previous studies on the effect of broccoli on 
cancer, inflammation, and lipid profiles, suggests that broccoli may have the 
potential to reduce the risk of T2DM through mechanisms that reduce processes such 
as ER stress. 
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1.2 Modelling the ER Stress Pathway to Understand its Dynamics 
1.2.1 The Importance of Studying Time Series Data 
The pathways involved in the UPR, and the protein interactions that occur in order 
to create the biological response to ER stress have been well studied, leading to a 
comprehensive map of genomic and proteomic reactions to describe the process. 
However, our understanding of the UPR and how it changes in response to different 
treatments is limited by the lack of knowledge about the time frame over which these 
interactions occur, and how the response varies over time. For instance, following 
treatment, should one expect a response in minutes, hours or days? Similarly, a 
certain treatment may be effective because it delays or speeds up a certain pathway 
response. Investigating time series data is therefore important in order to gain a full 
understanding of the ER stress response and how it changes following various 
interventions. 
Time series data have been important in studying the responses of many biological 
systems. For instance, time series data have been used to provide more information 
on the mechanisms of respiratory oscillations of yeast (Murray, Beckmann et al. 
2007), and their adaptation to temperature stress (Strassburg, Walther et al. 2010). 
Similarly, time series data have been used to elucidate the adaptation mechanisms 
of plants to various stresses (Kaplan, Kopka et al. 2004, Kim, Bamba et al. 2007, 
Urano, Maruyama et al. 2009, Espinoza, Degenkolbe et al. 2010) . Time series data 
have also been used to study human metabolism and responses, such as metabolic 
profile responses of stored red blood cells to hypoxia (Kinoshita, Tsukada et al. 2007), 
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and to create a model to distinguish and connect early and later drug responsive gene 
targets (Zhang, Mourad et al. 2012, Sriyudthsak, Shiraishi et al. 2016).  
Time series data are also useful for parameterising and validating simulated 
behaviours predicted by mathematical models, which are often used to aid the study 
of biological responses. Mathematical modelling involves describing a system using 
mathematical concepts, which allows the user to study the effects of different 
components of the system, as well as make predictions about its behaviour under 
different conditions. These predictions must then be validated by real-life time series 
data in order to refine the model and confirm its accuracy (Quinn and Kohl 2013).  
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1.2.2 Mathematical Modelling in Biology 
Biological systems invariably contain large numbers of molecules which all have 
multiple possible interactions that result in an exact response. For instance, the 
simple yeast system, Saccharomyces cerevisiae, contains 1418 metabolites, which 
participate in 2110 reactions (Heavner, Smallbone et al. 2012). This results in a 
complex network that cannot be explained and understood easily in simple terms. 
Mathematical modelling and computer simulations of such systems allow them to be 
visualised and studied in a way that elucidates their dynamics, regulation and 
responses.  
Several mathematical models that describe different biological events have been 
developed and are now well-used in biology. Examples of these are the Michaelis-
Menten model (Figure 1.2.2) that describes the dynamics of enzyme catalysed 
reactions, the Hodgkin-Huxley model of action potentials in neurons, the Lotka-
Volterra model characterising the interaction of species, and epidemiological models 
of epidemics (Torres and Santos 2015). There are also many 
pharmacokinetic/pharmacodynamic (PK/PD) models which are used to categorise 
the pharmacological effects of different compounds, simulate different dosing 
schedules and understand underlying mechanisms of drug response (Kamath, Yip et 
al. 2014, Tuntland, Ethell et al. 2014, Wind, Schnell et al. 2017). 
 Although there exist many useful mathematical models in biology and biomedicine, 
the creation and parameterisation of models that describe complex biological 
systems can be incredibly challenging. This is due to the fact that such systems are 
multiscale, usually composed of many interactions that affect outcomes at different 
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levels, e.g. molecular, cellular, in tissue, whole animals and ecological (Torres and 
Santos 2015). As well as this, biochemical reactions often obey nonlinear reaction 
kinetics, in that an increase in initial concentration of material does not necessarily 
result in a proportional increase in the end product. Finally, many of the occurrences 
within a cell or organism are random, or stochastic, and can lead to unexpected 
behaviour of the entire system (Fischer 2008). However, due to the advancement in 
technology for developing models over recent decades as well as for gathering large 
quantities of biological data (big data), using mathematical models to describe 
biological systems is becoming ever more commonplace despite the challenges that 
it involves. 
 
Figure 1.2.2 Michaelis-Menten Model: The Michaelis-Menten saturation curve for an 
enzyme reaction showing the relation between the substrate concentration ([S]) and 
reaction rate (Vo) for enzymes undergoing different types of inhibition. KM = Michaelis 
constant, Vmax = maximum reaction rate. Figure adapted from (Team 2017). 
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Models that successfully describe a biological system by taking into consideration the 
factors outlined above allow researchers to better understand the process that is 
occurring, as well as how the system is likely to respond to external or internal signals 
and perturbations (Quinn and Kohl 2013). Suitable models of biological systems allow 
computer simulations to be run that predict such responses. These dry experiments 
are much cheaper and less time-consuming than the equivalent wet lab experiments 
once a robust and valid model has been  created, and as such can be used to support 
experiment design by determining optimal conditions to use in future wet 
experiments (Fischer 2008).  
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1.2.3 Factors to Consider when Designing a Mathematical Model 
Building a mathematical model of a biological system requires a constant 
improvement of understanding, both in terms of biological insights and how the 
model can be adapted to incorporate these new insights (Figure 1.2.3). Before 
creating a model of a biological system, one must therefore consider several aspects 
of the process so that the model is able to describe the system effectively without it 
becoming so complex that it is unmanageable. This is a hard balance to achieve in 
biology due to the complexity of most processes, and one must define those 
interactions that are essential to the system versus those which can be omitted in 
order for the model to remain feasible, and more easily analysed and managed. 
Understanding more about what type of model will best describe the biological 
system under question is important in order to achieve the most relevant results. 
There are several areas to consider in terms of defining the model, for instance; 
whether the model is linear/non-linear, static/dynamic, or 
deterministic/probabilistic.  
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Figure 1.2.3 The Computational-Experimental Cycle: Building a mathematical model of a 
biological system requires a constant cycle where experimental data are continuously 
gathered in order to first build the model, parameterise it, validate it, and then incrementally 
improve it. Figure from (Nguyen 2015). 
 
The linearity of a model is determined by whether an increase in the initial level of 
product results in a proportional increase in the end product. If this is true for every 
interaction within the system, then the model of that system is said to be linear. This 
is very rare in biological pathways as most molecules (e.g. proteins) have an effect 
on numerous others. This non-linearity tends to result in biological models being 
harder to study (McIntosh and McIntosh 1980).  
Whether a model is static or dynamic depends on whether the model accounts for 
changes in the system over time. A static model describes a system that is in 
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equilibrium, as opposed to one where the model equations will need to account for 
adaptations within the system over time, which is known as a dynamic model. 
Dynamic models often consist of differential equations which describe the rates of 
change of physical quantities (e.g. molecules) over time, as well as a vector of state 
variables sufficient in dimension to summarise the properties of interest and for 
predicting how these properties will change over time (Ellner and Guckenheimer 
2006). Validated dynamic models are used widely in biological modelling as they have 
a basis for predicting the long-term consequences of the processes currently 
operating in the system (Ellner and Guckenheimer 2006). The inclusion of kinetic rate 
equations and model parameters for dynamic models is required in order to provide 
detailed quantitative description, quantitative prediction and relevant dynamic 
behaviours. However, these requirements make dynamic models much more 
complicated to create and they are therefore generally limited to small-scale systems 
(Sriyudthsak, Shiraishi et al. 2016).  
A deterministic model has variable states that are entirely determined by the 
structure and parameters of the model, and as such will repeatedly perform in the 
same way for a given set of initial conditions. A probabilistic model, or stochastic 
model, however, incorporates randomness or uncertainty specified in a precise 
mathematical way to characterise the performance of a system (Sriyudthsak, 
Shiraishi et al. 2016). It contains some variable states that are not described by 
unique values, but are calculated through probabilistic statistics, resulting in each run 
of a given model producing different results, whilst the statistical properties of the 
results of many runs are pre-determined by the mathematical formulation of the 
model (Wilkinson 2009). This allows predictions, information extraction, and 
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stochastic structure description to be carried out. Biochemical kinetics at the single-
cell level are intrinsically stochastic (McAdams and Arkin 1999), and it is now 
generally accepted that stochastic modelling of biosystems is required in order to 
properly capture the multiple sources of heterogeneity in a realistic way (Wilkinson 
2009). However, modelling biological systems in this way is more computationally 
demanding than deterministic modelling, and it is also harder to fit experimental data 
to such models, presenting more challenges for creating suitable, realistic models of 
biological systems (Sriyudthsak, Shiraishi et al. 2016).  
Once key characteristics have been decided upon in order to create the most 
appropriate model for the system under study, the molecular species that are to be 
included in the model should be determined. Only those species that are essential to 
the process should be included and any that create unnecessary complexity in the 
model should be excluded. This process of choosing when to be biochemically 
accurate and when to approximate can be one of the most challenging steps in 
creating a mathematical model of a biological system (Le Novère 2015). Once the 
components of the model have been identified, information about the interactions 
between them should be obtained. This can be done either through experimental 
research or through conducting a reliable literature search, which allows a pathway 
to be created that describes the system appropriately and provides an outline for the 
model (Le Novère 2015). 
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1.2.4 Designing Dynamic Models using Time Series Data 
Dynamic models involve physical constituents, known as variables (e.g. proteins) as 
well as parameters which provide more information about the variables and the 
interactions between them (e.g. kinetics and equilibrium constants) (Le Novère 
2015). Ordinary differential equations (ODEs) are usually used to define the model 
equations, which are formed based on the known kinetics, such as simple mass 
action, Michaelis-Menten, or Hill type kinetics (Soliman and Heiner 2010). 
Parameters are then required to populate the ODEs, regardless of the format the 
ODEs take. These may be estimated from experimental data – however, since such 
experimental data often include biological variation and analytical errors, parameter 
estimation from biological data can be a challenging and time-consuming process.  
There are essentially two methods to estimate parameter values – bottom-up, which 
involves determining enzymatic kinetic rates through in vitro enzymatic assays; and 
top-down, which indirectly estimates parameters from time series data (Sriyudthsak, 
Shiraishi et al. 2016). The bottom-up method involves each parameter being 
individually determined through experiments, and then integrated into a final model. 
However, this approach can be expensive and timely when obtaining parameter 
values for every reaction individually. The top-down approach allows estimation of 
multiple parameters from limited data sets by minimising the difference between 
experimental time-series data and model predictions. This approach is quicker and 
cheaper, however it relies on the accuracy of the datasets (Schadt 2013). Generally, 
the more parameters involved in a model, the more complex and less accurate 
parameter estimation becomes. However, a reasonable number of model equations 
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and parameters are required in order to accurately reproduce the biological 
observations and predict different scenarios, thus a compromise between model 
complexity and accuracy is a common challenge (Sriyudthsak, Shiraishi et al. 2016).  
Constraints are also required in order to give context to what the model represents, 
and under what conditions the model is realistic. From this information, a series of 
equations can be formed that describe the system within the constraints applied – it 
is these equations along with the parameters and constraints that form the model. 
Following construction of the model, a comprehensive evaluation should be carried 
out to determine how well it represents the real life data, as well as analysis of any 
discrepancies that are highlighted throughout this process. Examples of analysis that 
can be undertaken include; steady state analysis, which analyses the behaviour of a 
system in an equilibrium state (Antunes, Gonzalez et al. 2015); linearisation, which 
allows the assessment of local stability of the equilibria of a nonlinear system 
(Hinrichsen and Pritchard 2005); and asymptotic analysis, which describes the 
system’s limiting behaviour by finding conditions that the system approaches, but 
will never actually reach (Dalwadi, Garavaglia et al. 2018).   
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1.2.5 Modelling the Unfolded Protein Response 
There have been several attempts at creating a useful model of the UPR ranging from 
small models that are missing biological detail, to larger models that require many 
parameters that may not be as accurate and use arbitrary parameter estimation 
(Rutkowski, Arnold et al. 2006, Trusina, Papa et al. 2008, Erguler, Pieri et al. 2013). 
Trusina and collaborators modelled a simplified yeast version of the UPR in 2008, for 
which the schematic and system equations are shown in Figure 1.2.5 (Trusina, Papa 
et al. 2008). The focus of this work was to propose explanations as to why the 
translation attenuation (TA) mechanism varies in importance between cells, and is 
non-existent in lower eukaryotes such as yeast. Models of the UPR were constructed 
both with and without the TA mechanism, and it was discovered that the number of 
unfolded proteins during a response was reduced in the system that contained the 
TA mechanism, as was the accumulation of chaperones between two consecutive 
pulses of stress. This research is a prime example of how systems biology can provide 
more insight into the processes occurring in biological pathways; however, it is 
unclear what experimental data, if any, were used to parameterise and test the fit of 
the model to reality. This is a common problem also seen in subsequent models of 
the UPR, where there is a lack of suitable experimental data that can be used to 
characterise and validate the model effectively. As such, these models are qualitative 
in nature rather than quantitative. 
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Figure 1.2.5 Example Model from Trusina et al. 2008: Unfolded protein response (UPR) 
network in (A) yeast and (B) mammalian cells. A simplified version of the UPR (C) without or 
(D) with the translation attenuation mechanism, and corresponding mathematical models, 
developed by Trusina et al., where U represents unfolded proteins, H represents the 
upregulation of histone acetyltransferase 1 (Hac1) or its mammalian homologue, X-box 
binding protein (Xbp1), and C represents the upregulation of chaperones (Trusina, Papa et 
al. 2008). 
 
Another model of the UPR presented by Rutkowski et al. investigated the differences 
in the expression patterns of UPR proteins that contribute to cell survival or cell death 
(Rutkowski, Arnold et al. 2006). This model provided useful insight into how the 
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outcome of the UPR switches from survival to apoptosis, revealing that proteins 
involved in the apoptotic pathway appear to be relatively unstable compared to 
those in the survival pathway. This results in their rapid degradation following their 
initial upregulation after stress, and thus an intense episode of ER stress was required 
for the apoptotic pathway to succeed. As proteins involved in the survival pathway 
remain upregulated for longer periods of time, this provided an explanation as to 
why cells survive mild episodes of ER stress despite the initial upregulation of both 
survival and apoptotic proteins. Whilst this model has provided useful information 
on a possible mechanism for the switch between cell survival and cell death following 
ER stress, it only considered three proteins and their corresponding mRNAs and does 
not take into account other proteins that transfer the stress signals between them. 
In addition, each ODE only consists of a linear synthesis term and a linear degradation 
term, whilst in reality there is much more complexity to the up- and down-regulation 
of these proteins, including negative feedback loops, and the production of these 
proteins in other pathways. Despite this, the modelling predictions were measured 
against outcomes from experimental data and appeared to match these findings, 
suggesting that there is some accuracy to the model.  
Erguler et al. (Erguler, Pieri et al. 2013) also investigated the mechanism by which the 
UPR outcome switches between survival and death. The nonlinear model presented 
in this research was much more detailed than that created by Rutkowski et al., with 
27 species interconnected by 62 biochemical reactions in four different 
compartments. This resulted in an incredibly large number of parameters (82) 
required to describe the model. Due to this large number of parameters, the authors 
noted that it was not possible to carry out parameter estimation using experimental 
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data. In addition to this, due to the lack of sufficiently time-resolved studies on 
mammalian systems, arbitrary units of time and concentration were allocated to the 
model states and parameters. As such, results from this model can, at best, only be 
considered qualitative, as the model requires parameterisation using experimental 
data before quantitative values can be generated. Using this model, the authors 
demonstrated that the UPR may adopt low, intermediate and high activity states 
depending on the level of stress, and that the intermediate state may exhibit 
oscillations in translation attenuation and apoptotic signals. Whilst these results 
demonstrated an interesting concept as to how cells adapt to different levels of 
stress, the lack of experimental validation must be addressed before they can be 
trusted and used to further explore the stress response. Additionally, due to the high 
dimension complexity and the large number of parameters involved in the model, it 
is likely that it will need to be reduced in order or structure before robust parameter 
estimation can be carried out with experimental data, a necessary process before it 
can become a useful tool in potentially predicting experimental results. 
Despite these models providing more information on parts of the UPR, there is yet 
to be designed a useful model of the entire UPR that can be used to aid further 
experiments. This is most likely due to the complexity of the response, and the lack 
of experimental time series data that have been collected and utilised to validate 
such models. As such any smaller models, although useful for their original purpose, 
may lack biological accuracy, and higher dimensional models have not been suitably 
parameterised using experimental data.  
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This thesis explores the potential of designing a model of the UPR that focuses on 
one of its three biological pathways. In doing so, it reduces the complexity of the 
model whilst retaining biological accuracy of that pathway. The number of 
parameters required is therefore moderated and they are more likely to retain 
accuracy. Similarly, although the biological interactions included in the model will be 
reduced, those that are excluded will mostly be from pathways that have little 
crossover with the one modelled and the biological integrity will therefore be 
retained. This highlights an interesting compromise between complexity and 
accuracy of the model that minimises the negative impact of both sides of the 
compromise.  
The final intention is to continue to develop separate models for each arm of the UPR 
in order to study them individually before combining the models in order to create a 
full model of the entire UPR. Both the individual models and the larger combined 
model should provide more detailed information about how the UPR responds over 
time, and to different input perturbations. This information can then be utilised when 
designing future experiments. 
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1.3 Research Hypothesis, Aims and Objectives 
1.3.1 Research Hypothesis 
The hypothesis for this research is as such: Broccoli, in the form of freeze dried 
broccoli powder, protects adipocytes against ER stress induced by tunicamycin. Time 
series data from this research will aid in the construction of a mathematical model 
characterising the unfolded protein response. 
1.3.2 Research Aims 
5. To create a mathematical model of a pathway in the unfolded protein 
response using experimental time series data. 
6. To study ER stress in more detail by analysing how the expression of key ER 
stress proteins varies over time following treatment with tunicamycin. 
7. To investigate the potential protective effects of broccoli against ER stress in 
adipocytes. 
8. To examine the effects of broccoli on other mechanisms that also contribute 
to metabolic disease, such as ROS and mitochondrial dysfunction. 
 
1.3.3 Research Objectives 
1. The unfolded protein response is a complex system that may benefit from the 
development of a mathematical model to characterise it in order to 
understand how the interactions comprising the response change over time 
and in response to different input perturbations. In order to represent the 
response as accurately as possible with the available information in the 
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literature, the model that is developed will be dynamic, non-linear and built 
on basic mechanistic mass balance principles. Using mass action kinetics, a 
series of coupled ordinary differential equations will be created to describe 
the system dynamics and response. Experimental time series data of ER stress 
induced by tunicamycin will be collected at 17 time points over 72 hours, and 
these data will be used to parameterise and validate the model.  
 
2. There are currently very little time series data on proteins involved in ER 
stress, and as such it is not clear at what time point/s data should be collected 
to study the effects of various treatments. Data collected in the time series 
experiments will not only be useful for model parameterisation as described 
above, but will also be analysed biologically to elucidate protein expression 
patterns. This will be extremely useful for biological understanding and future 
experiments to determine at which time points data should be collected in 
order to obtain the most useful results.  
 
3. Broccoli has been shown to have many beneficial properties, such as 
improving lipid profiles, lowering inflammation and upregulating antioxidants 
in humans. It has thus been shown to reduce the risk of many cancers and 
inflammatory diseases. It is possible that, due to these properties, broccoli is 
able to protect against or reduce ER stress in adipocytes, which represents 
one of the major links between obesity and T2DM. As such, broccoli may be 
able to reduce the risk of obese patients developing T2DM. In order to 
investigate this, human adipocytes will be cultured and treated with a 
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broccoli extract, tunicamycin or a combination of the two. Protein and RNA 
samples will be collected and studied through Western Blotting, qRT-PCR and 
transcriptomic techniques in order to study the ER stress pathway and the 
effects of the treatments.  
 
4. ER stress is often linked to ROS and mitochondrial dysfunction which can both 
contribute further to metabolic diseases. It is therefore possible that broccoli 
may have a direct or indirect effect on these mechanisms. This will be 
investigated by treating cultured human adipocytes with a broccoli extract, 
tunicamycin, or a combination of the two, as above. Various techniques such 
as mitochondrial stress tests and colorimetric ROS assays will be undertaken 
in order to investigate any effects the different treatments have and to 
determine whether broccoli may reduce the risk of metabolic diseases via 
different mechanisms. 
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Chapter 2: 
Materials and Methods 
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2.1 Tissue Culture 
2.1.1 Human Preadipocyte Chub-S7 Cell Line 
The Chub-S7 cell line is a human subcutaneous white pre-adipocyte cell line which 
has been immortalised by the coexpression of human telomerase reverse 
transcriptase (hTERT) and papillomavirus E7 oncoprotein (HPV-E7) genes (Darimont, 
Zbinden et al. 2003). The cell line has been validated as a good model of human 
adipocyte biology as the cells retain the ability to undergo adipogenesis, and have 
been used to study the regulation of lipogenesis (Qiao, Maclean et al. 2005, 
Gathercole, Bujalska et al. 2007, Gathercole, Morgan et al. 2011). 
 
2.1.2 Cell Culture Media Composition 
Growth, differentiation and nutrition media were used in order to grow and 
differentiate the Chub-S7 cells during cell culture. 
Growth media: 
• DMEM/Ham’s F-12 phenol-free medium 500ml (Invitrogen #11039047) 
• Pencillin/streptomycin/L-glutamine 100x, 5ml (1%) (Invitrogen #10378-016) 
• Fetal bovine serum 50ml (10%) (Biosera # S1810) 
Differentiation media: 
• DMEM/Ham’s F-12 phenol-free medium 500ml (Invitrogen #11039047) 
• Fetal bovine serum, 15ml (3%) (Biosera #S1810) 
• Preadipocyte differentiation supplement pack x1 (Promocell #C-39436) 
• PromoCell supplements (listed with final concentrations): 
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- Insulin, recombinant human 0.5µg/ml 
- Dexamethasone 400ng/ml 
- D-biotin 8µg/ml 
- Isobutylmethylxanthine (IBMX) 44µg/ml 
- L-thyroxine 9ng/ml 
- Ciglitazone 3µg/ml 
Nutrition media: 
• DMEM/Ham’s F-12 phenol-free medium 500ml (Invitrogen #11039047) 
• Adipocyte nutrition supplement pack x1 (Promocell #C39439) 
• PromoCell supplements (listed with final concentrations): 
- Insulin, recombinant human 0.5µg/ml 
- Dexamethasone 400ng/ml 
- D-biotin 8µg/ml 
- Fetal calf serum 3% 
 
2.1.3 Growth and Differentiation of Preadipocytes 
Chub-S7 cells were grown in T75 flasks until they reached 80% confluency, at which 
point they were seeded on to treated polystyrene 6-well or 12-well plates (Corning) 
that had been coated with gelatin, at a density of 25,000 cells per cm2. In order to 
transfer cells from the T75 flask to the culture plates, media was aspirated and the 
cells washed three times with warm phosphate buffered saline (PBS) (37oC). 5ml of 
0.05% trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) was then added to the 
cells and left to incubate for 3 minutes before cells were dislodged by gentle tapping. 
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15ml of growth media was subsequently added to the trypsin-EDTA in order to 
neutralise it, and the solution was centrifuged at 1000rpm for 5 minutes to form a 
pellet. The supernatant was removed, and cells were resuspended in 5ml growth 
media before being counted with a haemocytometer and seeded on to plates. The 
seeding process required the addition of enough growth media to allow the desired 
number of cells to be added to each well in a volume of 1ml growth media. A further 
1ml of growth media was then added once the cells had adhered to the bottom of 
the plate. During the cell culture period, growth media was changed every 48-72 
hours until cells were confluent, at which point they were incubated in growth media 
for a further two days. Differentiation media was then used to initiate differentiation 
(day 0). From day 0 to day 6 of adipogenesis, differentiation media was changed 
every 48 hours; on day 6 media was changed to nutrition media and refreshed every 
48 hours until day 14. 
 
2.1.4 Treatments 
Following growth and differentiation of Chub-S7 cells, basal media was applied to 
cells for 24 hours prior to treatments in order to remove the effects of growth factors 
and other components in the nutrition media, and to allow the cells to equilibrate to 
the basal media before treatments were added. Each treatment, including the 
vehicle control, was placed in fresh basal media on the day of treatment. The 
concentration of tunicamycin (Tun) (Sigma #7765), 750ng/ml, was chosen according 
to previous studies investigating ER stress that used between 0.5µg/ml and 2.0µg/ml 
(Ozcan, Cao et al. 2004, Alhusaini, McGee et al. 2010, Mondal, Das et al. 2012), and 
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was diluted in dimethyl sulfoxide (DMSO). Broccoli extract was prepared by adding 
10ml of 100% ethanol to 1g of freeze dried broccoli powder (hybrid Brassica oleracea 
var. italic) and sonicating for 5 mins (10s on, 20s off x 10) on ice. This solution was 
then filtered using a 0.22µm steriflip filter (Millipore, SE1M179M6), and placed in a 
speed vacuum concentrator until there was no liquid left, at which point the 
remaining solid was resuspended in ethanol to create the desired concentration. The 
same volume of vehicle was applied to each well, including control wells, and all 
treatment media was filtered through a 0.22µm filter before being applied. All 
treatment was refreshed every 24 hours. 
2.1.5 Collection of Protein and RNA 
Protein samples were collected from culture cells using a lysis buffer consisting of 
5ml 1x radioimmunoprecipitation assay buffer (RIPA) (Millipore UK), 100µl of 
dissolved protease and phosphatase inhibitors (2 Roche Complete Mini protease 
inhibitor cocktail tablets and 8mg sodium fluoride (NaF, Fisher Scientific) and 20mg 
sodium vanadate (Na3VO4, Acros Organics) in 2ml 1 x RIPA). 250µl of protein lysis 
buffer was added to each well at 4oC and cells were subsequently scraped with a 
sterile scraper for 30 seconds. The contents of the well was then agitated with a 
pipette to promote cell lysis before being collected and stored at -80oC. This process 
was also used to collect RNA samples from cultured cells, using 350µl Buffer RLY 
(Bioline) and 3.5µl β-mercaptoethanol (β-ME) (Sigma) per well instead of protein lysis 
buffer. Either three or six protein and RNA samples were collected for each time 
point. 
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2.2 Analysis of Samples 
2.2.1 Protein Analysis 
Protein concentrations were determined using the Bradford assay, whereby 2µl of 
protein sample was added to 1ml of 1:4 Bradford stock reagent (Biorad, #5000006) 
and colorimetrically compared to known concentrations of bovine serum albumin 
(BSA) also added to 1ml of Bradford reagent. Western blot analysis was performed 
using a previously described method (Alhusaini, McGee et al. 2010). In brief, 20µg of 
protein sample was loaded onto a 10% denaturing polyacrylamide gel (GeneFlow, 
UK), separated by electrophoresis and transferred at 4oC, 25V overnight to 
membrane filter Immobilon-P transfer membranes with 0.45µm pore size (Fisher). 
Ponceau stain (Sigma-Aldrich, P7170) was then applied and membranes cut into 
strips containing different target proteins, before being washed in PBS and blocked 
in 0.2% I-Block PBS-tween (PBS-T) for 24 hours. Membranes were incubated in a 
primary antibody diluted in 0.2% I-Block PBS-T (p-eIF2α 1:500, total eIF2α 1:500, BiP 
1:500, β-actin 1:1000, Cell Signalling) at 4oC overnight; β-actin was used to confirm 
equal protein loading. Membranes were washed six times for five minutes in PBS-T 
and incubated in anti-rabbit IgG (whole molecule), horseradish peroxidase antibody 
produced in goat, IgG fraction of antiserum, buffered aqueous solution (Sigma 
#A9169). The chemiluminescent detection system, enhanced 
chemiluminescence/enhanced chemiluminescence+ (ECL/ECL+) (GE Healthcare, UK), 
was used to visualise protein bands, and densitometry was conducted using ImageJ 
software.   
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2.2.2 RNA Processing and Quantitative Real-Time Polymerase Chain Reaction 
RNA was extracted from cell culture samples using Isolate II RNA Mini Kit (Bioline, 
#BIO-52073) according to manufacturer’s instructions. RNA was eluted in 10µl 
RNase-free water and 1µl of each sample was used to quantify in duplicate using a 
spectrophotometer (Nanodrop ND-100, Labtech) at an absorbance of 260nm.  200ng 
of RNA from each sample was used to perform cDNA synthesis with a Bioline mRNA 
reverse transcription kit (#BIO-65026) according to manufacturer’s instructions. 
Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure 
gene expression, using ABI 7500 standard sequence detection system (Applied 
Biosystems, UK). 25µl sample volume was assayed, containing the cDNA sample, 
Taqman Universal PCR mastermix (#4304437 Applied Biosystems, UK), and a specific 
commercially available Taqman gene expression assay (ThermoFisher Scientific, UK, 
CHOP (DDIT3): Hs00358796_g1; ATF4: Hs00909568_g1; ATF6: HS00232586_M1). All 
reactions were assayed in triplicate and multiplexed with a housekeeping gene, 18S, 
a pre-optimised control probe (Applied Biosystems, UK). qRT-PCR was carried out as 
per the manufacturer’s instructions: 50oC for two minutes, 95oC for 10 minutes, 
followed by 40 cycles of 95oC for 15 seconds, and then 60oC for 1 minute. Data 
analysis was carried out using the following formula: 
mRNA expression = 2-ΔCt, where ΔCt = target gene Ct – 18S Ct 
 
 
 
 
Page 65 of 242 
 
2.2.3 Oil Red-O Staining 
Following the growth and differentiation of Chub-S7 cells as described above, Oil 
Red-O (ORO) stock solution was prepared by dissolving 0.5g of ORO powder in 200ml 
isopropanol in a 56oC water bath for 1hr. Working ORO solution was then prepared 
by diluting stock ORO with distilled water to make a 60% solution, which was then 
stirred well and left to stand for 10 minutes before being filtered through Whatman 
No 42 filter paper. Media was removed from each well and cells were washed twice 
with PBS before being fixed with 4% formalin for 15 minutes at room temperature. 
Excess formalin was removed and cells were washed twice with PBS for 5 minutes at 
room temperature, before being rinsed with 60% isopropanol. 500µl of working ORO 
was added to each well and incubated at room temperature for 30 minutes, before 
being removed and cells washed with PBS. Cells were then viewed under a light 
microscope to assess lipid accumulation, and digital photographs were taken.   
 
2.2.4 Seahorse Cell Mitochondria Stress Test 
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were 
measured using a Seahorse XF24 Extracellular Flux Analyser (Seahorse Bioscience, 
Agilent Technologies). Chub-S7 cells were grown in T75 flasks and seeded onto 
gelatin-coated 24-well plates (Seahorse Bioscience, 100850-001) at an optimised 
density of 10,000 cells per well. Cells were grown, differentiated and treated using 
the standard protocols described in sections 2.1.3 and 2.1.4 above; each 
experimental group had five replicates. The assay was performed in sterile, 
unbuffered assay media prepared with seahorse base media (Seahorse Bioscience, 
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102365-100) at 37oC, pH 7.4. This media also contained 1mM sodium pyruvate 
(Sigma, S8636), 2mM glutamine glutamax (Seahorse, included with plates) and 
17.5mM glucose (Sigma, G8769).  
Following a 30 minute calibration step and a 30 minute equilibration step, the assay 
protocol consisted of the following steps repeated for three cycles: mix (3 minutes), 
wait (2 minutes), measure (3 minutes). These cycles were initiated before and after 
each injection of Oligomycin (Sigma, O4876), Carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) (Sigma, C2920) and combined Rotenone 
(Sigma, R8875) and Antimycin A (Sigma, A8674). The injection of optimised reagents 
or vehicle control was done from a 10-fold concentrated stock solution to give final 
concentrations as described: 2 µM Oligomycin, 2 µM FCCP, 0.5 µM 
Rotenone/Antimycin A.  
 
2.2.5 Endogenous Antioxidant Activity Assays 
Endogenous antioxidants superoxide dismutase (SOD) and catalase were measured 
using OxiSelectTM Superoxide Dismutase Activity Assay (STA-340) and OxiSelectTM 
Catalase Activity Assay (STA-341) kits (Cell Biolabs). Chub-S7 cells were grown, 
differentiated and treated as described in sections 2.1.3 and 2.1.4 above, after which 
cells were washed three times with ice-cold PBS and harvested with a cell scraper in 
1ml ice-cold PBS. Samples were sonicated on ice and vortexed to encourage 
homogenisation, before being centrifuged and stored at -80oC until assayed. All 
assays were carried out in accordance with manufacturer’s instructions within one 
month of sample collection, using a PheraStar FS microplate reader (BMG Labtech) 
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to measure absorbance. Data analysis was carried out as per manufacturer’s 
instructions. 
 
2.2.6 Quantification of Total Reactive Oxygen and Nitrogen Species 
Total reactive oxygen and nitrogen species (ROS/RNS) were measured using 
OxiSelectTM in vitro ROS/RNS assay kit (STA-347, Cell Biolabs). Chub-S7 cells were 
grown, differentiated and treated as described in sections 2.1.3 and 2.1.4 above, 
after which cells were washed three times with ice-cold PBS and harvested with a cell 
scraper in 1ml ice-cold PBS. Samples were sonicated on ice and vortexed to 
encourage homogenisation, before being centrifuged and stored at -80oC until 
assayed. The assay was carried out according to manufacturer’s instructions, and 
fluorescence was measured after 30 minutes using a PheraStar FS microplate reader 
(BMG Labtech) with a 485/538nm filter and 530nm cutoff. Data analysis was carried 
out as per manufacturer’s instructions. 
 
2.2.7 Transcriptomics  
Chub-S7 cells were grown, differentiated and treated as described in sections 2.1.3 
and 2.1.4 above. Following protein analysis, RNA samples from the time point where 
cells exhibited the most protection against tunicamycin-induced ER stress by broccoli 
extract, 36 hours, were sequenced. RNA quality was assessed using a bioanalyser 
(Agilent 2100) before the mRNA samples were converted into libraries of template 
molecules using TruSeq RNA V2 (Illumina) as per manufacturer’s instructions 
(Illumina 2014). These libraries were then sequenced on a MiSeq platform, Illumina, 
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using a 75bp paired-end run, as per manufacturer’s instructions (Illumina 2015). The 
resulting data were quality checked using FastQC software (Andrews 2010), and 
adapters sequences as well as low quality regions in reads were trimmed using 
Trimmomatic software (Bolger, Lohse et al. 2014). Post trimming, BBNorm software 
(BBMap 2018) was employed to normalise coverage by down-sampling reads to 
obtain a flat coverage and also accelerate transcriptome assembly of all samples. 
Using these normalised reads, the transcriptomics assembly was prepared using Ray 
software (Boisvert, Raymond et al. 2012). Transcript quantification of individual 
samples was done with the above prepared transcriptome assembly using Salmon 
software (Patro, Duggal et al. 2013). Salmon uses a quasi-mapping based approach 
which has two steps – indexing and quantification. The indexing step is independent 
of the reads, and was therefore only required to be run once for a particular set of 
reference transcripts, whilst the quantification step is sample specific and was 
therefore run for each sample set.  
Post quantification, DESeq2 (Love, Huber et al. 2014) was used to perform 
comparisons between various sample conditions and the results were filtered using 
log2FC of greater than 0.5 and P-adj value of less than 0.1, where P-adj is the adjusted 
p-value following correction for multiple testing. Finally, the transcripts that were 
differentially expressed were searched against Uniprot protein human sequences set 
using RAPSearch2 (Zhao, Tang et al. 2012). The annotations linked to the resulting 
protein IDs were fetched using ID mapping files present in the Uniprot website 
(UniProt 2018). Accordingly, the GO annotation and pathway information was 
obtained. 
Page 69 of 242 
 
2.2.8 Statistical Analysis 
Statistical analyses were undertaken using Microsoft Excel 2010. Data are reported 
as mean ± standard error of the mean (SE), unless otherwise specified. Comparisons 
between samples were performed via two-tailed t-tests. p < 0.05 was considered 
statistically significant, and significance levels are indicated as follows: *p < 0.05, **p 
< 0.01, ***p < 0.001, and where more than one comparison was made: #p < 0.05, 
##p < 0.01, ###p < 0.001; +p < 0.05, ++p < 0.01, +++p < 0.001; ^p < 0.05, ^^p < 0.01, 
^^^p < 0.001. 
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CHAPTER 3:  
Modelling the Unfolded 
Protein Response 
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3.1 Introduction 
3.1.1 Obesity and Type 2 Diabetes Mellitus 
Obesity is a global epidemic, with the World Health Organisation reporting that the 
number of cases worldwide has almost tripled since 1975 (World Health Organisation 
2017). This is important as there are a range of serious health conditions that are 
associated with obesity, including type 2 diabetes mellitus (T2DM), heart disease, 
and some types of cancer (De Pergola and Silvestris 2013, Cefalu, Bray et al. 2015, 
Ndumele, Matsushita et al. 2016). Despite the number of diseases that are linked 
with obesity, it is T2DM that has a particularly strong interdependent relationship 
with the condition, and it has been shown that obesity accounts for 80-85% of the 
risk of developing T2DM (diabetes.co.uk 2017). It is not fully understood how the 
development of insulin resistance is caused by obesity, but it is likely due to a 
combination of responses activated during the condition. Inflammation, 
mitochondrial dysfunction, reactive oxygen species (ROS) and hypoxia have all been 
shown to occur during obesity and in turn can reduce the effectiveness of insulin 
signalling (Hummasti and Hotamisligil 2010, Kawasaki, Asada et al. 2012, Tripathi and 
Pandey 2012). Another response that occurs during obesity is endoplasmic reticulum 
stress, which can be induced by each of the conditions listed above, and can lead to 
reduced insulin sensitivity and T2DM. 
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3.1.2 Endoplasmic Reticulum Stress 
The endoplasmic reticulum (ER) is a cellular organelle which is responsible for the 
correct folding and trafficking of proteins, the synthesis of lipids, and the 
maintenance of calcium homeostasis. Nascent proteins enter the ER lumen as they 
are being synthesised, and chaperones within the ER assist in their correct folding 
before they are distributed to their final destination. However, if the rate of nascent 
proteins entering the ER exceeds the rate that can be correctly folded with the 
available chaperones, the ER becomes stressed and filled with unfolded and 
misfolded proteins that cannot be trafficked to their destination. In these conditions, 
the unfolded protein response (UPR) is activated in an attempt to relieve the stress, 
or to initiate apoptosis in order to protect the organism if the stress cannot be 
relieved.  
There are three main pathways in the UPR, each controlled by different 
transmembrane sensor proteins: activating transcription factor 6 (ATF6), protein 
kinase RNA-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme-1 
alpha (IRE1α) (Figure 3.1.2) (Carrara, Prischi et al. 2013). Under normal conditions, these 
sensor proteins are bound to the ER-resident chaperone binding immunoglobulin 
protein (BiP); however when ER stress ensues, BiP is separated from the sensors in 
order to assist with folding the excess number of unfolded proteins. This separation 
from BiP activates the sensor proteins, either through dimerisation and 
transphosphorylation (as with PERK and IRE1α), or translocation to the Golgi where 
cleavage occurs (as with ATF6) (Gardner, Pincus et al. 2013). Once these sensor 
proteins are activated, they initiate cascades which result in the inhibition of general 
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translation, upregulation of chaperones and activation of the endoplasmic-
reticulum-associated protein degradation (ERAD) process (Hetz, Chevet et al. 2015). 
Consequently, fewer nascent proteins enter the ER, more chaperones are available 
to help fold the existing unfolded proteins, and any misfolded proteins are degraded 
through the ERAD process. However if the stress continues despite these measures, 
the UPR switches to upregulate proteins involved in apoptosis in an attempt to save 
the organism from the stressed cell (Dufey, Sepúlveda et al. 2014).  
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Figure 3.1.2 Unfolded Protein Response: Stress within the endoplasmic reticulum (ER) 
causes the unfolded protein response (UPR) to be initiated. This involves the dissociation of 
BiP (binding immunoglobulin protein) from ATF6 (activating transcription factor 6), PERK 
(protein kinase RNA-like endoplasmic reticulum kinase) and IRE1 (inositol requiring enzyme 
1), initiating three protein cascades which result in the phosphorylation of eIF2α (eukaryotic 
initiation factor 2α), activation of ATF4 (activating transcription factor 4), and the splicing of 
XBP1 (X-box binding protein 1). These cascades cause the upregulation of chaperones and 
ERAD (endoplasmic-reticulum-associated degradation) proteins, and the downregulation of 
general protein translation. Acute UPR activation can reduce ER stress, however chronic 
activation can induce insulin resistance. Figure adapted from (Chakrabarti, Aboulmouna et 
al. 2016). 
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Despite the UPR being a mechanism designed to reduce ER stress, many of the 
downstream pathways cause upregulation of pro-inflammatory mediators, such as 
NFĸB and JNK (Zhang and Kaufman 2008). Activation of these proteins can lead to 
the inhibitory phosphorylation of insulin receptor substrate 1 (IRS-1), a key 
component of the insulin signalling pathway, and can consequently induce insulin 
resistance (Flamment, Hajduch et al. 2012). During obesity, cellular responses occur 
that induce ER stress over a prolonged period of time due to constant stimulation by 
nutrient intake and high fat diets. Consequently, the increased level of ER stress is 
maintained, creating a state of chronic inflammation which contributes to long-term 
insulin resistance through the inhibitory phosphorylation of IRS-1, which can 
eventually lead to T2DM (Hotamisligil 2008, Schonthal 2012).  
As chronic ER stress is one of the components that links obesity to T2DM (Hotamisligil 
2008), it may be possible to reduce the risk of subjects developing T2DM by 
mitigating the ER stress that they experience. In order to do this, it is important to 
first develop the understanding of the pathways within the UPR. It is not sufficient to 
examine individual molecules within such a complex biological pathway; interactions 
between the molecules must also be assessed to allow investigation of regulatory 
processes and how disruption of the pathway may affect the outcome (Klipp and 
Liebermeister 2006). Mathematical modelling is a crucial tool in this respect as it not 
only allows the individual molecular interactions to be studied, but also has the 
potential to show how these interactions contribute to the system as a whole (Fischer 
2008).   
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3.1.3 Mathematical Modelling of the Unfolded Protein Response 
Mathematical modelling has become increasingly recognised in biological sciences as 
a useful tool to aid the understanding of spatio-temporal pattern formations in 
biological systems (Motta and Pappalardo 2013). Models are being utilised in many 
different research areas, and even within the study of diabetes there is an array of 
models that vary in focus from molecular and cellular biology through clinical science 
to health service research. A summary of the mathematical models that have been 
created to aid the understanding of diabetes can be found in a review by Ajmera et 
al. (Ajmera, Swat et al. 2013). This review details how, despite the large number of 
models aiding the research into diabetes, there is still a large disproportion between 
the data collected from experimental approaches and their representation in 
mathematical models. This is accurate for research into the UPR, as there has been 
much study into it experimentally, yet there are comparatively very few attempts at 
mathematically modelling the response. There have, however, been some previous 
attempts at using mathematical models to study the UPR. 
Trusina and collaborators created a simplified model of the yeast UPR in order to 
investigate why the translation attenuation (TA) mechanism is more important in 
some cell types than others (Trusina, Papa et al. 2008). Rutkowski et al. used a linear 
model of the UPR to examine how protein expression patterns vary between those 
that contribute to cell survival compared to those that contribute to cell death 
(Rutkowski, Arnold et al. 2006). Finally, Erguler et al. created a large model that 
investigated how the UPR switches between favouring cell survival and apoptosis 
(Erguler, Pieri et al. 2013). These models vary greatly with regards to complexity and 
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biological detail, demonstrating the challenge of modelling such a complex biological 
pathway. It is unclear what experimental data, if any, Trusina et al. used for 
parameterisation, and whilst Rutkowski et al. created a small model that was 
therefore able to be parameterised and semi-validated with experimental data, it 
lacked biological detail. Conversely, Erguler et al. created a biologically accurate, 
detailed model of the UPR that was unable to be validated due to its complexity. This 
demonstrates the importance of considering the complexity of the model as well as 
gathering experimental data that will allow effective parameterisation and 
validation. 
The aim of the study in this chapter was therefore to investigate the complexity of 
UPR model that would best provide a balance between biological detail and accuracy 
of parameter estimation using experimental data. For this, literature searches and 
experimental studies were undertaken to: 
1. Identify the appropriate level of complexity for a mathematical model of the 
UPR. 
2. Collect experimental data of proteins involved in the UPR that can be used to 
aid model development. 
3. Develop a mathematical model of the UPR based on information from the 
literature search and experimental data. 
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3.2 Methods 
3.2.1 Cell Culture 
In order to gather experimental data that could aid in the development and 
validation of a mathematical model of the UPR, adipogenesis was induced in Chub-
S7 preadipocytes for 14 days. Oil Red-O staining was carried out at the beginning and 
end of the differentiation process to ensure that the pre-adipocyte cells had 
differentiated into mature adipocytes, by identification of red stained lipid droplets. 
Cells were then exposed to 750ng/ml tunicamycin for 24, 48 or 72 hours, with fresh 
tunicamycin exposure every 24 hours. Control cells were grown in the same manner 
and treated with the same concentration of DMSO, the vehicle for tunicamycin. 
Following this, cells were harvested, protein extraction was carried out and the 
expression of UPR proteins was assessed via Western blot analysis. 
 
3.2.2 Initial Modelling of the UPR 
A literature search was carried out in order to determine the best methods to 
evaluate the proteins studied during this experiment through a modelling approach. 
A mass action kinetics approach was implemented to create ordinary differential 
equations (ODEs) and these ODEs were then entered into Berkeley Madonna – a 
software package that solves differential equations numerically using the Runge-
Kutta 4th order algorithm and enables the output to be mapped against and fitted to 
experimental data. Parameters were then manually adjusted using the programme’s 
slider function with the aim of reducing the difference between the model output 
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and the dataset. The complexity of the model was considered throughout this 
process with the aim of ensuring accuracy, whilst maintaining manageability. 
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3.3 Results 
3.3.1 Oil Red-O Staining Confirmed Pre-Adipocyte Differentiation 
Oil Red-O staining of cells before (day 0) and after (day 14) the differentiation process 
highlighted a substantial accumulation of lipid droplets, confirming that the cells had 
differentiated into mature adipocytes over the time-frame (Figure 3.3.1.1).  
 
Figure 3.3.1.1 Adipocyte Staining: Oil Red-O staining of Chub-S7 cells at Day 0 and Day 14 of 
differentiation show a build-up of stained lipid droplets at the end of the differentiation 
process, indicating cells have developed into mature adipocytes. 
 
 
 
Day 0 10x Day 14 10x Day 14 20x 
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3.3.2 Protein Expression of UPR Markers Following Treatment with Tunicamycin 
Western blot analysis of samples exposed to tunicamycin over 24, 48 or 72 hours 
revealed that all ER stress proteins measured experienced changes in expression over 
time. BiP increased steadily over time, whilst P-PERK and PERK both experienced 
changes in expression that could indicate that oscillation is occurring (Figures 3.3.2.1 
and 3.3.2.2). The ratio of P-PERK to PERK was also studied in order to determine how 
phosphorylation rate varied independently of the availability of PERK molecules. 
Studying this ratio also indicated a possible oscillation was occurring, with an inverse 
pattern to that of P-PERK and PERK (Figure 3.3.2.2). Arbitrary units were used as 
Western blotting is a semi-quantitative technique that allows comparison between 
samples but does not provide a quantitative concentration. 
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Figure 3.3.2.1 Expression of BiP and P-PERK Proteins following Tunicamycin Treatment: 
Expression of endoplasmic reticulum (ER) stress proteins (A) binding immunoglobulin protein 
(BiP) and (B) phosphorylated protein kinase RNA-like endoplasmic reticulum kinase 
(phospho-PERK) following treatment with 750ng/ml tunicamycin over 72 hours. BiP 
expression increased uniformly over time, whilst P-PERK underwent a flux that may indicate 
oscillation of expression. Statistical analysis was performed for 48 and 72 hour time points 
vs. 24 hour time point, p-value: * p < 0.05. 
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Figure 3.3.2.2 Expression of PERK and Relative P-PERK following Tunicamycin Treatment: 
Expression of endoplasmic reticulum (ER) stress proteins (A) protein kinase RNA-like 
endoplasmic reticulum kinase (PERK) and (B) phospho-PERK (P-PERK) relative to PERK 
following treatment with 750ng/ml tunicamycin over 72 hours. PERK experienced changes 
in expression that could indicate oscillation, whilst P-PERK/PERK ratio underwent an increase 
followed by a decrease, revealing that phosphorylation rate had an inverse pattern to the 
protein expressions of PERK and P-PERK. Statistical analysis was performed for 48 and 72 
hour time points vs. 24 hour time point, p-value: * p < 0.05. 
  
A 
B 
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3.3.3 Model Creation 
A literature search revealed that the UPR involves hundreds of protein and mRNA 
molecules interconnected by over one thousand interactions (Chakrabarti, 
Aboulmouna et al. 2016). Modelling the entire system would therefore result in an 
unmanageable number of parameters that would not be reliably estimated; hence it 
was decided that only one pathway of the three involved in the UPR should be 
modelled. Studying the UPR process revealed the PERK pathway (Figure 3.3.3) as the 
most appropriate pathway to choose based on previous models and prior knowledge 
in the literature. The PERK pathway is important in both the survival and apoptotic 
processes, and is the sole contributor to the translation attenuation that occurs 
during the UPR. Additionally, the reactions responsible for the initiation of translation 
attenuation occur early in the pathway and only involve protein modification rather 
than gene translation. This immediately simplified the modelling process for the 
translation attenuation system as only protein data was required. Terms for the 
translation of genes into proteins would not be needed, and as such gene data would 
not be necessary to verify this. In summary, the initial section of the PERK pathway 
was identified as a useful portion of the UPR to model as it has a distinct function 
that involves few molecules, all of which are proteins. It may therefore provide useful 
information without the need to include a large number of species that would reduce 
the reliability of parameterisation. One must take care to avoid overparameterisation 
when creating a model in order to allow effective prediction of future data points. 
Overparameterisation increases the complexity of a model to an extent where it fits 
all or most of the available data, which can lead to poor predictive power when 
extrapolating to predict new data points. It can also require more computer power, 
Page 85 of 242 
 
slowing the process of running the model, and can reduce parameter identifiability – 
reducing the chance of determining individual parameters. The complexity of a 
model can also vary depending on what species measurements are possible to 
collect, as well as what data are available. Model reduction may be necessary in order 
to assess the appropriate level of complexity. This involves creating models with 
varying complexity and comparing the resulting outputs using some appropriate 
measure (e.g. Akaike information criterion (AIC), Bayesian information criterion (BIC). 
There are also certain limitations associated with the creation of a mathematical 
model of this biological pathway. For instance, the ability to sufficiently parameterise 
the model relies upon a comprehensive knowledge of the pathway itself, and whilst 
the pathway has been studied extensively, there are still some aspects that are 
unknown which would aid in the parameterisation. Considering the computational 
power is also important when studying such as complex pathway, as well as the 
amount of data collected to support it. The dataset collected in this investigation was 
not large enough to support a large scale model of the entire pathway, and as such a 
sub-model describing a distinct part of the system was designed instead, allowing it 
to be adequately characterised and robustly parameterised with regards to the data 
available. The biochemical reactions involved in the model are shown in Figure 3.3.3. 
This simple model was created with the intention of expanding it to involve further 
downstream interactions. 
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Figure 3.3.3 The PERK Pathway: (A) The unfolded protein response initiates a series of 
cascades involving activating transcription factor 6 (ATF6), protein kinase R-like endoplasmic 
reticulum kinase (PERK) and inositol requiring enzyme 1 (IRE1), when the endoplasmic 
reticulum (ER) can no longer cope with the demand of unfolded proteins. ATF6 initiates Bcl-
2-associated death promoter (Bad) phosphorylation, whilst inositol requiring enzyme 1 
(IRE1) splices x-box protein 1 (XBP1). The PERK pathway (highlighted) specifically activates 
the translation attenuation system through phosphorylation of the alpha subunit of 
eukaryotic initiation factor 2 (eIF2α) and upregulation of activating transcription factor 4 
(ATF4), which decreases general protein production. ATF6 and IRE1 pathways upregulate 
endoplasmic-reticulum-associated protein degradation (ERAD) proteins, as well as 
chaperones such as binding immunoglobulin protein (BiP). Figure adapted from (Chakrabarti, 
Aboulmouna et al. 2016) (B) The initial part of the PERK pathway cascade involves three 
steps: 1. Dissociation of BiP from PERK, 2. PERK dimerisation, and 3. PERK phosphorylation.  
 
The three reactions used for the model included the dissociation of BiP:PERK 
proteins, followed by PERK dimerisation and phosphorylation (Figure 3.3.3B). This 
model involved five species: BiP:PERK, BiP, PERK, PERK:PERK and Phospho-PERK, and 
six parameters. In each of these reactions, the rate is directly proportional to the 
A B 
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product of the concentrations of the reactants, and a mass action kinetics approach 
was therefore used to create ODEs to describe the pathway. The nonlinear ODEs 
derived from the chemical reactions are described below: 
 
1. 
𝑑
𝑑𝑡
(𝐵𝑖𝑃) = 𝑘𝑑1(𝐵𝑖𝑃: 𝑃𝐸𝑅𝐾) − 𝑘𝑎1(𝐵𝑖𝑃)(𝑃𝐸𝑅𝐾) 
2. 
𝑑
𝑑𝑡
(𝐵𝑖𝑃: 𝑃𝐸𝑅𝐾) = 𝑘𝑎1(𝐵𝑖𝑃)(𝑃𝐸𝑅𝐾) − 𝑘𝑑1(𝐵𝑖𝑃: 𝑃𝐸𝑅𝐾) 
3. 
𝑑
𝑑𝑡
(𝑃𝐸𝑅𝐾) = 𝑘𝑑1(𝐵𝑖𝑃: 𝑃𝐸𝑅𝐾) − 𝑘𝑎1(𝐵𝑖𝑃)(𝑃𝐸𝑅𝐾) +
𝑘𝑑2(𝑃𝐸𝑅𝐾: 𝑃𝐸𝑅𝐾) − 𝑘𝑎2(𝑃𝐸𝑅𝐾)(𝑃𝐸𝑅𝐾) 
4. 
𝑑
𝑑𝑡
(𝑃𝐸𝑅𝐾: 𝑃𝐸𝑅𝐾) = 𝑘𝑎2(𝑃𝐸𝑅𝐾)(𝑃𝐸𝑅𝐾) − 𝑘𝑑2(𝑃𝐸𝑅𝐾: 𝑃𝐸𝑅𝐾) +
𝑘4(𝑃𝑃𝐸𝑅𝐾) − 𝑘3(𝑃𝐸𝑅𝐾: 𝑃𝐸𝑅𝐾) 
5. 
𝑑
𝑑𝑡
(𝑃𝑃𝐸𝑅𝐾) = 𝑘3(𝑃𝐸𝑅𝐾: 𝑃𝐸𝑅𝐾) − 𝑘4(𝑃𝑃𝐸𝑅𝐾). 
 
These nonlinear ODEs were entered into the Berkeley Madonna programme, and 
parameters were estimated to permit synthetic simulations. Constraints were placed 
on the model for simulation and parameter fitting purposes, namely that all species 
are non-negative (based on the fact that it is not possible to have a negative amount 
of protein), and model parameters/rate constants, once assigned, are also non-
negative.  
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3.3.4 Parameter Estimation Using Experimental Data 
In order to test the goodness-of-fit and better parameterise the model, the 
experimental data for BiP, PERK and phospho-PERK protein expression (Figure 3.3.2) 
were entered into the programme and compared with the model output. Using the 
slider function in Berkeley Madonna, the parameters were adjusted to minimise the 
differences between the model-generated and experimental data to perform a basic 
sensitivity analysis. This slider function prompts the model to re-run instantly with 
each movement of a slider, displaying the new solution immediately and allowing 
fine-tuning of the model output. The output from this initial model was biologically 
qualitatively realistic, as determined using biological insight to study the geometric 
shape of the output and match the long term data to known biological behaviours of 
the system (Figure 3.3.4).  
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As the experimental data used to parameterise the model were only over three time 
points (24hr, 48hr and 72hr), this was intended to give a better initial indicator of 
what order of magnitude the parameters might take, with the knowledge that more 
regular time points would be needed to reliably parameterise the model. A summary 
of the model data is displayed in Table 3.3.5, showing the initial conditions and values 
for species, as well as parameter values obtained from the model. There is limited 
data published on concentrations of proteins present in unstressed conditions, so for 
this model biological insight was used and the BiP:PERK complex was the only species 
with an initial condition more than zero, as this complex is known to be present in 
unstressed conditions, and dissociate in conditions of stress (Grootjans, Kaser et al. 
2016). The value for the initial condition of the BiP:PERK complex was also considered 
as an unknown parameter as this cannot be readily measured or assigned. This initial 
condition parameter was then adjusted along with parameter values to best fit the 
experimental data.  
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Table 3.3.5 Species and Parameter Details of Initial PERK Model: A mathematical model of 
part of the protein kinase R-like endoplasmic reticulum kinase (PERK) pathway of the 
unfolded protein response (UPR) was created using nonlinear ordinary differential equations 
and was compared with experimental data. These tables describe (A) initial conditions and 
known values for the species in the model and (B) parameter values for the model. Arbitrary 
units were used as the protein measurement technique is semi-quantitative and gives non-
dimensional results. 
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3.4 Discussion 
This study was designed to produce a mathematical model of the UPR, with a 
complexity that would allow an appropriate compromise between biological detail 
and parameter estimation. The experimental data collected during this study 
provided an insight into the effect of tunicamycin on Chub-S7 cells, revealing that 
whilst BiP expression increased uniformly over time, PERK and P-PERK appeared to 
have a more cyclic expression profile. Developing a mathematical model of the initial 
part of the PERK pathway highlighted that focussing on one particular arm of the UPR 
may allow the creation of more manageable models, whilst retaining biological 
accuracy. This model also indicated that much of the change in protein expression 
might occur within the first 12 hours of treatment, providing useful information 
regarding future experimental procedures. 
Experimental data collected during this research supported the numerous studies 
showing that tunicamycin alters the expression of UPR proteins (Oslowski and Urano 
2011, Hou, Gutschmidt et al. 2014, Wang, Wang et al. 2015), however this had not 
been identified in differentiated Chub-S7 cells before. This data also highlighted how 
different proteins respond to tunicamycin treatment in different ways. The 
expression of BiP, a chaperone which binds to each of the sensor proteins within the 
UPR and acts as a switch to control the UPR response, increased steadily, whilst PERK 
and P-PERK expression appeared to vary, with a possible cyclic expression profile. 
This is the first experimental evidence that supports the outcome of the model 
created by Erguler et al. which suggested that many of the system components 
dramatically oscillate between low and high activity states (Erguler, Pieri et al. 2013). 
Page 93 of 242 
 
This cyclic expression was also observed with the P-PERK/PERK ratio, which exhibits 
the inverse expression profile to both PERK and P-PERK. This ratio provides 
information on the rate of phosphorylation of PERK, and these results highlight the 
importance of studying the ratio in order to better understand the activation of the 
UPR. The ratio is important as the rate of phosphorylation is a better indicator of the 
level of ER stress occurring compared to the raw expression of either PERK or P-PERK, 
as it represents the protein’s capacity for signal transduction (PERK) vs. its activation 
(P-PERK) (Bass, Wilkinson et al. 2017). These results demonstrate that the ratio can 
greatly differ from the raw expression values, and as such it is important to study 
both types of data.  
The biologically qualitatively realistic output from the mathematical model, which 
consisted of six nonlinear ODEs, highlighted that modelling each particular arm of the 
UPR separately may allow more accurate parameter estimation without 
compromising biological detail. This identified a novel solution to the problems 
experienced by Rutkowski and Erguler regarding the difficulty of parameter 
estimation when model complexity is increased to prioritise accurate biological 
detail. Attempts to compare parameter values from this model with those developed 
by Rutkowski and Erguler highlighted the large variety in model development, as only 
two similar parameters were included in this model and Erguler’s, whilst Rutkowski’s 
model only included parameters for the translation, transcription and degradation of 
protein and mRNA rather than the interactions between them. 
Results from this study have also demonstrated the importance of combining 
experimental data with mathematical models. Studying the experimental data alone 
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provided novel data indicating that tunicamycin alters the expression of different 
UPR proteins in different ways. Using these data to parameterise and validate the 
mathematical model provided information regarding time points where most 
changes are likely to occur, which can be used to more appropriately plan future 
experiments. The success of this initial model indicated that collecting more granular 
time series data, along with developing ODEs that better represent the data 
collected, may be worthwhile to more accurately estimate the activity of proteins 
not directly measured through experimental procedures. This would also allow 
further analysis into the cyclic expression of proteins in the translation attenuation 
system.  
Whilst the data collected during this study provided a broad overview of the 
expression profiles of the proteins studied, it also highlighted the importance of 
obtaining data on acute expression to determine the immediate impact of 
tunicamycin on protein expression. As such, this study has provided important 
information not only with regards to the data collected and the model developed, 
but also with regards to which time points to study in the future and how often to 
collect data in order to support an improved mathematical model of the UPR.  
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3.5 Conclusions 
This study has demonstrated that tunicamycin induces ER stress in Chub-S7 cells, 
resulting in varying responses in UPR protein expression profiles. It has also provided 
the first experimental evidence in support of Erguler’s theory that proteins involved 
in the translation attenuation system experience an oscillating expression profile. 
The mathematical model developed was qualitatively biologically accurate, and 
identified a novel solution to the common problem of modelling biological systems 
by modelling individual functions of a system rather than the system itself. This 
chapter has contributed to the first aim of this thesis, to create a mathematical model 
of a pathway in the unfolded protein response using experimental data. 
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CHAPTER 4:  
Studying the Unfolded 
Protein Response over 
Time 
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4.1 Introduction 
4.1.1 Biological Data in the Parameterisation Process 
In recent years, the use of in silico modelling to study biological systems has become 
more widespread, allowing users to analyse complex high-dimensional systems more 
easily. These biological models are important as they allow users to view simulations 
of the system under various conditions, as well as make informed decisions based on 
predictions that the model makes. In order for these models to make accurate 
simulations and predictions, they must be validated using as large a data set as 
possible, as well as expert knowledge (Hussain, Langmead et al. 2015). One of the 
challenges encountered when creating a biological model is finding values for 
parameters that allow the model to replicate biological data accurately. Once these 
parameters have been determined, however, the model can be used to simulate the 
activity of the biological system under a variety of conditions. Such models of 
biological systems are relevant to communicate concepts, test hypotheses, enhance 
the understanding of the dynamic characteristics of the system, and as such help to 
drive forward biological research objectives (O'Hara, Livigni et al. 2016). 
In order to parameterise a model, experimental data must be collected with the 
understanding that they are likely to contain some degree of error or inaccuracy. 
There are many inaccuracies involved with collecting biological data in a living system 
and it is in the researcher’s interest to reduce these as much as possible. In order to 
decrease the impact of any inaccuracies, a surplus of data can be collected to 
compensate for any uncertainty in measurements (Ledder 2013). Collecting multiple 
biological samples for the same data point allows any inconsistencies to be identified 
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and a suitable procedure, such as removal of an inconsistent point or artefact, to be 
carried out.  Considering each averaged time point in conjunction with the rest of the 
time series data also allows the identification of potential inaccurate results, or 
outliers, and as such a time series with frequent time points which each have multiple 
sample replicates limits the level of inaccuracy within the data (Wooley and Lin 2005).  
 
4.1.2 Time Series Data 
Time series data, a collection of data points over a specific period of time that 
represents the state variables over that time-frame, are often used for the 
parameterisation of models (Guo, Abdelraouf et al. 2011, Mochan, Swigon et al. 
2014, Cantone, Santos et al. 2017). The more frequent the time points, the more 
reliable and useful the data are in the parameterisation process, and the finer 
granularity the data will have. The previous chapter discussed an initial model for the 
unfolded protein response (UPR), however in order to create a more robustly 
parameterised, fine-tuned and detailed model, a larger time series dataset was 
required. Collecting time series data is not only useful for model parameterisation 
and validation, but can also provide detailed information about the biological system 
directly. Currently in the literature, there is a lack of time series data for the UPR, 
with most researchers looking at just one time point whilst comparing a treatment 
with a control. Studies that have collected samples at multiple time points have 
usually studied a limited number of time points over a matter of hours. For instance, 
one of the more comprehensive time series investigations into the UPR, carried out 
by Mintz et al. in 2008, studied a restricted number of time points, four, over a short 
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time frame of 24 hours (Mintz, Vanderver et al. 2008). The lack of sufficient time 
series data available has limited our understanding of how the UPR varies over a 
longer time-frame – information which may shed light on how certain interactions 
impact on the total response, and at what point the UPR undergoes the most flux or 
enters a steady state. 
The aim of the research in this chapter was to collect a more granulated, 
comprehensive time series dataset of the UPR over a longer time-frame than has 
previously been studied. The ambition was to understand how the adipocyte UPR 
responds to tunicamycin over time, as well as to develop and extend the 
mathematical model described in the previous chapter. 
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4.2 Methods 
4.2.1 Cell Culture 
Adipogenesis was induced in Chub-S7 preadipocytes for 14 days. Lipid accumulation 
was confirmed as explained in Chapter 3. Cells were exposed to 750ng/ml 
tunicamycin for the following lengths of time: 0hr, 30 mins, 1hr, 2hr, 4hr, 6hr, 12hr, 
18hr, 24hr, 30hr, 36hr, 46hr, 48hr, 54hr, 60hr, 66hr, or 72hr, with fresh Tunicamycin 
exposure every 24 hours. Control cells were grown in the same manner and treated 
with the equivalent concentration of DMSO vehicle (Figure 4.2.1). Following 
treatment, cells were harvested and protein extraction was carried out to allow 
analysis by Western blot. Six samples at each time point were collected, processed 
and analysed in order to increase the reliability of the results. 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1 Treatment of Adipocytes with Tunicamycin: Chub-S7 adipocytes were grown 
and differentiated before being treated with tunicamycin (750ng/ml). Control cells were 
grown in the same manner and treated with the equivalent concentration of DMSO. Protein 
samples were collected at 17 time points over 72 hours (0hr, 30 mins, 1hr, 2hr, 4hr, 6hr, 12hr, 
18hr, 24hr, 30hr, 36hr, 46hr, 48hr, 54hr, 60hr, 66hr, or 72hr).  
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4.2.2 Model Development and Parameterisation 
Following protein extraction and analysis, biological data from the 17 time points 
were imported into Berkeley Madonna and compared against the previous model 
simulation. The ODEs were re-assessed for biological accuracy using information 
from the previous chapter regarding appropriate model complexity, and the slider 
function was used within Berkeley Madonna to give an initial estimate for the 
unknown parameter values. The Curve Fit function was then utilised to 
computationally identify parameter values that resulted in the closest match 
between the model simulation and biological data. The residual sum of squares was 
calculated for the species in each model and was used as a measure in order to assess 
whether changes to model parameters resulted in a closer fit to experimental data. 
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4.3 Results 
4.3.1 ER Stress Proteins Respond in Different ways to Tunicamycin Treatment over 
Time 
As anticipated, the expression of all UPR proteins analysed was altered following 
treatment with tunicamycin, a known inducer of ER stress. The expression of BiP, a 
chaperone that dissociates from each sensor protein to assist with protein folding 
during stress, increased steadily over time, reaching a peak of 9.5-fold its original 
expression level over the 72 hours (Figure 4.3.2.1).  
 
Figure 4.3.1.1 BiP Expression following Tunicamycin Treatment: Following treatment of 
Chub-S7 adipocytes with 750ng/ml tunicamycin, binding immunoglobulin protein (BiP) 
expression increased steadily over 72 hours, peaking at 9.5-fold its original expression level. 
This is demonstrated in both the graph and via the Western blot images of BiP and the 
housekeeping control protein, β-Actin. 
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P-eIF2α is involved in the translation attenuation system through inhibiting 
guanosine diphosphate (GDP)/guanosine triphosphate (GTP) exchange. These results 
indicated that P-eIF2α underwent an initial peak in expression before experiencing a 
slight oscillation (Figure 4.3.1.2).  
 
Figure 4.3.1.2 P-eIF2α Expression following Tunicamycin Treatment: The expression of 
phosphorylated eukaryotic initiation factor 2 alpha (P-eIF2α) was measured in Chub-S7 
adipocytes following treatment with 750ng/ml tunicamycin over time. As illustrated in the 
graph and Western blot images, P-eIF2α expression underwent an initial peak before 
experiencing a slight oscillation. 
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Expression of eIF2α, the inactive form of P-eIF2α which is activated through 
phosphorylation by P-PERK, varied the most out of the three proteins studied and 
exhibited a more prominent oscillation. There was a large 70% reduction in 
expression within the first 30 minutes, after which oscillation occurred with 
amplitude increasing over time (Figure 4.3.1.3).  
 
Figure 4.3.1.3 eIF2α Expression following Tunicamycin Treatment: Eukaryotic initiation 
factor 2 alpha (eIF2α) protein expression was analysed in Chub-S7 adipocytes following 
treatment with 750ng/ml tunicamycin over time. Western blot analysis revealed an 
oscillation of eIF2α protein expression. This is demonstrated in both the graph and Western 
blot images, along with the β-Actin control.  
 
The perceived oscillatory effect of P-eIF2α and eIF2α is confirmed when taking into 
account the ratio of the two proteins. This is an important process to understand if 
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the change in P-eIF2α is due to an altered rate of phosphorylation, or because there 
is a variation in the concentration of eIF2α available to be phosphorylated. These 
results illustrated a clear oscillation whereby the relative expression of P-eIF2α rises 
rapidly within the first 6 hours before falling and continuing to oscillate between 3-
fold and 9-fold of the resting state (Figure 4.3.1.4).  
 
 
Figure 4.3.1.4 P-eIF2α Expression Relative to eIF2α following Tunicamycin Treatment: 
Expression of phosphorylated eukaryotic initiation factor 2 alpha (P-eIF2α) relative to its un-
phosphorylated counterpart, eIF2α, was analysed in response to treatment with 750ng/ml 
tunicamycin in Chub-S7 adipocytes. Analysis revealed a clear oscillation of phosphorylation 
rate that altered between 3-fold and 9-fold of the resting state value. Western blot images 
are provided alongside the β-Actin control.   
 
 
Page 106 of 242 
 
4.3.2 Comprehensive Time Series Data Allowed More Accurate Model Simulation 
Expanding on knowledge gained from creating the mathematical model in the 
previous chapter, the process of extending the model to incorporate these new 
biological results was assisted by creating a biological schematic of the system being 
modelled (Figure 4.3.2.1). The previous model provided information on the ideal 
complexity for this model, ensuring only relevant interactions that could be reliably 
parameterised, or are essential to the biological integrity, were represented.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.2.1 Model Schematic for PERK Pathway:  A schematic of the protein kinase RNA-
like endoplasmic reticulum kinase (PERK) pathway within the unfolded protein response 
(UPR) was developed, including only those proteins essential to the initiation of translation 
attenuation. This reduced complexity enabled kinetic equations to be created in order to 
develop a mathematical model of the pathway. Proteins involved include binding 
immunoglobulin protein (BiP), PERK and eukaryotic initiation factor 2 alpha (eIF2α). P 
indicates a phosphate group added during phosphorylation. Ø denotes BiP leaving the 
system as it enters other pathways not considered here.  
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Using the schematic in Figure 4.3.2.1, a set of kinetic equations was developed to aid 
in the translation of the schematic into the corresponding ODEs. The kinetic 
equations include the parameters involved in each reaction, and are displayed in 
equations 1-6 below, where:  
BiP = binding immunoglobulin protein,  
PERK = protein kinase RNA-like endoplasmic reticulum kinase,  
PPERK = phosphorylated PERK,  
eIF2α = eukaryotic initiation factor 2 alpha,  
PeIF2α = phosphorylated eIF2α,  
BiPX = BiP bound to proteins other than PERK (such as other UPR sensors or unfolded 
proteins),  
PERK:PERK = PERK dimer,  
PPERK:PPERK = phosphorylated PERK dimer,  
PPERK:PPERK:eIF2α = PPERK dimer in complex with eIF2α,  
PPERK:PPERK:PeIF2α = PPERK dimer in complex with PeIF2α: 
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The ODEs created from the schematic and kinetic equations formed the base of the 
new model, and are described in differential equations 7-16, where:  
BiP = binding immunoglobulin protein,  
PERK = protein kinase RNA-like endoplasmic reticulum kinase,  
PPERK = phosphorylated PERK,  
eIF2α = eukaryotic initiation factor 2 alpha,  
PeIF2α = phosphorylated eIF2α,  
BiPX = BiP bound to proteins other than PERK (such as other UPR sensors or unfolded 
proteins),  
BiP:PERK = BiP in complex with PERK,  
PERK:PERK = PERK dimer,  
PPERK:PPERK = phosphorylated PERK dimer,  
PPERK:PPERK:eIF2α = PPERK dimer in complex with eIF2α,  
PPERK:PPERK:PeIF2α = PPERK dimer in complex with PeIF2α: 
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In order to compare the model output to experimental data, the following terms 
were added to express the total amount of each protein measured. These terms were 
created by summing the different states involving each protein, and are described in 
equations 17-19, where: 
BiP = binding immunoglobulin protein,  
PERK = protein kinase RNA-like endoplasmic reticulum kinase,  
PPERK = phosphorylated PERK,  
eIF2α = eukaryotic initiation factor 2 alpha,  
PeIF2α = phosphorylated eIF2α,  
BiPX = BiP bound to proteins other than PERK (such as other UPR sensors or unfolded 
proteins),  
PPERK:PPERK = phosphorylated PERK dimer,  
PPERK:PPERK:eIF2α = PPERK dimer in complex with eIF2α,  
PPERK:PPERK:PeIF2α = PPERK dimer in complex with PeIF2α,  
BiPtot = total BiP protein measured via Western blot,  
eIF2αtot = total eIF2α measured via Western blot,  
PeIF2αtot = total PeIF2α measured via Western blot: 
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Including terms that express the total amount of each protein measured was 
necessary as the Western blot method of protein measurement incorporates the 
entire protein of interest in the result. This is regardless of whether it is bound to 
another protein in a complex, or if it is in its free form, and thus the ODEs used must 
reflect this. 
An ODE that represents the ratio of P-eIF2α to eIF2α was also added due to the 
biological significance of this ratio that was observed with the data, allowing more 
thorough study of the phosphorylation event. This ODE was generated using the 
quotient rule, which can be used to find the derivative of a function that is the ratio 
of two differentiable functions. For example, if 𝑓(𝑡) = 𝑔(𝑡)/ℎ(𝑡), where g and h are 
both differentiable and h does not equal 0, then the derivative of f(t), f’(t), is: 
 
𝑓′(𝑡) =  
𝑔′(𝑡)ℎ(𝑡) − 𝑔(𝑡)ℎ′(𝑡)
[ℎ(𝑡)]2
 
 
As such, if f represents the ratio of P-eIF2α to eIF2α (P-eIF2α:eIF2α), g represents the 
total P-eIF2α measured by Western blot (PeIF2αtot) and h represents the total eIF2α 
measured by Western blot (eIF2αtot), the following equation can be written, where:  
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PeIF2α:eIF2α = ratio of phosphorylated eukaryotic initiation factor 2 alpha (PeIF2α) 
and its unphosphorylated counterpart eIF2α,  
eIF2α = eukaryotic initiation factor 2 alpha,  
PeIF2α = phosphorylated eIF2α,  
PPERK:PPERK = phosphorylated PERK dimer,  
PPERK:PPERK:eIF2α = PPERK dimer in complex with eIF2α,  
PPERK:PPERK:PeIF2α = PPERK dimer in complex with PeIF2α: 
  
Once the set of ODEs were entered into Berkeley Madonna, the available slider 
function was utilised. This allows the user to manually adjust the model output to 
match the experimental data as best as possible. The residual sum of squares was 
also calculated, which gave an indicator of the discrepancy between the data and the 
model. The outputs of this model are documented in Figure 4.3.2.2 and Figure 
4.3.2.3, with the residual sum of squares for each species shown in Table 4.3.2.4.  
20. 
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Table 4.3.2.4 Residual Sum of Squares from PERK Model with Manually Adjusted 
Parameters: Manual parameterisation of the model of the protein kinase RNA-like 
endoplasmic reticulum kinase (PERK) pathway of the unfolded protein response was carried 
out to best fit the available experimental data, where Chub-S7 adipocytes were treated with 
750ng/ml tunicamycin over 72 hours. The residual sum of squares was calculated for binding 
immunoglobulin protein (BiP), eukaryotic initiation factor 2 alpha (eIF2α), phosphorylated 
eIF2α (P-eIF2α) and P-eIF2α relative to eIF2α (P-eIF2α/eIF2α) in order to provide a measure 
of how well the model fitted the experimental data. 
 
A list of parameters for this model that utilised the slider function in Berkeley 
Madonna for manual parameterisation are listed in Table 4.3.2.5.  
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Table 4.3.2.5 Parameters used in the Manually Parameterised UPR Model: A mathematical 
model of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathway of the 
unfolded protein response (UPR) was designed and developed, using experimental data for 
parameterisation. Experimental data were collected following the treatment of Chub-S7 
adipocytes with 750ng/ml tunicamycin over 72 hours. Manual parameterisation using the 
slider function in Berkeley Madonna software resulted in the parameter values shown. 
BiP = binding immunoglobulin protein, PERK = protein kinase RNA-like endoplasmic 
reticulum kinase, P-PERK = phosphorylated PERK, eIF2α = eukaryotic initiation factor 2 alpha, 
P-eIF2α = phosphorylated eIF2α, BiPX = BiP bound to proteins other than PERK (such as other 
UPR sensors or unfolded proteins), BiP:PERK = BiP in complex with PERK, PPERK:PPERK:eIF2α 
= PPERK dimer in complex with eIF2α, PPERK:PPERK:PeIF2α = PPERK dimer in complex with 
PeIF2α.  
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The initial findings using the slider function highlighted the impact that subtle 
changes in parameter values can have on model output and thus their sensitivity. It 
was determined that parameters kd1 (which represents the dissociation of the 
BiP:PERK complex) and ka2 (which represents the association of one PERK protein 
with another to form a dimer,) were the most sensitive, resulting in large changes in 
model output with only small changes in parameter values (Figure 4.3.2.7). 
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Figure 4.3.2.7 Model output following Sensitivity Analysis: A mathematical model of the 
protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathway of the unfolded 
protein response was developed and parameterised using the slider function in Berkeley 
Madonna. This function was also used to assess parameter sensitivity, where (A) kd1, which 
represents the dissociation of the BiP:PERK complex, and (B) ka2, which represents PERK 
dimerisation, were discovered to be the most sensitive parameters, resulting in the largest 
changes in model output  following a 2-fold change in parameter value. Chub-S7 adipocytes 
were treated with 750ng/ml tunicamycin over 72 hours and the following protein 
expressions were measured: binding immunoglobulin protein (BiP): black; eukaryotic 
initiation factor 2α (eIF2α): red; phospho-eukaryotic initiation factor 2α (P-eIF2α): green; and 
P-eIF2α/eIF2α ratio: blue. Bold lines represent model output, dotted lines represent 
experimental data. Lines between experimental data points represent linkages between 
discrete mean values for data collected and are not true trajectories over time. Initial 
conditions are as follows (AU) BiP:PERK (10), BiP (1), BiPX (20), PERK (0), PERK:PERK (0), 
PPERK:PPERK (0), eIF2α (10), PPERK:PPERK:eIF2α (0), PPERK:PPERK:PeIF2α (0), PeIF2α (0), 
BiPtot (1.70), eIF2αtot (4.38), PeIF2αtot (1.76), PeIF2α/eIF2α (0.35). 
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Using the slider functions to adjust model output resulted in parameter estimates 
that could be entered into the Curve Fit function. This function computationally 
identifies parameter values that, if the fitting algorithm converges, are likely to result 
in a close fit to the experimental data. The parameter estimation from this function 
resulted in the graphs shown in Figure 4.3.2.8 and Figure 4.3.2.9, and the 
corresponding residual sum of squares represented in Table 4.3.3.10. Computational 
parameterisation reduced the overall RSS value by 33% compared to manual 
parameterisation, indicating that there is less discrepancy between model output 
and experimental data when the Curve Fit function is utilised. 
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Table 4.3.2.10 Residual Sum of Squares from PERK Model with Computationally Adjusted 
Parameters: Computational parameterisation of a model of the protein kinase RNA-like 
endoplasmic reticulum kinase (PERK) pathway of the unfolded protein response was carried 
out in order to best fit the available experimental data, where Chub-S7 adipocytes were 
treated with 750ng/ml tunicamycin over 72 hours. The residual sum of squares was 
calculated for binding immunoglobulin protein (BiP), eukaryotic initiation factor 2 alpha 
(eIF2α), phosphorylated eIF2α (P-eIF2α) and P-eIF2α relative to eIF2α (P-eIF2α/eIF2α) in 
order to compare computational parameterisation with manual parameterisation that was 
previously carried out to determine which provided the best fit to the experimental data. 
 
 
The final parameter values of the UPR model which resulted in the closest match 
between model output and experimental data (via the minimum residual sum of 
squares), are described in Table 4.3.2.11 below.  
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Table 4.3.2.11 Parameters used in PERK Model using Computational Parameterisation: A 
mathematical model of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) 
pathway of the unfolded protein response (UPR) was designed and developed, using 
experimental data for parameterisation. Experimental data were collected following the 
treatment of Chub-S7 adipocytes with 750ng/ml tunicamycin over 72 hours. Computational 
parameterisation using the Curve Fit function in Berkeley Madonna software calculated the 
parameter values shown to give the closest fit between model output and experimental data. 
BiP = binding immunoglobulin protein, PERK = protein kinase RNA-like endoplasmic 
reticulum kinase, P-PERK = phosphorylated PERK, eIF2α = eukaryotic initiation factor 2 alpha, 
P-eIF2α = phosphorylated eIF2α, BiPX = BiP bound to proteins other than PERK (such as other 
UPR sensors or unfolded proteins), BiP:PERK = BiP in complex with PERK, PPERK:PPERK:eIF2α 
= PPERK dimer in complex with eIF2α, PPERK:PPERK:PeIF2α = PPERK dimer in complex with 
PeIF2α. 
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4.4 Discussion 
This study detailed both acute and chronic expression profiles of UPR proteins, 
illustrating that the expression of some proteins is immediately affected by 
tunicamycin treatment, whilst others experience change at a noticeably slower rate. 
Studying the expression of P-eIF2α and eIF2α supported evidence in the previous 
chapter that proteins involved in the translation attenuation system experience 
oscillatory expression. This thesis provides the first experimental data for this cellular 
response, supporting the model output from Erguler et al. who first suggested 
oscillation of these proteins (Erguler, Pieri et al. 2013). A mathematical model was 
also created that better represented the UPR compared to the initial model 
presented in Chapter 4.  This is attributed to the inclusion of terms for total protein 
expression as well as using computational parameter estimation which was 
demonstrated to reduce RSS values compared to simple manual adjustment of 
parameter values. 
Examination of lipid droplets through Oil Red-O staining confirmed that the Chub-S7 
preadipocyte cells used in this study had differentiated into mature adipocytes over 
the 14 day period. This highlights the uniformity of the cell-line that provides the 
consistency required to use the experimental data for parameterisation of the 
mathematical model. Comparatively, as primary adipocytes cultured from humans 
do not have identical genetic composition, they are less uniform, differentiating over 
different periods of time and as such are less suited for use in mathematical model 
parameterisation (Kaur and Dufour 2012, Niu and Wang 2015). 
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Experimental data from this study revealed that the expression of BiP is not 
dramatically affected by acute treatment of tunicamycin, but has a 9.5-fold increase 
following chronic treatment. Conversely, P-eIF2α and eIF2α both undergo an 
immediate increase with acute tunicamycin treatment and experience oscillatory 
expression with chronic treatment. This difference is most likely due to the fact that 
BiP translation occurs at the end of protein cascades within the UPR, and 
phosphorylation of eIF2α is required before further downstream proteins such as 
activating transcription factor 4 (ATF4) can upregulate BiP (Matassa, Amoroso et al. 
2013). This may initially seem counter-intuitive, as BiP is an important chaperone that 
aids in the reduction of ER stress, and therefore cells would benefit from having a 
quick acute response in its upregulation (Lewy, Grabowski et al. 2017). However, as 
the Western blot procedure only measures the total amount of BiP present in cells, 
it cannot account for the BiP molecules that have dissociated from sensor proteins 
such as PERK in order to assist protein folding in the ER. As such, although an increase 
in BiP production may take longer than other proteins within the UPR, the increase 
in ‘free’ BiP that is able to assist protein folding and reduce ER stress is the first 
process to occur in the UPR pathway, and it is this process that initiates the protein 
cascades within the UPR (Gong, Wang et al. 2017). 
The increase in number and granularity of time points allowed a much more reliable 
analysis of protein expression over time. This resulted in data that clearly 
demonstrated the oscillation of proteins involved in the translation attenuation 
system, building on initial evidence from the previous chapter. The additional time 
series data affirm the predictions made by Erguler et al. as discussed in chapter 4 
which suggest that the existence of oscillations allows translation to occur for brief 
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periods during ER stress, enabling routine cellular activity to be carried out during 
the stress response (Erguler, Pieri et al. 2013). Further to this, as experimental data 
were not used to confirm Erguler’s model, these findings provide important 
information regarding the time scale over which these oscillations occur. These 
results have further implications for others studying the translation attenuation 
system of the UPR, as it leaves researchers susceptible to obtaining false positives if 
only one time point is studied when comparing treated cells to control cells. For 
instance, if a comparison was made when the protein in question was at a low point 
in its oscillatory cycle, it may appear that the treatment used did not induce ER stress 
when in reality the peak expression may simply not have been measured. This 
suggests that, when studying ER stress, it is more appropriate to examine protein 
expression over several time points over at least a 24 hour period. 
This chapter also highlighted the importance of including terms for ODEs that reflect 
the biological data collected. The inclusion of terms for total protein expression 
ensured that the model output more accurately represented useful biological data. 
This was supported by the increased frequency and reliability of the data collected, 
as well as through a series of balances and checks which reduced the number of 
inaccuracies and ensured more biologically accurate model outputs. These outputs 
were further improved by the use of computationally estimated parameters, which 
reduced the RSS values by 33% compared to manually adjusted parameters. 
Sensitivity analysis identified kd1, which represents the dissociation of the BiP:PERK 
complex, and ka2, which represents the association of two PERK proteins to form a 
dimer, as the two most sensitive parameters. This can be explained biologically as 
the dissociation of the BiP:PERK complex is the most important step in the process, 
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initiating the pathway response, whilst the dimerisation of PERK is the second 
reaction to occur in the cascade, further demonstrating biological accuracy of the 
model. This builds upon suggestions from the previous chapter that modelling 
particular functions of the UPR initially, rather than the system as a whole, may be 
useful to ensure that parameterisation can occur whilst maintaining accurate 
biological detail.  
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4.5 Conclusions 
Experiments carried out in this chapter have demonstrated that different UPR 
proteins respond differently to acute and chronic treatments of ER stress inducers. 
Additionally, these results have confirmed those in the previous chapter that proteins 
involved in the translation attenuation system undergo oscillation during ER stress – 
a theory proposed by Erguler et al. that had previously lacked any experimental 
evidence. This chapter has also highlighted the importance of including ODEs that 
reflect the biological data collected, including the use of terms for total protein 
expression, whilst mathematically modelling the response. Novel parameters were 
estimated using experimental time series data in a form that has not been used 
before, resulting in a biologically qualitatively accurate mathematical model that has 
the potential to be used in a predictive capacity, or to test ‘what if’ input scenarios in 
the future. As such, these findings suggest that modelling individual functions of the 
UPR may be more beneficial than modelling the entire system as a whole, satisfying 
the first and second aims of this thesis as follows: 
1. To create a mathematical model of a pathway in the unfolded protein 
response using experimental time series data. 
2. To study ER stress in more detail by analysing how the expression of key ER 
stress proteins varies over time following treatment with Tunicamycin. 
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CHAPTER 5:  
The Effect of Broccoli on 
Tunicamycin-Induced ER 
Stress 
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5.1 Introduction 
It is recognised that obesity can induce chronic ER stress, leading to the misfolding of 
proteins and dysfunction of cellular processes (Pagliassotti, Kim et al. 2016). This 
occurs through conditions such as overnutrition, endotoxemia, hyperglycaemia, 
elevated circulating free fatty acids and glucose deprivation (Pagliassotti, Moran et 
al. 2014). Studies have shown that chronic ER stress is one of the mechanisms in 
obesity that can contribute to insulin resistance and type 2 diabetes (T2DM) either 
directly, through the inhibitory phosphorylation of insulin receptor substrate 1 (IRS-
1), or through other indirect mechanisms (Ozcan, Cao et al. 2004, Kawasaki, Asada et 
al. 2012, Lindholm, Korhonen et al. 2017).  
The UPR, activated during ER stress, can also affect a wide spectrum of physiological 
functions. Each pathway within the UPR provides a specific function that can be 
involved in certain developmental and metabolic processes, such as cellular 
differentiation and neurological activities (Lee, Scapa et al. 2008, Mao, Shao et al. 
2011, Zhu and Lee 2015, Saito and Imaizumi 2017). There is growing evidence 
suggesting that the individual pathways of the UPR are required for these roles 
throughout the lifetime of a cell. However, a more intense, chronic upregulation of 
UPR pathways in response to cellular stress can lead to significant dysfunction, as 
observed in pathogenesis of diseases (Wu and Kaufman 2006, Matsuzaki, Hiratsuka 
et al. 2015). It may therefore be beneficial to investigate ways to protect cellular 
systems from significant ER stress and establish ways to reduce the pathogenesis of 
obesity mediated T2DM.  
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One potential way to prevent increased ER stress may be through dietary factors that 
are known to impair mechanisms that initiate the stress. Chronic inflammation, ROS 
and mitochondrial dysfunction are all such mechanisms that not only induce ER stress 
but are themselves induced by ER stress and consequently further impair insulin 
signalling through feedback loops (Cao and Kaufman 2014, Park 2014). As such, it is 
possible that dietary factors which are known to reduce the intensity of these 
mechanisms may also reduce the level of ER stress and therefore reduce the risk of 
insulin resistance and T2DM. 
Cruciferous vegetables, such as broccoli, have been studied regarding their potential 
to impact a number of diseases, and have been shown to reduce the risk of 
myocardial infarction and cardiovascular related mortality, as well as many types of 
cancer (Zhang, Shu et al. 2011, Bosetti, Filomeno et al. 2012, Tang, Meng et al. 2017). 
Studies have also highlighted that such vegetables in powder form can reduce 
inflammation and improve damaging lipid profiles of humans (Bahadoran, Mirmiran 
et al. 2012, Jiang, Wu et al. 2014, Armah, Derdemezis et al. 2015). Additionally, 
broccoli contains high levels of biochemical compounds such as glucoraphanin which, 
once broken down to sulforaphanes, are known to enhance antioxidant activity and 
eliminate ROS (Clarke, Dashwood et al. 2008, Boddupalli, Mein et al. 2012). As such, 
these qualities suggest that it may be favourable to investigate broccoli extracts as a 
potential dietary factor to protect against ER stress, and thus reduce T2DM risk. 
The aim of this study was therefore to investigate whether a broccoli powder extract 
could protect against and/or reduce the intensity of ER stress induced by tunicamycin 
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in order to explore its potential as a dietary supplement that may reduce the risk of 
subjects developing T2DM. 
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5.2 Methods 
5.2.1 Optimisation of Broccoli Extract Concentration  
In order to determine the optimum concentration of broccoli extract (BE) to use, 
differentiated Chub-S7 preadipocyte cells were exposed to one of the following 
treatments:  
• Vehicle Control (hereafter referred to as Control) 
• 750ng/ml Tunicamycin 
• 10ng/ml BE 
• 1000ng/ml BE 
• 100,000ng/ml BE 
• 10ng/ml BE + 750ng/ml Tunicamycin 
• 1000ng/ml BE + 750ng/ml Tunicamycin 
• 100,000ng/ml BE + 750ng/ml Tunicamycin 
The concentration of tunicamycin was chosen according to previous studies 
investigating ER stress that used between 0.5µg/ml and 2.0µg/ml (Ozcan, Cao et al. 
2004, Alhusaini, McGee et al. 2010, Mondal, Das et al. 2012). Concentrations of BE 
were chosen in line with prior evaluations of compounds known to influence ER 
stress, such as lipopolysaccharide (LPS) (Kusminski, da Silva et al. 2007, Alhusaini, 
McGee et al. 2010). Cells were exposed to these treatments for 24hr, 48hr or 72hr to 
assess acute and chronic impacts. Those cells treated with both BE and tunicamycin 
were pre-treated with BE for 24hr prior to the addition of tunicamycin, and fresh 
treatment was provided to all cells every 24hr. Cells were then harvested for RNA, 
with three samples for each treatment collected per time point (24hr, 48hr or 72hr). 
Page 133 of 242 
 
qRT-PCR analysis was carried out in order to study the expression of UPR marker 
genes. 
 
5.2.2 Time Course Analysis of the Impact of Broccoli Extract 
Once the optimum concentration of BE had been determined, a comprehensive time 
course experiment was designed in order to analyse the impact of BE on ER stress at 
an increased level of granularity over time. Chub-S7 preadipocyte cells were 
differentiated into mature adipocytes over 14 days. Cells were treated with 750ng/ml 
tunicamycin, 10ng/ml BE or a combination of the two; those treated with both 
tunicamycin and BE were pre-treated with BE for 24hr prior to the addition of 
tunicamycin. Control cells were grown in the same manner and treated with the 
equivalent concentrations of the treatment vehicles. Cells were exposed to the 
treatments for the following lengths of time: 0hr, 30mins, 1hr, 2hr, 4hr, 6hr, 12hr, 
18hr, 24hr, 30hr, 36hr, 46hr, 48hr, 54hr, 60hr, 66hr, or 72hr, with fresh treatments 
provided every 24hr (Figure 5.2.2). Following treatment, cells were harvested and 
protein extraction was carried out to allow analysis by Western blot. Six samples 
were collected at each time point for each treatment, which were then processed 
and analysed. 
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Figure 5.2.2 Treatment of Adipocytes with Tunicamycin and Broccoli Extract: Chub-S7 
adipocytes were grown and differentiated before being treated with tunicamycin 
(750ng/ml), broccoli extract (10ng/ml) or a combination of the two. Control cells were grown 
in the same manner and treated with the equivalent concentration of treatment vehicles. 
Protein samples were collected at 17 time points over 72 hours (0hr, 30 mins, 1hr, 2hr, 4hr, 
6hr, 12hr, 18hr, 24hr, 30hr, 36hr, 46hr, 48hr, 54hr, 60hr, 66hr, or 72hr).  
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5.3 Results 
5.3.1 Broccoli Extract does not Exacerbate ER Stress 
In order to assess whether BE itself had any detrimental effects with regards to 
physiological ER stress response, differentiated Chub-S7 pre-adipocyte cells were 
exposed to different concentrations of BE, as well as 750ng/ml tunicamycin to 
provide a reference for the level of stress occurring. ER stress marker genes ATF4, 
ATF6 and CHOP cover a range of the UPR pathways and were therefore selected for 
analysis to assess the level of ER stress occurring. ATF4 is expressed partway through 
the PERK arm of the UPR, and upregulates both CHOP and GADD34 which are 
involved in the initiation of apoptosis (Iurlaro and Muñoz-Pinedo 2016, Zong, Feng et 
al. 2017). ATF6 is the initial sensor of the ATF6 arm of the UPR, and also leads to the 
upregulation of CHOP as well as chaperones such as BiP (Takayanagi, Fukuda et al. 
2013). RNA analysis of these genes revealed that in most cases there was no 
significant change in ER stress levels due to BE exposure. In two cases, the 
100,000ng/ml BE treatment resulted in significant increases of UPR proteins, 
increasing the expression of ATF6 and ATF4 at 48hr (p < 0.01), and as such this high 
dose was removed from further investigations; however in all other cases BE 
concentrations either had no significant effect or, in one case, reduced expression of 
ER stress proteins by 15% (Figure 5.3.1).  
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Figure 5.3.1 Effect of Broccoli Extract on Physiological ER Stress mRNA: (A) Activating 
transcription factor 4 (ATF4), (B) activating transcription factor 6 (ATF6) and (C) CCAAT-
enhancer-binding protein homologous protein (CHOP) mRNA were analysed following 
treatment of Chub-S7 adipocytes with one of three concentrations of broccoli extract (BE; 
10ng/ml, 1000ng/ml, 100,000ng/ml) or tunicamycin (Tun; 750ng/ml) to assess whether BE 
induced endoplasmic reticulum (ER) stress. Statistical analysis was undertaken with control 
vs. treatment, p-values: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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5.3.2 Broccoli Extract Reduces Tunicamycin-Induced ER Stress 
Expression of ER stress genes ATF4, ATF6 and CHOP was also studied in order to 
determine the effect of BE on ER stress induced by tunicamycin. Cells were treated 
with a combination of BE and tunicamycin alongside individual tunicamycin 
treatment as a reference. Each marker analysed revealed that treatment with BE 
significantly reduced tunicamycin-induced ER stress at particular time points, with 
only one time point of ATF6 undergoing a significant increase in stress due to the 
presence of BE. These results also illustrated that, in many cases, a concentration of 
10ng/ml BE was most effective in preventing the increase in expression that occurred 
with exposure to tunicamycin. As such, this concentration was selected for use in 
further studies (Figure 5.3.2).  
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Figure 5.3.2 Effect of Broccoli Extract on Tunicamycin-Induced ER Stress mRNA: mRNA 
expression of (A) activating transcription factor 4 (ATF4), (B) activating transcription factor 6 
(ATF6), and (C) CCAAT-enhancer-binding protein homologous protein (CHOP) was analysed 
following treatment of Chub-S7 adipocytes with tunicamycin (Tun; 750ng/ml), or a 
combination of tunicamycin and one of three concentrations of broccoli extract (BE; 
10ng/ml, 1000ng/ml, 100,000ng/ml) over time (24hr, 48hr, 72hr). Statistical analysis was 
carried out with tunicamycin vs. BE+Tun treatments, p-values: * p < 0.05, ** p < 0.01, *** p 
<0.001. 
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5.3.3 Time Series Effect of Broccoli Extract on Unfolded Protein Response 
The previous results demonstrated that at certain time points, BE reduced the 
intensity of the ER stress marker genes studied. In order to explore this effect in more 
detail, a time series experiment was carried out in which the protective effect of 
broccoli was examined at 17 time points over 72hr. The protein expression of BiP, P-
eIF2α, eIF2α and housekeeping protein β-Actin was examined at each time point, 
revealing the extent to which BE protects against ER stress. 
Assessing the protein expression of BiP added evidence to the earlier finding that BE 
itself has little to no effect on the expression of UPR markers compared to control 
cells. A similar profile was formed from both control and BE treated cells, despite 
there being a significant reduction in expression due to the BE treatment at five time 
points (2hr, 24hr, 46hr, 48hr and 66hr) (p < 0.05) (Figure 5.3.3.1). The addition of BE 
to the tunicamycin treatment resulted in a delay of the initial peak in expression of 
BiP from 36hr to 46hr, however at other time points the presence of BE did not 
demonstrate a particularly strong protective effect against BiP expression, despite 
significantly reducing its expression at three time points (6hr, 36hr and 48hr) (p < 
0.05). Furthermore, at 72hr a significant increase in expression occurred when BE 
was included in the treatment (p = 0.005) (Figure 5.3.3.2). 
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Studying the expression of P-eIF2α revealed that treatment with BE resulted in a very 
similar profile compared to control (Figure 5.3.3.3). When investigating whether BE 
reduces the intensity of the stress response induced by tunicamycin however, it was 
discovered that the addition of BE to the tunicamycin treatment elicited a protective 
effect at almost every time point, with a maximum decrease in expression of 51% 
occurring at 66hr (p = 0.01) (Figure 5.3.3.4).   
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BE had similar effects on eIF2α protein expression to P-eIF2α expression. In cells 
treated with BE alone, eIF2α was expressed at a similar level compared to the control, 
with a significantly reduced level of expression at three time points (48hr, 54hr and 
66hr), and a reduction of the peak expression at 54hr by 27% (p = 0.02) (Figure 
5.3.3.5). The presence of BE in the tunicamycin treatment prevented the 
upregulation of eIF2α that was otherwise observed with tunicamycin treatment. This 
effect was sustained over time with a maximum 55% decrease in expression 
occurring at 48hr (p = 0.002) (Figure 5.3.3.6). 
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The rate of phosphorylation of eIF2α to P-eIF2α was also useful as a measure of ER 
stress, and as an indicator of the translation attenuation pathway that occurs within 
the UPR. The relative expressions of the two proteins were used to observe this 
phosphorylation rate, which revealed that BE reduced the maximum peak rate of 
phosphorylation naturally occurring in control cells by 37% (p = 0.01) (Figure 5.3.3.7).  
Broccoli extract in combination with tunicamycin (BE+Tun) significantly reduced the 
phosphorylation rate relative to tunicamycin on its own at six time points (6hr, 12hr, 
18hr, 36hr, 66hr and 72hr) (p<0.05). As well as this, the addition of BE altered the 
oscillation cycle that occurred with the tunicamycin treatment, as described in the 
previous chapter, delaying the occurrence of the first sustained peak in the 
phosphorylation rate from 4hr to 18hr. Furthermore, the time periods over which 
the peaks occurred were reduced when BE was present (Figure 5.3.3.8). 
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Representative Western blot images analysed to determine the protein expression 
of BiP, P-eIF2α, eIF2α and β-Actin following treatment, and used to create figures 
5.3.3.1 – 5.3.3.8, are displayed below (Figure 5.3.3.9). This allowed direct comparison 
of treatments at each time point. 
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Figure 5.3.3.9 Western Blot Time Series Images: Representative Western blots of binding 
immunoglobulin protein (BiP), phosphorylated eukaryotic initiation factor alpha (P-eIF2α), 
eukaryotic initiation factor alpha (eIF2α) and β-Actin expression following treatment with 
750ng/ml tunicamycin (Tun), 10ng/ml broccoli extract (BE) or a combination of the two 
(BE+Tun) compared to control (Con) at (A) 30 minutes, 1hr, 2hr (B) 4hr, 6hr, 12hr (C) 18hr, 
24hr, 30hr (D) 36hr, 46hr, 48hr (E) 54hr, 60hr, 66hr (F) 72hr. 
 
Page 153 of 242 
 
Findings from the time series experiment are summarised below as a table of 
percentage changes in a heat map fashion, with significant changes highlighted 
(Figure 5.3.3.10). A green cell represents a significantly lower expression of ER stress 
marker protein in samples containing either BE or BE+Tun, compared to their 
respective controls (control/tunicamycin), whilst a red cell represents a significantly 
increased expression due to the presence of BE (p < 0.05). As shown, out of the values 
that were significantly different to control cells, the presence of BE decreased the 
expression of the marker proteins studied in 67% of cases (Figure 5.3.3.10 A). 
Similarly, out of the values that were significantly different to tunicamycin treatment, 
the combined BE and tunicamycin treatment resulted in a decrease in expression in 
87% of time points and proteins assessed (Figure 5.3.3.10 B).  
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Figure 5.3.3.10 Summary of Broccoli Extract Effect on ER Stress (A) Percentage changes 
induced by treatment with broccoli extract (BE; 10ng/ml) compared with untreated control 
cells (Con). (B) Percentage changes induced by a combined treatment of BE and Tunicamycin 
(BE+Tun; 10ng/ml, 750ng/ml) compared to Tunicamycin (Tun; 750ng/ml). Green cells 
represent a significantly decreased expression of ER stress protein in samples treated with 
either BE or BE+Tun, compared to their respective controls (Con/Tun) (p<0.05). Red cells 
represent a significantly increased expression of the ER stress proteins due to the presence 
of BE in the sample compared to controls (Con/Tun) (p < 0.05). White cells represent no 
significant change with the presence of BE. 
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5.4 Discussion 
The aim of this study was to determine if a broccoli extract could prevent or reduce 
ER stress induced by tunicamycin over time to ascertain whether BE may offer a 
potential protective mechanism over periods of sustained ER stress. These 
investigations revealed three key findings. Firstly, broccoli extract did not itself 
exacerbate the normal physiological ER stress protein response within adipocytes. 
Secondly, broccoli extract significantly reduced tunicamycin-induced ER stress, 
highlighting the potential role of broccoli in dampening an ER stress response. Finally, 
the effects of broccoli extract can be sustained over time despite the continued ER 
stress insult.    
Initial studies were carried out in order to identify the effect of BE treatment on the 
levels of physiological ER stress occurring within adipocytes, to determine that BE 
could reduce insult driven ER stress without acting as an inhibitor of normal 
physiological ER stress protein response. mRNA studies indicated that there was very 
little change in the expression of ER stress markers with the treatment of BE 
compared with untreated control cells. Similar results were also observed during a 
subsequent, additional, multiple time series interval analysis study, which revealed 
that protein expression was mostly unchanged over the multiple time points studied. 
These findings suggest that BE does not have adverse effects on the physiological ER 
stress occurring in adipocytes over time.  
Further studies were carried out in order to determine whether BE could reduce the 
level of ER stress that occurs with tunicamycin treatment. Tunicamycin is often used 
to artificially induce ER stress in cell culture experiments as it blocks the initial step 
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of glycoprotein biosynthesis, causing an accumulation of unfolded glycoproteins in 
the ER and leading to ER stress (Oslowski and Urano 2011). As has been observed in 
many other studies (Bogdanovic, Kraus et al. 2015, Wang, Wang et al. 2015), 
tunicamycin did induce ER stress throughout these experiments. Studies using mRNA 
expression data assessed the impact of BE on tunicamycin-induced ER stress, which 
revealed that treatment with three different concentrations of BE all prevented the 
upregulation of ER stress marker genes ATF4, ATF6 and CHOP in a time-dependent 
manner. The only time point where BE significantly increased the expression of ER 
stress genes when added to the Tun treatment was with ATF6 at 48hr. If ATF6 is 
expressed in a cyclic manner, as other UPR components have been demonstrated to 
in this thesis, it is possible that the addition of BE may alter the expression pattern 
such that a peak in expression with combined BE+Tun treatments is being compared 
with a dip in expression with Tun treatment. This highlights the importance of 
investigating more frequent time points when studying components of the UPR. 
However, as this was the only time point where BE significantly increased the 
expression compared to Tun out of all the genes studied, it was considered 
worthwhile to continue with the study using 10ng/ml for the concentration of BE.  It 
is hard to determine how this concentration may translate to amount of broccoli 
required in the diet to obtain similar results in vivo. The nutritional content of 20g of 
freeze dried broccoli powder is roughly equivalent to one large head of broccoli, 
however it is currently unknown how much broccoli would have to be consumed by 
humans in order to replicate the results seen in these experiments. This is a standard 
problem encountered with in vitro studies, as whilst it provides useful information 
with regards to cellular processes, extrapolation to in vivo can lead to erroneous 
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conclusions. Future in vivo studies would therefore have to be carried out in order to 
investigate this. 
BE demonstrated the most protection with CHOP mRNA, where the protective effect 
of BE increased over time, culminating in a 62% reduction in the expression induced 
by tunicamycin at 72hr. This prominent effect with CHOP is most likely due to the 
fact that it is up-regulated at the end of all three arms of the UPR, resulting in a much 
more intense expression during ER stress and a more pronounced protective effect 
of BE (Nishitoh 2012, Li, Guo et al. 2015). ATF4 and ATF6, however, both occur earlier 
in their respective pathways, and are each involved in only one arm of the UPR; 
consequently, their expression does not increase to the same extent during ER stress 
and the protective effect of BE is not as prominent. These findings have further 
implications, as CHOP is a promoter of apoptosis (Li, Guo et al. 2015), and has 
recently been identified as a key mediator of insulin resistance and glucose 
intolerance during obesity development (Suzuki, Gao et al. 2017). As such, these 
results indicate that BE may reduce the level of apoptosis and insulin resistance that 
occurs during obesity-mediated ER stress, thus aiding in the survival of the organism.  
Protein expression of BiP, P-eIF2α and eIF2α was also assessed to determine the 
effect of BE at protein level. BiP is a major chaperone located in the ER which is critical 
for protein quality control, as well as for regulating the activation of ER stress 
signalling molecules (Gething 1999, Wang, Wey et al. 2009). Protein analysis revealed 
that BiP experienced the least protection by the addition of BE to the tunicamycin 
treatment: despite BE causing a delay in the initial major increase in expression from 
36hr to 46hr, it also significantly increased expression at the final 72hr time point. It 
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is possible that whilst BE delays the expression of BiP, allowing the cell to function 
normally for a prolonged period of time, it is unable to counter the ability of 
tunicamycin to induce ER stress for more than 66hr. This reduced effect of BE 
protection on BiP expression is most likely due to the important role that BiP has in 
the detection of ER stress and the subsequent activation of the UPR. As the initial 
sensor of ER stress, as well as acting as a switch for each of the UPR arms, BiP 
expression is tightly controlled, with evidence suggesting that it is more tightly 
regulated at the post-translational level, rather than the transcriptional level (Gülow, 
Bienert et al. 2002, Takayanagi, Fukuda et al. 2013).  This suggests that the protective 
effects of BE may occur at the transcriptional level and, as such, BiP is less affected 
by BE treatment than other UPR proteins.  
P-eIF2α and eIF2α were selected for analysis to examine what effect BE has on the 
translation attenuation system. This system is part of the UPR which reduces protein 
synthesis rates during ER stress to lessen the load of substrates on the folding 
machinery in the ER lumen (Harding, Zhang et al. 2000). The previous chapters 
detailed the importance of the translation attenuation system, and illustrated how 
P-eIF2α and eIF2α undergo oscillation when exposed to tunicamycin in an attempt 
to reduce stress whilst maintaining a sufficient level of protein production for the cell 
to survive. When exposed to BE alongside the tunicamycin treatment, both P-eIF2α 
and eIF2α had a distinct reduction in expression compared to tunicamycin on its own. 
The maximum expression of P-eIF2α was reduced by 42% in the presence of BE, 
resulting in a less intense, more stable level of the protein. P-eIF2α is a known 
transcription factor of ATF4, which in turn is a transcription factor of CHOP, a key 
component of the apoptosis pathway (Li, Guo et al. 2015, Rozpedek, Pytel et al. 
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2016); thus, these results support observations from the mRNA data that reduced 
expression of P-eIF2α may prevent apoptosis occurring in adipocytes. Similarly, BE 
reduces the peak expression of eIF2α induced by tunicamycin at 48hr by 55%. These 
data indicate that the translation attenuation system is less likely to be activated 
when BE is present alongside inducers of ER stress such as tunicamycin, thus 
improving the health of adipocytes across these time points. 
Analysing the ratio of P-eIF2α to eIF2α to provide information on the rate of eIF2α 
phosphorylation revealed that BE delays the oscillation cycle that occurs with 
tunicamycin treatment, with the second major peak occurring at 18hr as opposed to 
4hr. Furthermore, the peaks in the phosphorylation rate are much shorter-lived 
when BE is present. These results are indicative of the adipocytes experiencing a 
reduced level of ER stress when BE is present, despite an equal dose of tunicamycin 
being provided. Recent research has revealed that reversal of the translation 
attenuation system with an inhibitor potently suppresses the expression of PERK-
dependent inflammatory genes, without disrupting normal immune function 
(Guthrie, Abiraman et al. 2016). It is also known that the translation attenuation 
system, whilst blocking general translation, promotes the induction of pro-apoptotic 
transcriptional factors (Sano and Reed 2013). As such, the delayed, shorter-lived peak 
rates of eIF2α phosphorylation that occur with BE treatment may reduce both 
inflammatory and apoptotic cellular signals, preventing further damage to the cell.  
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5.5 Conclusions 
This study has demonstrated that BE is able to mitigate the chronic ER stress 
response that is induced by tunicamycin, without preventing the routine 
physiological ER protein response that occurs within adipocytes. Consequently, with 
the use of BE, damaging cellular processes that result in insulin resistance and 
apoptosis are less likely to occur.  There is therefore the potential that a broccoli 
supplement in the diet may decrease the level of chronic ER stress that occurs during 
obesity, thus promoting cellular health and reducing the risk of T2DM. The results in 
this chapter have contributed to the third aim of this thesis – to investigate the 
potential protective effects of broccoli against ER stress in adipocytes. 
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CHAPTER 6:  
The Effect of Broccoli on 
Mitochondria and ROS 
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6.1 Introduction 
As documented previously, ER stress contributes to increased T2DM risk (Ozcan, Cao 
et al. 2004, Eizirik, Cardozo et al. 2008, Back and Kaufman 2012). This can arise 
through the interplay of other associated cellular mechanisms, which ultimately 
leads to cellular dysfunction and insulin resistance. These associated cellular 
mechanisms include reactive oxygen species (ROS) production, mitochondrial 
damage and chronic inflammation. These mechanisms form a complicated signalling 
network that prepares the cell for a response against the cause of the stress; however 
this process can increase the risk of developing diseases such as T2DM, as discussed 
below. 
ROS and reactive nitrogen species (RNS) form within cells as a natural by-product of 
processes such as oxygen metabolism and protein folding (du Plessis, Harlev et al. 
2017), however excessive production can cause cellular damage (Di Meo, Reed et al. 
2016). ROS/RNS is a broad term that encompasses many types of reactive species, 
which each have specific antioxidants to counter them (Di Meo, Reed et al. 2016). 
Catalase, for example, converts hydrogen peroxide (H2O2) ROS to water and oxygen, 
whilst superoxide dismutase is a mitochondrial protein that prevents the build-up of 
superoxide by-products of oxidative phosphorylation.  
In the ER, correct folding of proteins often requires the generation of disulphide 
bonds which results in the production of hydrogen peroxide (H2O2), a form of ROS 
(Bulleid and van Lith 2014). Similarly, ROS is produced in mitochondria during 
oxidative phosphorylation as electrons from complex I and complex III from the 
electron transport chain partially reduce oxygen to form superoxide (Cao and 
Page 163 of 242 
 
Kaufman 2014). Under routine circumstances, a balance between ROS and 
antioxidants that attenuate their damaging effects is maintained, and in some 
instances ROS can act as protective signalling molecules. However, in cases when 
overproduction of ROS occurs, or excess ROS is not eliminated, oxidative stress can 
occur which causes cell and tissue damage (du Plessis, Harlev et al.).  
During ER stress, the tightly controlled microenvironment of ER protein folding can 
become compromised, resulting in a futile cycle of disulphide bond formation and 
reduction which generates large amounts of H2O2 ROS (Cao and Kaufman 2014). 
Production of ROS is exacerbated further through an efflux of Ca2+ from the ER to 
mitochondria which leads to the inhibition of complex III of the electron transport 
chain (ETC). This increases the production of ROS due to higher levels of the 
ubisemiquinone radical intermediate being formed (Cao and Kaufman 2014). In 
addition to this, increased levels of Ca2+ in the mitochondria stimulates the Krebs 
cycle, boosting oxygen consumption and further ROS production. This substantial 
increase in ROS production outbalances the number of antioxidants, and thus can 
cause significant damage to the cell. 
Whilst low levels of ROS are required for some cellular processes, continuous 
exposure to ROS can also damage mitochondria. This can lead to oxidative damage 
to ETC complexes, mitochondrial DNA (mtDNA) and lipids, and cause mitochondrial 
dysfunction (Besse-Patin and Estall 2014). Mitochondrial dysfunction is characterised 
by a loss of efficiency in the electron transport chain and reductions in the synthesis 
of high-energy molecules such as adenosine-5’-triphosphate (ATP) (Nicolson 2014). 
When this occurs, it requires adaptation through (1) fusion of partially dysfunctional 
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mitochondria and mixing of their undamaged components to improve overall 
function, (2) the separation of damaged mitochondria into smaller mitochondria 
(fission), and (3) the removal and complete degradation of dysfunctional 
mitochondria (mitophagy) to avoid cellular damage (Nicolson 2014). Impaired 
mitochondrial function can be a cause of insensitivity towards insulin, arising due to 
insufficient energy supplies, or defects in the insulin signalling pathway (Abdul-Ghani 
and DeFronzo 2008, Victor, Rocha et al. 2011, Wang, Chi et al. 2012). Further to this, 
ER stress, ROS and mitochondrial dysfunction are all known to induce inflammation, 
which is a major contributor to insulin resistance and T2DM (Cefalu 2009, Mittal, 
Siddiqui et al. 2014). Mitochondrial function can be assessed by using a Seahorse XF 
analyser, which provides information on the extracellular acidification rate (ECAR) 
and oxygen consumption rate (OCR) of cells. ECAR provides an indication of glycolytic 
rate, as cells undergoing higher rates of glycolysis exhibit higher rates of proton 
production than cells using oxidative phosphorylation. Higher OCR levels indicate 
that cells are preferentially producing ATP through oxidative phosphorylation, the 
more efficient form of energy production. The ratio of OCR to ECAR provides 
information on the preference of cells for oxidative phosphorylation over glycolysis 
(Zhang, Nuebel et al. 2013). 
Studying the OCR relative to the baseline of each treatment also provides 
information on how the cells respond to particular pharmacological inhibitors as part 
of a stress test. The sequential addition of oligomycin (an ATP synthase inhibitor), 
FCCP (carbonyl cyanide p-trifluoromethoxyl-phenylhydrazone, a protonophoric 
uncoupler), and a combination of rotenone & antimycin A (electron transport 
inhibitors) allows assessment of key factors of mitochondrial function, such as: 
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• Proton leak – an indicator of mitochondrial inefficiency: increased proton leak 
decreases oxidative phosphorylation yield and can be caused by high levels 
of ROS. 
• ATP production – rate of ATP being produced. 
• Maximal respiration – maximum rate of ATP being produced in the 
mitochondria. 
• Spare capacity – extra mitochondrial capacity available in a cell to produce 
energy under stressful conditions. An indicator of long-term cellular survival 
and function. 
An example of how the stress test can provide this information is provided below 
(Figure 6.1). 
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Figure 6.1 Mitochondrial Functions determined by Oxygen Consumption Rate (OCR) Stress 
Test: Indicators of mitochondrial function such as basal respiration, ATP production, proton 
leak, maximal respiration, respiratory reserve (also known as spare capacity) and non-
mitochondrial respiration, can be compartmentalised by the sequential addition of 
pharmacological inhibitors, oligomycin (oligo), carbonyl cyanide p-trifluoromethoxy-
phenylhydrazone (FCCP) and a combination of rotenone (R) & antimycin A (A). Figure from 
(Yang, Chadwick et al. 2017). 
 
The previous chapter demonstrated the positive influence broccoli extract can have 
on reducing ER stress; it is therefore plausible that it may also protect against both 
ROS and mitochondrial dysfunction. Investigating key pathways that may be 
influenced by the addition of broccoli extract may provide an insight into its 
mechanism of action, identifying specific cellular components that are involved in its 
activity.  
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As such, the aims of this study were to: 
1. Determine the effects of tunicamycin on ROS production and mitochondrial 
health. 
2. Assess whether the protective effects of broccoli extend to ROS production 
and mitochondrial dysfunction. 
3. Identify possible pathways through which broccoli extract acts to provide 
cellular protection. 
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6.2 Methods 
6.2.1 Effect of Broccoli on Mitochondrial Function and ROS 
Chub-S7 preadipocyte cells were differentiated over 14 days before being exposed 
to 10ng/ml broccoli extract (BE), 750ng/ml tunicamycin (Tun), or a combination of 
the two for 24hr. Those cells treated with both BE and tunicamycin were pre-treated 
with BE for 24hr prior to the addition of tunicamycin. Vehicle control cells were 
grown alongside under the same conditions, and are hereafter referred to as control. 
Following treatment, cells were analysed for ROS, or studied with a Seahorse XF 
Analyser to determine impact on mitochondrial function. 
 
6.2.2 Investigating Transcriptomic Targets of Broccoli 
In order to examine potential pathways through which broccoli extract acts, mRNA 
samples at the time point where BE had the most impact over the various 
experiments, 36hr, was studied with transcriptomics. RNA quality was assessed using 
a bioanalyser, and samples were then converted into libraries of templates that were 
sequenced and compared to one another to identify any significant changes in 
expression. Triplicate samples were used for each treatment. Comparing the 
transcripts that were differentially expressed against Uniprot protein human 
sequences then allowed pathway information to be obtained. 
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6.3 Results 
6.3.1 Broccoli Extract Prevents Tunicamycin-Induced ROS/RNS 
Analysis of different types of ROS revealed that tunicamycin significantly increased 
ROS/RNS production at 24hr by 28%, whilst BE prevented this increase (p = 0.005). 
There were no significant changes in catalase or SOD specific ROS expression with 
treatment (Figure 6.3.1). 
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Figure 6.3.1 Effect of Tunicamycin and Broccoli on Reactive Oxygen Species Production: (A) 
Total reactive oxygen species (ROS) and reactive nitrogen species (RNS), (B) superoxide 
dismutase and (C) catalase production were analysed following treatment with 10ng/ml 
broccoli extract (BE), 750ng/ml tunicamycin (Tun) or a combination of the two (BE+Tun). 
Statistical analysis was undertaken with control vs. tunicamycin and tunicamycin vs. BE + 
tunicamycin treatments, p-values: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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6.3.2 Effect of Tunicamycin and Broccoli on Mitochondrial Function 
Key mitochondrial functions were studied in live cells using a Seahorse XF Analyser. 
Tunicamycin resulted in a 71% increase in overall oxygen consumption rate (OCR), 
whilst OCR was unaffected by broccoli extract treatment. The combined broccoli 
extract and tunicamycin treatment (BE+Tun) reduced the 71% increase to only 25%. 
Conversely, overall ECAR was significantly increased by 24% with BE+Tun treatment 
(p < 0.05), whilst individual BE and tunicamycin treatments resulted in similar levels 
as control cells (Figure 6.3.2.1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.2.1 Mitochondrial Function following Broccoli Extract and Tunicamycin 
Treatment: (A) Oxygen consumption rate (OCR) and (B) extracellular acidification rate (ECAR) 
of adipocytes following treatment with broccoli extract (BE, 10ng/ml), tunicamycin (Tun, 
750ng/ml) or a combination of the two (BE+Tun). Statistical analysis was undertaken with 
control vs. treatment (* = Con vs. Tun, # = Con vs. BE+Tun) and BE+Tun vs. Tun (+), p-values: 
* p < 0.05, ** p < 0.01, *** p < 0.001. 
Page 172 of 242 
 
Analysing OCR results as a percentage of the baseline following application of stress 
test chemicals provided information on aspects of mitochondrial function, as 
described in Figure 6.1. Broccoli extract treatment had no detrimental effect on 
maximal respiration, whilst tunicamycin treatment reduced maximal respiration by 
37% relative to control. BE+Tun combined treatment resulted in only an 18% 
reduction in maximal respiration compared to control. Similar results were also 
observed with regards to spare capacity, an indicator of long-term cellular survival 
and function – tunicamycin reduced the spare capacity by 46%, whilst BE+Tun 
resulted in a smaller reduction of 23% and BE treatment was similar to control (Figure 
6.3.2.2).  
 
Figure 6.3.2.2 OCR% Baseline following Broccoli Extract and Tunicamycin Treatment: 
Oxygen consumption rate (OCR) of Chub-S7 adipocytes was measured and calculated as a 
percentage of the baseline measurement following treatment with broccoli extract (BE, 
10ng/ml), tunicamycin (Tun, 750ng/ml) or a combination of the two (BE+Tun). 
Pharmacological inhibitors oligomycin (oligo), carbonyl cyanide p-trifluoromethoxy-
phenylhydrazone (FCCP) and a combination of rotenone (R) & antimycin A (A) were added 
sequentially, as indicated. Statistical analysis was performed with control vs. treatment (* = 
Con vs. Tun, # = Con vs. BE+Tun, ^ = Con vs. BE), and Tun vs. BE+Tun (+), p-values: * p < 0.05, 
** p < 0.01, p < 0.001. 
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Studying the ratio of OCR to ECAR revealed that tunicamycin induced a significantly 
higher rate of OCR at 56 minutes relative to ECAR, and increased the overall ratio by 
95%. BE treatment and BE combined with tunicamycin exhibited similar results to 
control cells (Figure 6.3.2.3).  
 
 
 
 
 
 
 
 
Figure 6.3.2.3 OCR/ECAR Ratio following Broccoli Extract and Tunicamycin Treatment: The 
ratio of oxygen consumption rate (OCR) to extracellular acidification rate (ECAR) was 
measured following treatment with broccoli extract (BE, 10ng/ml) Tunicamycin (Tun, 
750ng/ml), or a combination of the two (BE+Tun) in order to determine cellular preference 
for glycolysis or oxidative phosphorylation. Statistical analysis was performed with control 
vs. treatment (* = Con vs. Tun, # = Con vs. BE+Tun, ^ = Con vs. BE), and Tun vs. BE+Tun (+), 
p-values: * p < 0.05, ** p < 0.01, *** p < 0.001). 
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Area under the curve was determined for each factor of mitochondrial function 
measured. These results are displayed below as a percentage of control values in the 
form of a heat map (Table 6.3.2.4). 
 
 
 
Table 6.3.2.4 Effect of Tunicamycin and Broccoli Treatments on Mitochondrial Function: 
Area under the curve (AUC) of oxygen consumption rate (OCR), extracellular acidification 
rate (ECAR), OCR as a percentage of baseline measurement (% OCR Baseline), maximal 
respiration (Max. Respiration), spare capacity and OCR/ECAR ratio was measured following 
treatment with 10ng/ml broccoli extract (BE), 750ng/ml Tunicamycin (Tun), or a combination 
of the two (BE+Tun). Results are displayed relative to control values as a heat map where red 
cells indicate a detrimental change to the mitochondria and green or white cells indicate 
similar values to control. 
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A summary of the results obtained on the effect of treatments on mitochondrial 
dysfunction is provided in Table 6.3.2.5, indicating that BE provides protection 
against mitochondrial dysfunction induced by tunicamycin. 
 
 
Table 6.3.2.5 Summary of Mitochondrial Characteristics following Treatment: Oxygen 
consumption rate (OCR), extracellular acidification rate (ECAR), maximal respiration, spare 
capacity and OCR/ECAR ratio were all assessed in Chub-S7 adipocytes following treatment 
with broccoli extract (BE, 10ng/ml), tunicamycin (Tun, 750ng/ml), and a combination of the 
two (BE + Tun).  
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6.3.3 Broccoli Extract Upregulates Mevalonate Biosynthesis 
Transcriptomics studies revealed a multitude of genes that were altered with 
treatment. The 20 most up- and down-regulated genes for each treatment are 
displayed in Figures 6.3.3.1 – 6.3.3.3 below.  
 
 
  
Table 6.3.3.1 Up- and Down-Regulated Genes following Broccoli Extract Treatment: 
Chub-S7 cells were treated with 10ng/ml broccoli extract (BE) for 36 hours. The 20 most 
(A) up- and (B) down-regulated genes are displayed alongside the associated protein 
name, log2 fold-change and p-value following adjustment for multiple testing (p-adj). 
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Table 6.3.3.2 Up- and Down-Regulated Genes following Tunicamycin Treatment: 
Chub-S7 cells were treated with 750ng/ml tunicamycin for 36 hours. The 20 most (A) 
up- and (B) down-regulated genes are displayed alongside the associated protein name, 
log2 fold-change and p-value following adjustment for multiple testing (p-adj). 
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Table 6.3.3.3 Up- and Down-Regulated Genes following Combined Broccoli Extract + 
Tunicamycin Treatment: Chub-S7 cells were treated with 10ng/ml broccoli extract (BE) 
and 750ng/ml tunicamycin (Tun) for 36 hours. The 20 most (A) up- and (B) down-
regulated genes are displayed alongside the associated protein name, log2 fold-change 
and p-value following adjustment for multiple testing (p-adj). 
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Transcriptomics studies revealed three results of particular interest: 
1. Tunicamycin initiates lipolysis. 
2. Carbohydrate degradation is significantly upregulated with tunicamycin 
treatment, whilst carbohydrate biosynthesis is significantly upregulated with 
broccoli extract treatment. 
3. HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase), a 
component of the mevalonate pathway, is significantly upregulated in the 
two treatments where BE was present (BE and BE+Tun). The BE treatment 
induced a 45-fold increase (p = 1.5 x 10-5), whilst the BE+Tun treatment 
resulted in a 21-fold increase (p = 5.2 x 10-4). 
Similarities and differences between treatments are represented in Tables 6.3.3.4 
and 6.3.3.5. 
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A. 
B. 
Table 6.3.3.4 Differences in Pathways Activated through Treatment: Unique, 
significant and important differences in gene expression in pathways activated through 
treatment with (A) broccoli extract (BE, 10ng/ml), (B) tunicamycin (Tun, 750ng/ml) and 
(C) BE+Tun, determined through transcriptomics (p < 0.05). 
C. 
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6.4 Discussion 
The purpose of this study was to examine the effects of tunicamycin on ROS and 
mitochondrial dysfunction, as well as to determine whether a broccoli extract could 
provide protection against the induction of these mechanisms. Using a human 
adipocyte model, it was revealed that factors such as tunicamycin that induce ER 
stress also increase cellular ROS and mitochondrial dysfunction. Furthermore, these 
studies highlighted that broccoli extract provides protection against the impact of 
tunicamycin treatment on these cellular mechanisms. Examining transcriptomics 
data at the time point with the largest observed protection by broccoli extract 
revealed the mevalonate pathway as a potential target through which broccoli 
extract acts.  
Data from ROS assays indicated that treating adipocytes with broccoli extract does 
not alter the level of ROS present in cells. This is important to establish as studies 
have shown that although elevated intracellular levels of ROS can cause damage to 
lipids, proteins and DNA, ROS can also act as signalling molecules in the maintenance 
of physiological functions (Schieber and Chandel 2014, Kurutas 2016). It is therefore 
beneficial that the physiological levels of ROS are unchanged with broccoli extract 
treatment. Further assessment of the data revealed that tunicamycin treatment 
significantly increased the level of total ROS/RNS at 24hr by 28%. Whilst the specific 
type of ROS upregulated was undetermined due to no similar increase observed in 
SOD or catalase assays, the increase in total ROS/RNS was prevented with the 
addition of broccoli extract to the tunicamycin treatment. This suggests that BE offers 
metabolic protection by preventing the increase in ROS/RNS that has been 
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implicated in various disease states, without depleting the level of ROS that may be 
required for cellular signalling.  
Studies into how treatments may impact mitochondria were carried out by assessing 
data on specific indicators of mitochondrial function. Data obtained on each 
parameter following treatment suggested that mitochondrial function was not 
altered from control cells with the addition of broccoli extract. This indicates that 
broccoli extract treatment does not have a detrimental effect on mitochondria and 
does not affect their physiological role. Treatment with tunicamycin, however, 
resulted in an overall 71% increase in OCR, 95% increase in OCR/ECAR ratio, 37% 
reduction in maximal respiration and a 46% reduction in spare capacity compared 
with control. The addition of broccoli extract to the tunicamycin treatment 
prevented such dramatic changes from control values in each of these cases. The 
exception to this pattern of results is with ECAR data, whereby individual broccoli 
extract and tunicamycin treatments did not evoke any changes from control, whilst 
the combined broccoli extract and tunicamycin treatment caused a 24% increase.  
The increase in OCR and OCR/ECAR ratio with tunicamycin demonstrated that 
oxidative phosphorylation is dramatically increased with the treatment, which can 
be indicative of ER and oxidative stress causing an influx of Ca2+ into the mitochondria 
(Covian, French et al. 2014, Du, Amarachintha et al. 2016). During ER stress, Ca2+ 
released from the ER is taken up by mitochondria, causing the permeability transition 
pore to release cytochrome c, enhancing ROS production (Görlach, Bertram et al. 
2015). Additionally, increased mitochondrial Ca2+ levels stimulate Krebs cycle 
dehydrogenases, which boost oxygen consumption and further ROS production 
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(Traaseth, Elfering et al. 2004). This transfer of Ca2+ and subsequent mitochondrial 
ROS production following ER stress initiates a vicious cycle that leads to impaired 
cellular homeostasis and can induce apoptosis (Cao and Kaufman 2014).  The 
addition of broccoli extract to the tunicamycin treatment reduced both OCR and 
OCR/ECAR ratio values compared to the individual tunicamycin treatment. These 
results demonstrate the protection that broccoli extract provides against cellular 
dysfunction, preventing the cycle of ER stress, mitochondrial dysfunction and ROS 
production that often leads to apoptosis. As such, the addition of broccoli extract 
may prevent macrophage infiltration into adipose tissue, insulin resistance and other 
obesity-associated metabolic complications that are linked to adipocyte apoptosis, 
improving cellular health and reducing disease risk (Alkhouri, Gornicka et al. 2010).  
Conversely to other results, analysing ECAR values showed that both individual 
broccoli extract and tunicamycin treatments resulted in similar levels to control, 
whilst the combined broccoli extract and tunicamycin treatment induced a 24% 
increase. ECAR is a measure of glycolysis, a less efficient form of ATP production than 
oxidative phosphorylation. Although it appears that the addition of broccoli extract 
to tunicamycin treatment results in mitochondria relying more on glycolysis for ATP 
production than with individual tunicamycin treatment, the low level of ECAR in 
tunicamycin treated cells is likely due to the overuse of oxidative phosphorylation 
that is caused by Ca2+ transfer. Furthermore, there is evidence that stimulation of 
glycolysis can enhance the repair of DNA damage, and that glycolysis can be utilised 
as a means to minimise oxidative stress due to the increased production of pyruvate, 
an effective scavenger of ROS, during the process (Brand 1997, Bhatt, Chauhan et al. 
2015). As such, studying the results of OCR, ECAR and OCR/ECAR ratio together 
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indicate that tunicamycin treatment leads to severely unhealthy cells that are prone 
to apoptosis, whilst the addition of broccoli to the tunicamycin treatment prevents 
such extensive damage through elevating glycolysis to protect against ROS. This is 
further evidence that the addition of broccoli extract can lead to the stimulation of 
protective mechanisms against cellular damage, reducing dysfunction and 
preventing apoptosis. 
Using specific pharmacological inhibitors during the stress test provided further 
evidence that broccoli extract can reduce the detrimental effects of tunicamycin. 
Maximal respiration, a measure of the maximum ability of the electron transport 
chain to generate ATP, was reduced by 37% with tunicamycin treatment, whilst the 
addition of broccoli extract with tunicamycin resulted in only an 18% reduction. This 
indicates that tunicamycin has a detrimental impact on mitochondrial health and 
efficiency of ATP production, whilst the presence of broccoli extract prevents such a 
pronounced negative effect. In addition to this, spare capacity, which represents the 
ability of a cell to produce energy under conditions of increased stress, was also 
reduced by 46% with tunicamycin. This suggests that tunicamycin damages the long-
term survival and function of cells by impacting their ability to produce sufficient 
energy in stressful conditions. The addition of broccoli extract to tunicamycin 
reduced the reduction in spare capacity to only 23%, improving the long-term 
function of cells under increased stress. The individual broccoli extract treatment did 
not impact maximal respiration or spare capacity compared to control, 
demonstrating that it has no detrimental effect on mitochondrial function, whilst 
improving many of the parameters affected by tunicamycin treatment.  
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Whilst time constraints limited the amount of transcriptomics analysis possible, the 
data identified three key findings relating to the influence of treatments on potential 
pathway changes. Firstly, the data indicated that tunicamycin increased lipolysis 
transcripts which affirms current literature that suggests this could be a possible 
reason for the incapacity of obese white adipocytes to manage lipids effectively, 
leading to triglyceride breakdown and reduced triglyceride storage in adipose tissue 
(Picard and Deshaies 2012). The altered dysregulation of triglyceride management in 
obese adipocytes could therefore contribute to increased triglycerides in the 
circulation, leading to ectopic fat deposition in other organs and their subsequent 
dysfunction (Bogdanovic, Kraus et al. 2015, Smith 2015). Carbohydrate degradation 
was also discovered to be significantly upregulated with tunicamycin treatment, 
whilst carbohydrate biosynthesis was significantly upregulated with the broccoli 
extract treatment. These two opposing outcomes highlight the differing effects of 
the treatments and could indicate one possible process through which broccoli 
reduces the impact of tunicamycin treatment. Finally, and most significantly, activity 
of the mevalonate pathway (Figure 6.4.1) was increased in cells treated with broccoli 
extract, either with or without tunicamycin. HMG-CoA reductase (3-hydroxy-3-
methyl-glutaryl-coenzyme A reductase), an enzyme involved in this pathway, was 
significantly upregulated; this is particularly noteworthy as tunicamycin is known to 
inhibit, or reduce the activity of, HMG-CoA reductase (Volpe and Goldberg 1983, 
Engstrom, Larsson et al. 1989, Larsson and Engström 1989). Statins, which target the 
mevalonate pathway to reduce cholesterol production, have been shown to promote 
ER stress (Chen, Wu et al. 2008, Mörck, Olsen et al. 2009, Lee and Kim 2013). It is 
therefore possible that as well as the primary mechanism by which tunicamycin 
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induces ER stress, through inhibiting N-linked glycosylation, tunicamycin may also 
induce ER stress through inhibiting HMG-CoA reductase and the mevalonate 
pathway. It should be noted, however, that in some cell types such as cardiac 
myocytes, statins have been shown to reduce ER stress (Li, Lu et al. 2017)  and further 
insights are therefore required in this area. Inhibition of the mevalonate pathway has 
also been linked to mitochondrial dysfunction (Tricarico, Crovella et al. 2015), which 
is consistent with present findings in these studies where tunicamycin induces 
mitochondrial dysfunction whilst broccoli extract protects against it.  
 
Figure 6.4.1 The Mevalonate Pathway: Broccoli extract (BE) activates the mevanolate 
pathway by significantly upregulating HMG-CoA reductase. The consequential upregulation 
of coenzyme Q10 could explain the protection against ER stress, ROS and mitochondrial 
dysfunction that has been observed with BE in these studies. Figure from (Mohamed, Smith 
et al. 2015). 
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Activation of the mevalonate pathway is known to improve mitochondrial function, 
inhibit oxidative stress and reduce ER stress (Deichmann, Lavie et al. 2010, Lee, Lin 
et al. 2012, Yubero-Serrano, Gonzalez-Guardia et al. 2012, Alam and Rahman 2014, 
Xu, Huo et al. 2017). It is therefore possible that the protective effect of broccoli 
extract that has been demonstrated throughout this thesis is due to its activation of 
the mevalonate pathway. This suggests that broccoli extract may have further impact 
on cellular metabolism, as upregulation of mevalonate pathway products, such as 
coenzyme Q10, have been associated with increased antioxidant activity, improving 
lipid metabolism, ameliorating obesity and suppressing lipid accumulation 
(Deichmann, Lavie et al. 2010, Lee, Lin et al. 2012, Yubero-Serrano, Gonzalez-Guardia 
et al. 2012, Alam and Rahman 2014, Xu, Huo et al. 2017). Furthermore, coenzyme 
Q10 is known to decline with age, with diseases such as T2DM, cardiovascular 
disease, metabolic syndrome and many more associated with this deterioration (Xu, 
Huo et al. 2017), highlighting the potential wider benefits of broccoli extract in 
preventing these diseases. Additionally, both mice and human studies have begun to 
examine the use of coenzyme Q10 in the diet as a supplement, with results showing 
inhibition of weight gain, reduction of white adipose tissue content, enhanced brown 
adipose tissue function and increased metabolic function amongst other positive 
effects (Xu, Huo et al. 2017). This has demonstrated that dietary coenzyme Q10 can 
suppress lipid accumulation and mitigate metabolic dysfunction. These present 
studies indicate that use of broccoli extract could enhance coenzyme Q10, and 
studies using coenzyme Q10 as a supplement suggest that this could have benefits in 
patients with T2DM (Shen and Pierce 2015). Therefore, examining the role of broccoli 
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extract in vivo would be of interest to examine its potential as an active cellular 
component to restore metabolic function. 
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6.5 Conclusion 
In summary, these data have provided an insight into the wider impact of 
tunicamycin on cellular health and have demonstrated that broccoli extract can 
protect not only against tunicamycin-induced ER stress, but also against the ROS 
production and mitochondrial dysfunction that ER stress leads to. This chapter has 
satisfied the final aim of this thesis, which was to examine the effects of broccoli on 
other mechanisms that also contribute to metabolic disease, such as ROS and 
mitochondrial dysfunction. In addition to this, analysis of mRNA through 
transcriptomics revealed the mevalonate pathway as a potential target through 
which the protective effects of broccoli are delivered. These data provide further 
evidence that a broccoli supplement may lead to improved cellular health, and 
suggest the mevalonate pathway as a potential target through which this may occur. 
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CHAPTER 7:  
Conclusions 
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This thesis explored how changes in the unfolded protein response (UPR) in human 
adipocytes varied over time following activation by an inflammatory stimulus, 
tunicamycin, and a treatment considered to reduce inflammation, broccoli extract. 
This time series experimental study allowed a mathematical model of the PERK 
pathway within the UPR to be designed and developed beyond solely using 
theoretical calculations as in previous studies (Trusina, Papa et al. 2008, Erguler, Pieri 
et al. 2013). Further experimental research also highlighted the protective effects of 
broccoli against ROS and mitochondrial dysfunction, as well as identifying a potential 
molecular pathway through which the broccoli extract may act.  
In order to begin the process of mathematically modelling the UPR, current 
mathematical models of the system were reviewed in order to gain insight into the 
ideal complexity of a model for this ER stress response. This also gave an 
understanding of the challenges associated with developing a model of a biological 
system of this level of complexity. Evidence for the role of broccoli and other 
Brassicas in the prevention of diseases was also reviewed to design appropriate 
experiments in order to gain new molecular insights into the stress response, as well 
as to provide data to support the mathematical modelling process. Following this 
review, standard cell culture and analytical laboratory practices were carried out in 
order to collect sufficient experimental data to develop and validate the 
mathematical model, as well as to investigate the effect of broccoli on various cellular 
mechanisms. This research identified several novel outcomes that provide new 
information into how the UPR responds over time.  Additionally, these studies 
revealed that the intensity of ER stress, as well as ROS and mitochondrial dysfunction, 
is reduced with the addition of a broccoli extract, potentially through activation of 
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the mevalonate pathway. This current thesis adds to the developing evidence of the 
health benefits of Brassicas on inflammation (Seow, Yuan et al. 2002, Hsu, Chow et 
al. 2007, Kirsh, Peters et al. 2007, Lam, Ruczinski et al. 2010, Youn, Kim et al. 2010, 
Bosetti, Filomeno et al. 2012, Hwang and Lim 2014, Jiang, Wu et al. 2014) and the 
potential impact that broccoli could have on cellular health by dissociating the impact 
of obesity and the subsequent induction of insulin resistance and T2DM. 
A literature review into current mathematical models of the UPR revealed two 
particular models of interest that highlighted the difficulty in selecting an appropriate 
size and complexity for a model of a biological system. Rutkowski et al. created a 
model that focussed on studying the differences in expression patterns of UPR 
proteins contributing to cell survival or cell death, and how the outcome 
subsequently switches from survival to apoptosis (Rutkowski, Arnold et al. 2006). 
This model was relatively small, considering only three proteins and their 
corresponding mRNAs. Additionally, each ODE only involved one linear synthesis 
term and one linear degradation term, when in reality the upregulation of proteins 
and mRNAs is much more complex than this. However, due to the small size of the 
model, experimental data were sufficient to parameterise it and the subsequent 
predictions did match the expression profiles of the data, suggesting that there is 
some accuracy to the model. The second relevant model, by Erguler et al., was also 
designed to study the switch in focus of the UPR from survival to apoptosis (Erguler, 
Pieri et al. 2013). Conversely to Rutkowski’s model, however, Erguler’s model 
involved a much wider range of UPR components, which prevented the process of 
parameter estimation using experimental data, resulting in a model that could only 
provide responses of a qualitative nature. Despite this, conclusions drawn from this 
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study identified how the presence of low, intermediate and high activity states of the 
UPR may determine whether cell survival or cell death becomes the desired 
outcome. It was also suggested that during the intermediate state, oscillations occur 
with both translation attenuation and apoptotic signals, which has not been 
proposed before. However, this was not confirmed in their study due to the lack of 
experimental data to support this hypothesis.  
Following this literature review, an initial mathematical model of the UPR was 
developed in an attempt to incorporate the benefits of both Rutkowski’s and 
Erguler’s models. In order to maintain biological detail without creating a model that 
was too large to be parameterised and validated with experimental data, only one of 
the three arms of the UPR was selected to be modelled. This ensured that the 
reactions controlling the expression of proteins within the pathway could be 
modelled as in Erguler’s et al. model, rather than only using one linear synthesis and 
degradation term per ODE as Rutkowski et al did, whilst keeping the model small 
enough to allow parameterisation with experimental data. This initial model, 
discussed in Chapter 4, was developed using experimental data over three time 
points. In order to improve the accuracy of the model, a comprehensive time series 
study was designed to provide more reliable, granular data. Using information on 
appropriate model complexity obtained in Chapter 4, an improved model was 
designed using a biological schematic to develop kinetic equations that were then 
used to create ODEs in Chapter 5. This is a technique often used when creating 
mathematical models of biological systems, and resulted in an improved 
mathematical model that qualitatively matched the biological data. As the 
mathematical model developed here represents a standard biological process that 
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occurs in multiple cell types, there is the possibility that the method used throughout 
this thesis could be generalised to other situations. This could include studying the 
effect of different BE concentrations on the pathway, or indeed other superfoods 
entirely, in a multitude of cells. The model could also be extended to include the 
effects of comparator drugs and inhibitors. However, limitations of the model and 
software must be acknowledged, such as the relatively low computer power 
associated with Berkeley Madonna, the dangers of overparameterisation, and the 
benefits of obtaining more biological data to support the model. 
 
Further to aiding the parameterisation and validation of the new UPR mathematical 
model, the data collected during this experiment revealed novel results with regards 
to the expression profiles of UPR proteins over time. As well as exploring the time 
frame over which proteins are expressed in response to tunicamycin, the expression 
of proteins involved in the translation attenuation system were discovered to 
oscillate over time. This was particularly interesting, as it had been predicted through 
Erguler’s et al. model of the UPR but had not been previously supported with 
experimental data. Thus, these data support the proposition of an intermediate UPR 
state whereby proteins in the translation attenuation system oscillate, as suggested 
by Erguler et al. (Erguler, Pieri et al. 2013). Analysis of the ODEs, including 
linearisation, steady state and asymptotic analyses can provide further information 
on the system, such as when it may reach an equilibrium state, how stable the 
equilibria are, and what the limiting behaviours of the system are. This would provide 
further information and confirmation that the model dynamics match the required 
known biological responses.  
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The studies in Chapter 6 were designed following a literature search that highlighted 
the positive impact that cruciferous vegetables, in particular broccoli, can have on 
diseases such as cancer and cardiovascular disease (Zhang, Shu et al. 2011, Bosetti, 
Filomeno et al. 2012, Tang, Meng et al. 2017). Investigating this further revealed that 
such vegetables can also reduce inflammation and improve damaging lipid profiles 
of humans (Clarke, Dashwood et al. 2008, Bahadoran, Mirmiran et al. 2012, 
Boddupalli, Mein et al. 2012, Jiang, Wu et al. 2014, Armah, Derdemezis et al. 2015). 
As such, this emphasised the potential of broccoli as a treatment to reduce the 
impact of ER stress that occurs in obesity and can lead to T2DM. Following the 
optimisation of a broccoli extract, a comprehensive time series experiment was 
carried out which revealed that the extract did not exacerbate physiological ER stress 
that occurs naturally within cells, but appeared to prevent such an intense induction 
of ER stress following treatment with tunicamycin. This effect was particularly 
apparent with mRNA and proteins expressed downstream in the UPR, such as CHOP, 
which is upregulated at the end of all three arms of the UPR. This study demonstrated 
the tight control over the expression of proteins such as BiP, which is the initial sensor 
of ER stress and acts as a switch for each of the UPR arms, supporting studies that 
suggest BiP expression is more tightly regulated at the post-translational level rather 
than at the transcriptional level (Gülow, Bienert et al. 2002, Takayanagi, Fukuda et 
al. 2013). These results established for the first time that broccoli could provide 
notable protection against the development of insulin resistance in cells exposed to 
inducers of ER stress, and revealed the potential for a broccoli supplement in the diet 
that could promote cellular health and reduce T2DM risk. This study did, however, 
lack a comparator drug known to reduce ER stress to allow comparison with the BE. 
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Most ER stress inhibitors affect specific proteins within the ER stress pathway, such 
as ATF6 and P-eIF2α, rather than the whole response. It may not therefore be 
suitable to compare BE treatment with a known inhibitor, although there is the 
potential to incorporate this into future experiments if a suitable inhibitor is 
identified. 
Following the results in Chapter 6, further studies were designed to investigate 
whether the protective effects of broccoli would extend to ROS and mitochondrial 
dysfunction. Whilst there is little evidence that tunicamycin itself can induce ROS and 
mitochondrial dysfunction, it is well known that these mechanisms can occur 
following ER stress (Cao and Kaufman 2014, Park 2014). The aims of the studies in 
Chapter 7 were therefore to determine firstly whether tunicamycin treatment can 
induce ROS and mitochondrial dysfunction in adipocytes, and secondly whether BE 
can protect against these mechanisms. Following cell culture experiments, it was 
determined that tunicamycin does induce ROS and mitochondrial dysfunction, 
confirming reports in the literature that ER stress, ROS and mitochondrial dysfunction 
are interlinked and that induction of ER stress can cause further cellular dysfunction 
(Tse, Yan et al. 2016, Zeeshan, Lee et al. 2016, Chen, Zhong et al. 2017). Whilst 
studying the effects of BE on these mechanisms, it was revealed that BE itself did not 
exacerbate the physiological levels of ROS or mitochondrial characteristics, but 
reduced the upregulation induced by tunicamycin. As such, it was concluded that BE 
not only protects against ER stress induced by tunicamycin, but also prevents further 
cellular dysfunction that occurs with the treatment. In order to gain insight into how 
BE may have such an effect, transcriptomics was carried out to examine RNA 
expression at the time point where BE had the most impact. This revealed the 
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activation of the mevalonate pathway in cells treated with BE, which is known to 
produce coenzyme Q10, a molecule with numerous cellular health benefits that has 
also been shown to inhibit weight gain (Deichmann, Lavie et al. 2010, Lee, Lin et al. 
2012, Yubero-Serrano, Gonzalez-Guardia et al. 2012, Alam and Rahman 2014, 
Garrido-Maraver, Cordero et al. 2014, Grenier-Larouche, Galinier et al. 2015, Xu, Huo 
et al. 2017). This is a novel insight that begins to explain the positive results 
demonstrated by BE treatment, and highlights the importance of this pathway. 
Whilst further work is required to confirm these results, the studies carried out in 
Chapter 7 support those in the current literature that suggest that Tunicamycin 
inhibits HMG-CoA reductase - the enzyme within the mevalonate pathway that is 
specifically upregulated by BE (Volpe and Goldberg 1983, Engstrom, Larsson et al. 
1989, Larsson and Engström 1989). It is therefore possible, as demonstrated in 
Chapters 6 and 7, that BE provides protection against tunicamycin-induced ER stress, 
ROS and mitochondrial dysfunction through activation of the mevalonate pathway, 
which would otherwise be inhibited by tunicamycin treatment. The results in this 
thesis have therefore fulfilled the aims set out in the Thesis Outline and in section 
1.3. 
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7.1 Limitations 
As with all studies, there were certain limitations in this thesis that would need to be 
accounted for in any future work. For instance, whilst Berkeley Madonna suited the 
mathematical modelling carried out here, in order to continue studying and 
expanding the pathway, tests across computer software packages should be 
undertaken to determine which package may be best to proceed with. This is 
required to reduce the time taken for the software to solve the ODEs making up the 
model. The model should also be validated further using data from experiments with 
different treatments, e.g. the BE, Tun or BE+Tun data, giving increased credibility and 
reliability to the model. It may also be possible to carry out population studies once 
enough data have been collected, utilising the biological replicates for each time 
point in order to do so. 
Due to the complexity in the nature of modelling a cellular system with experimental 
data, a cellular model was used that provided consistency and reproducibility across 
time and events. In one aspect, this supported the development of a mathematical 
model, but caused a limitation in another by not utilising different patient based 
human adipocytes and therefore was not able to view the variability across patients 
with different BMIs, ages or metabolic conditions.  There was the possibility to utilise 
human samples, but the level of variability in responses, as noted in previous simple 
measurements of adipokine release (Fain 2010, Lehr, Hartwig et al. 2012) (Kusminski, 
da Silva et al. 2007), was considered unfeasible without first defining the model more 
clearly.   
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The time series data allowed a much more detailed analysis of change compared to 
prior studies, however it would have been interesting to follow certain key proteins 
continuously across time to examine the time series changes in even more subtle 
detail. The complexity of trying to gain continuous expression data for multiple 
proteins across time, even using a fluorescent system within confocal microscopy as 
an example, however, would not have given sufficient quantitative insight into 
changes. Furthermore, the time frame over which data could be collected would 
need to be much shorter due to technical limitations with cell viability in such a 
process.  
The optimisation of BE concentration could have been improved by carrying out a 
full dose-response curve experiment, rather than just looking at three 
concentrations. Similarly, a better insight into the activity of BE could have been 
obtained by comparing it to known inhibitors of ER stress. A potential problem with 
this is that most ER stress inhibitors inhibit specific proteins within the pathway, 
rather than the whole response, however this could provide information on which 
part of the pathway is most affected by BE. 
Due to a lack of time, the transcriptomics analysis was not as detailed as it could have 
been. There is a multitude of information that can be obtained from such analysis, 
and one comparison that would add to these experiments is the direct comparison 
between Tun and BE+Tun data, rather than comparing them both to control data and 
subsequently defining the differences between them. Further analysis, including this 
direct comparison, can be carried out in future work.   
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7.2 Future Work 
The work in this thesis has highlighted several areas which it may be beneficial to 
study in the future. Firstly, developing mathematical models for the ATF6 and IRE1 
arms of the UPR using further experimental data may be beneficial in order to gain a 
broader perspective of how the response changes over time. Following model 
parameterisation and validation, it may then be possible to combine and couple the 
sub-models and form one that represents the whole unfolded protein response that 
has been parameterised with experimental data. Using a different computational 
system such as Matlab, as well as collecting more data for the testing and validation 
processes may be required in order to do this. The lack of accurate parameterisation 
has been a constant problem in prior mathematical models of the UPR and this work 
represents the potential to create a validated model of the whole UPR that could be 
used to aid further experiments.  
Secondly, the model in this thesis could be used to compare how dynamics of the 
PERK pathway are altered when BE treatment is present, both with and without 
tunicamycin. Comparing the differences in parameter values between treatments 
could provide information on which protein interactions are altered by the presence 
of BE. This could further our understanding on how BE specifically affects processes 
within the UPR.  
Additionally, to understand how BE has broader impacts in the cell, the theory 
proposed in this thesis that BE activates the mevalonate pathway could be examined 
further. qRT-PCR could be undertaken to investigate the presence of gene transcripts 
involved in the pathway across treatments to confirm whether genes within the 
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mevalonate pathway are truly upregulated by BE. Further analysis of the 
transcriptomics data could also be undertaken to see if there are other genes or 
pathways specifically altered by BE treatment. 
In order to gain more information on the effects of BE across the cell, confocal 
microscopy work could be used to assess mitochondrial dynamics, both in terms of 
fusion and fission, and mitochondrial associated membranes (MAMs) between ER 
and mitochondria. Studying fusion and fission would highlight any mitochondrial 
elongation and fragmentation occurring which could provide information on 
mitochondrial dysfunction and cellular health (Westermann 2012). Similarly, the 
number of MAMs increase when cells experience ER stress (Carreras-Sureda, Pihán 
et al. 2017). As such, investigating MAMs through confocal microscopy could provide 
further evidence that tunicamycin induces ER stress and has implications on 
mitochondrial function, and that BE prevents this stress and any subsequent impact 
on mitochondria. The use of known ER stress inhibitors may aid in these experiments 
to allow valid comparison with the effects that BE treatment has on the cellular 
systems. 
Finally, there is the potential to explore how the UPR differs between lean and obese 
cellular adipocyte populations. Using a defined age and BMI would provide 
consistency that may allow the mathematical model developed here to provide 
information on which parameters are altered due to the lean or obese cell type. 
Following this, the impact of using a BE treatment on these cells could be investigated 
to determine how the lean or obese cell type affects the protection that BE has 
shown in these studies.  
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7.3 Final Conclusions 
In conclusion, this thesis has researched how the expression profiles of proteins 
within the UPR vary over time following treatment with tunicamycin, utilising both 
biological and mathematical modelling techniques, as well as investigating the 
protective effects of broccoli against ER stress, ROS and mitochondrial dysfunction. 
The outcomes of this study are as follows: 
1. The production of a mathematical model of the PERK pathway of the UPR 
which qualitatively matches experimental data. 
2. Identification of novel oscillating expression profiles of proteins involved in 
the translation attenuation system that support Erguler’s hypothesis of an 
intermediate stress state. 
3. Evidence that broccoli extract reduces the impact of tunicamycin on ER stress, 
ROS and mitochondrial dysfunction, possibly through activation of the 
mevalonate pathway. 
Collectively, these findings meet the initial thesis aims and suggest that broccoli 
supplementation may be beneficial in preventing cellular dysfunction in cells exposed 
to stress. These initial results are promising and may represent the possibility of 
disconnecting obesity and T2DM, through the manufacturing of a freeze dried 
broccoli powder that is available to the public. This would have a substantial 
worldwide impact, with emphasis on healthcare, wellbeing and diet – areas that, with 
650 million obese adults and 422 million people suffering from diabetes worldwide 
(World Health Organisation 2016, World Health Organisation 2017), are vital to 
improve. In order to confirm these findings, further research would be required to 
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determine the outcome in specific in vivo investigations. If successful, clinical trials 
would then need to be carried out to analyse the outcomes in humans.  
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